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Chapter I 
INTRODUCTION AND OBJECTIVES 
1. Quality Assurance (QA) 
1.1. Objectives of QA 
Unreliable laboratory results may have 
serious consequences for the health of 
individuals or communities. The main objectives 
of QA are to provide reliable laboratory data 
in all health care activities and to ensure 
comparability of results, particularly in 
epidemiological investigations, health surveys, 
environmental monitoring , medical research and 
other public health activities. In the direct 
clinical care of patients the objectives are to 
improve the accuracy of clinical diagnosis and 
therapeutic monitoring, to reduce health care 
costs, to provide a basis for the continuing 
education of physicians and laboratory 
scientists in scientific methods of 
investigation, laboratory organization and 
management, and analytical techniques (1}. 
1.2 Justification of terminology in QA 
The choice of terms should be governed by 
a knowledge of the underlying principles and 
objectives and by an understanding of the 
effects that words can have on people's 
thoughts and actions. In this thesis we adopt 
an amended (!FCC) terminology, as recently 
recommended by members of a WHO working group, 
including haematologists (l-5), and as adopted 
by ECCLS in their "proposed standard for 
quality assurance" ( 27). They point out that 
the well-known !FCC term "external quality 
control" (3) is a misnomer in that it 
provides retrospective quality assessment 
rather than control over results of a 
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particular laboratory. On the other hand the 
total set of procedures defined by IFCC as 
"internal quality control" does indeed exert 
"control" over results released by a 
laboratory ( 2, 4). "Control" involves internal 
assessment of quality plus the measures taken 
within the laboratory to maintain and/or 
improve quality. Internal quality control and 
external quality assessment are two, 
fundamentally different components of a 
comprehensive quality assurance programme. The 
three terms are defined as follows (2,4l: 
- Internal quality control (IQC) is the 
set of procedures undertaken by staff of a 
laboratory for continuously assessing work and 
results in order to decide whether they are 
reliable enough to be released together with 
the implementation of measures to maintain 
and/or improve the quality. 
Thus, quality control procedures have an 
immediate effect and should actually control 
as opposed to merely examining - the 
laboratory's output (2,4). 
-External quality assessment (EQA), 
which term should be used in preference to 
"External quality control", refers to a system 
of objective checking laboratory results by 
means of an external agency. The checking is 
necessarily retrospective and the comparison of 
a laboratory's performance on a certain day 
with that of other laboratories cannot be 
ascertained until some time later, so this 
comparison will not have any influence on the 
test laboratory's consistency but will 
establish between-laboratory comparability. 
(2,4,5). 
- Quality assurance (QA) comprises the 
constant practice of IQC, participation in EQA 
schemes and a further series of monitoring, 
education and training systems concerned not 
only with specimen examination but also with 
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specimen collection, transport and handling and 
with methods for reporting of results. The term 
"quality assurance" does not imply that 
perfectly reliable results can be "assured" at 
all times, but that a systematic effort is 
being continually made towards achieving the 
highest poss~ible quality of performance ( 2, 4). 
A large number of organisations other 
than the IFCC are engaged in defining 
terminology: BCR, BIPM, ECCLS, ICSH, ISO, 
IUPAC, NBS, NCCLS, WHO, just to mention a few! 
This has resulted in a wide variety of 
definitions for the same concepts and terms, 
often dependent on the special requirements of 
the specialty concerned. There is a great need 
for standardisation in terminology. However, 
since we cannot possibly contribute to a 
solution to the confusion of terms, in this 
thesis we adhere to the IFCC terminology, a 
glossary of which is compiled in Ref {3). 
2. Haemocytometry (Hey) 
2.1 Clinical significance of haemocytometry 
Haemocytometry (Blood cell counting and 
sizing) has been an established diagnostic tool 
of paramount clinical importance for many 
decades. Since modern clinical haem. textbooks 
(6,7) extensively deal with the clinical 
significance of hey we shall, for the sake of 
brevity, refrain .from reviewing the more common 
aspects of the subject. Consequently, we shall 
only briefly highlight here some features of 
recent clinical progress. 
Modern therapeutic treatments add to the 
ever growing demand by clinicians for an 
expanded range of blood cell tests of superior 
precision and accuracy (8,9). This applies 
especially to the low ranges of both wbc and 
plt counts where therapeutic decisions are 
based on relatively small changes of these 
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quantifications (e.g. transfusions, cessation 
or resumption of chemotherapy, radiotherapy 
etc.) (8,9). Reviews on the great clinical 
importance of low (10-12) and high MCV (12) 
have recently been updated. An improved 
classification of anaemias based on MCV, RDW 
and rbc-histograms has recently been proposed 
(13-15). Studies on the significance of plt 
characteristics have only recently begun to 
appear in the literature (16-22). 
Hey is also of great importance in a 
quantitative sense. Some 100.000 comprehensive 
(eight-parameter) blood cell determinations per 
year are performed in the haem. departments of 
our 860-bed hospital. It has been estimated 
that over 10 million full blood counts are 
carried out in the world each day (23). 
Other aspects of the clinical 
significance of hey will be dealt with in Ch 
II, S 4.2. and inCh III. 
2.2. Progress in flow haemocytometry. 
The advent of advanced multiparameter 
instruments for high-speed analyses of blood 
cells in a fluid suspension (flow haemocyto-
metryl has revolutionized the operation of the 
modern haem. laboratory. Breakthrough 
improvements such as hydrodynamic focusing, 
pulse editing and sweep flow application (24) 
(Ch Ill) enable the simultaneous enumeration 
and characterization of wbc, rbc and plt and 
contribute to better quality of the 
measurements of cells and their characteris-
tics. While increasing the operational simpli-
city these major fluidic and electronic im-
provements have yielded so-called eight-para-
meter instruments of improved performance (9). 
They provide excellent resolution, greater pre-
cision and linearity, less carry-over, faster 
analysis rates and better cost efficiency than 
the now obsolescent older-generation, automated 
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haem. analyzers (9). Additionally, these 
instruments have the potential to provide 
increased information on hitherto unexploited 
cellular parameters. They eventually may prove 
of relevant or even vital clinical importance 
in the diagnosis, evaluation, treatment and 
therapeutic monitoring of haem. diseases (15-
22). Furthermore, the implementation of these 
instruments enable laboratories to cope with 
the ever growing clinical demands for quick and 
better-quality blood cell analyses over the 
entire, wide range of haem. values (8,9) (Ch 
III l. 
3. Problems of haemocytometry: QA 
The progress in instrumentation described 
above forms the basis for future perfection. 
However, advancement in instrumentation has 
exceeded that of QA (24,25). In fact, QA 
techniques should be brought to the same high 
level as the instrumentation. The poor state 
of the art of QA can be attributed to the 
following facts: 
a. Calibration techniques have not kept 
pace with the improvement in precision (25). 
Despite the joint efforts of many international 
bodies ( 26) "definitive" and ref preparations 
and methods do not (yet) exist in haem. with 
the exception of the lib-determination (26) (Ch 
II l. 
b. 
attention 
conditions 
Insufficient knowledge of and/or 
to the influence of numerous other 
on haem. values :e.g. sampling, 
transport, storage, interpretation errors, 
physiological and pharmacological influences 
(Ch II). 
c. Incompatibility between results of 
instruments based on different principles (23) 
(Ch III). 
The d. 
literature on 
almost complete 
the preparation of 
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absence of 
medium-term 
multiparameter internal quality control (IQCl 
materials, let alone standards (Ch IVl. 
4. Outline and objectives of this thesis 
The objectives of this thesis are: 
a. to review the state of the art, the 
concepts, the problems and the perspectives of 
comprehensive QA in hey (Chapters II and III); 
b. to study the basic principles and 
problems of cell counting and sizing and the 
recent progress in approaching these problems; 
to describe the fluidic and electronic impro-
vements in modern instruments, enabling the 
simultaneous measurement of wbc, rbc and plt 
and their characteristics, with special 
reference to the Coulter Counter Model S Plus-
II (Ch IIIl; 
c. to develop IQC materials of medium 
and/or long-term stability with special 
emphasis on ease of preparation and low costs, 
thus contributing to optimization of IQC (Ch 
IV l. 
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Chapter g 
STATE OF THE ART OF QUALITY ASSURANCE (QA) IN 
HAEMOCYTOMETRY 
L Introduction 
"There is no simple over-all answer, 
and any answer that we find will be 
temporary, depending on the progress 
of medical knowledge and technology" 
R.N. Barnett 1968 (1) 
Haemocytometric testing has many 
important functions. It generally provides 
essential data in the processes of diagnosis, 
prognosis, disease and drug monitoring as well 
as delineation of risk factors. 
In order to assure High-Standard 
Laboratory Performance (HSLPl (2), Quality 
Assurance (QAl (3) should be an integral part 
of the activities of the haematological (haem. l 
laboratory. Achieving and maintaining HSLP in 
haemocytometry (hcyl is a challenging task, 
further compounded by the need to provide the 
test results quickly, cheaply, and at anytime 
day or night, including weekends and holidays. 
Simply stated, HSLP requires obtaining an 
adequate specimen which is handled properly, 
analyzed reliably and interpreted correctly 
(2,4). HSLP should apply to: 
a. the pre-analytical phase 
- requisition of the proper 
- correct preparation of 
appropriate drawing, 
administration, transport 
the blood specimen 
b. the analytical phase 
test(s) 
the patient and 
collection, 
and storage of 
- careful monitoring and checking of 
precision and accuracy of the measuring 
instrument(s) in internal (IQC) and 
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external (EQAl programmes 
c. the post-analytical phase 
- appropriate recording and reporting of the 
results 
- appropriate interpretation, follow-up and 
decision making 
Besides, HSLP should encompass favourable 
cost-benefit conditions, an important aspect in 
these days of consumerism and governmental 
budgetary measures in the medical discipline. 
In this Chapter we shall elaborate on 
most of these different aspects of 
comprehensive QA in hey with special emphasis 
on the analytical problems. 
2.Pre-analytical phase 
Although somewhat taken for granted, the 
blood specimen is the centre piece of all our 
efforts, since, quite obviously, the best 
analysis is worthless if done on an improper 
specimen. HSLP in hey requires constant 
vigilance in order to assure the integrity of 
the specimen. In many instances we tend to 
become so absorbed in the analytical process 
that we gloss over the fundamental principles 
that deal with obtaining an adequate specimen 
(2,5,6). These principles comprise the 
appreciation and assessment of the sources of 
error inherent in the requisition of tests, the 
preparation of the patient and the drawing and 
processing of the specimen before the actual 
analysis. Consequently, it is imperative for 
HSLP that the entire pre-analytical process be 
in the hands of experts, these being either 
laboratory technicians or professional 
phlebotomists (2,7,8). 
The requisition is usually considered to 
be the respons1bility of the attending 
physician. In general however, HSLP is served 
best when there is a close cooperation between 
the physician and the laboratory in deciding 
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the best choice of tests (2,9,10). Since 
requisition and interpretation of tests are 
closely related, these topics are discussed in 
the post-analytical Section on interpretation 
(S 4). Influences of the requisition pattern on 
laboratory costs will be dealt with in S 5. 
The adequate preparation of the patient 
is of special significance in obtaining a good 
specimen (7,8). It has been repeatedly 
emphasized that standardization of blood 
sampling is a prerequisite for minimizing the 
variability of (haemocytometric) values. 
Differences in Hb, Hct, WBC and rbc values of 3 
- 8% due to posture of patients during 
venipuncture have been described (5,11,12). 
These differences are recognized by ICSH (the 
International committee for Standardization in 
Haematologyl and IFCC (the International 
Federation of Clinical Chemistry). They are 
reflected in a joint document proposing an ICSH 
standard procedure for blood specimen 
collection for ref values either for people 
confined to bed or for those who are ambulant 
(13). Blood specimens obtained by venipuncture 
on ambulant persons while applying moderate and 
short term stasis (60 mm of mercury during 60 
seconds) have 6 - 8% higher haemocytometric 
values than those obtained from the same 
persons in a recumbent position for 15 min. 
without stasis (11). Immediately after 
strenuous exercises increases of Hct, Hb and 
RBC up to 10 - 30% due to decreases of plasma 
volumes were found depending on the intensity 
and duration of the exercises and ambieng 
temperature(5). Leucocytes even up to 50xl0 
wbc/1 were found under these conditions (5)! 
Quite obviously recent blood transfusions will 
have their bearing on haemocytometric values. 
Notably higher MCV and RDW-values (in the 
Coulter s Plus II) due to bimodal rbc 
distribution are clearly demonstrable after 
transfusions into microcytic patients (14). 
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Large variations due to the time of sampling 
were observed for the wbc-count (5,15). Veni-
puncture specimens are strongly preferred to 
fingerstick blood. Fingerstick specimens not 
only have Hb-values discrepant to venous 
specimens, but, more importantly, the precision 
of blood drawing is clearly worse (about 3.5%) 
than with venipunctures (about 1.7%) (5,16-18). 
Comparable problems apply to WBC, RBC, Hct and 
PLT (5,16-19). Similarly, several studies have 
shown that Hb and Hct determinations in 
specimens from earlobe punctures give erroneous 
results and show unacceptable variability 
(5,20). 
The collection and careful administration 
of a specimen for hey deserves special 
attention (2,5,7). Possibilities of error are: 
- incorrect patient and/or container 
identification 
- usage of incorrect needles causing 
inappropriate flow rates (21) 
- use of the wrong anticoagulant: e.g. 
oxalates and heparine are less suitable 
than ED'rA 
- delayed or inadequate mixing with the 
anticoagulant 
- insufficient container filling leading to 
too high EDTA concentrations with 
concomitant MCV decreases (22) 
- failure to examine for clots 
- inhomogeneous-blood spill due to leakage of 
containers 
- delayed delivery 
Little attention has been given to 
detecting or minimizing laboratory blunders. 
Yet the clinician is much more likely to be 
aware of, and the patient more likely to suffer 
from, laboratory blunders than from small 
analytical variations. The "blunder rate" is 
variously estimated at about 2% (sic!) (23-25). 
No adequate solutions have yet been reportad to 
further reduce this most serious phenomenon. 
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Long distance transport and storage of 
blood specimens are limited by the instability 
~iai:ho!e ~~~~f1i~~26~~8 lthr~~hl~a;; :~· <~6b 
provided the blood is intermittently mixed. 
However, these observations are challenged by 
Simmons, who mentions a stability of 8 hours at 
room temperature and of 24 hours at 4°C (28). 
Pneumatic tube transport does not influence the 
blood parameters <29). 
A last, most important factor 
contributing to the overall quality of 
performance should be mentioned here. Technical 
expertise, experience, attitude, continuing 
education, organisation and general working 
conditions <job satisfaction, work-load, 
stress) of the personnel ultimately determine 
the quality of the laboratory (2,4,8,30,31). 
The impact of workload and stress is 
intuitively felt to be important. Performance 
in an EQA scheme has recently been inversely 
correlated with workload over a period of four 
years (p < O.Oll (32,33). The most frequent 
source of stress was found to be pressure for 
immediate results, the most intense stressor 
was shown to be lack of communication (34). 
In conclusion, this Section on pre-
analytical QA clearly demonstrates that the 
reliability of haemocytometric tests can be 
<grossly) affected by many factors beyond the 
actual functioning of the instrumentation. 
These factors should be fully appreciated and 
should be subject to QA no less stringent than 
that for the analyses proper (2,4,5,30,31). 
3. Analytical phase 
3.1 Basic problems of analytical QA 
3.1.1. General problems of calibration and 
IQC 
The classical study of Belk and Sunderman 
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in 1947 (35) on the accuracy of analyses in 
chemical laboratories led to a wide variety of 
activities in the area of laboratory perfor-
mance evaluation. Many of the problems in 
achieving optimal precision and accuracy have 
been addressed in a series of recommendations 
on QC prepared by the !FCC (36-41). They deal 
with general principles and terminology (Part 
ll, assessment of analytical methods for 
routine use (Part 2), calibration and control 
materials (Part 3), internal QC (Part 4), 
external QC (Part 5) and quality requirements 
from the point of view of health care (Part 6). 
Moreover, several papers (42-45) and extensive 
overviews on analytical QA have recently been 
published (46-48). 
The concepts of accuracy and precision 
are often elucidated using the results obtained 
by a champion-shot and an ordinary-shot, both 
using the same excellent and the same inferior 
rifle. (Fig. l; Courtesy B.Leijnse- 44). It is 
a very good example. It illustrates how by 
craftmanship and superb quality of instruments 
the production process is improved by way of 
correcting the assignable cause of error, thus 
reducing the influence of chance on variation, 
and it also demonstrates that some stable 
system of chance causes is inherent in any 
particular scheme of production. However, an 
important difference between haem. and clinical 
chemical analyses on the one hand and 
markmanship on the other hand must not be 
overlooked. For the marksman the middle of the 
target is the true mark to hit. Therefore a 
rifle can be adjusted without any reasonable 
doubt, whereas in chemical analysis and hey 
such a certainty cannot be achieved even with 
the use of ref material of the highest quality. 
One is not sure that the assigned value equals 
the true value (44,49). 
The main statistical tool employed in IQC 
is the control chart, introduced in clinical 
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chemistry by Levey and Jennings in 1950 (50). 
This technique was derived from the pioneering 
work of Shewhart on IQC in industry in the 
thirties (51). The main principle of his method 
is stated briefly: Measured quality of 
manufactured product is always subject to a 
certain amount of variation as a result of 
chance. Some "stable system of chance causes" 
is inherent in any particular scheme of 
production and inspection. Variation within 
this stable pattern is inevitable. The reason 
for variation outside this stable pattern may 
be discovered and corrected. An excellent 
example of this train of thought is the well-
known Youden technique applied in clinical 
chemistry and haem. to detect systematic errors 
(S 3.4) (44-45). 
CHAMPION SHOT OR!lNARY SHOT 
=ruEm~m ~' ~' 
INFERiffi .FLE ~' ~-, 
Fig 1. !: accuracy and precision, 2: accuracy and :mprecisior,, 
3: inaccuracy and precision, 4: inaccuracy and imorec1sion. 
In many respects, IQC programmes are 
similar for all disciplines, but in hey there 
is a particular problem because of the 
difficulties in establishing ref preparations 
owing to the instability of blood cells, and, 
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except for Hb, the lack of suitable ref 
preparations. While precision has dramatically 
improved with the advent of electronic cell 
counters, the need for ref preparations for the 
blood count has become of paramount importance. 
Unfortunately, the accuracy of blood cell 
counting cannot be simply tested by a pulse 
generator. While this testing can have value in 
verifying that the electronic calibration of 
specific instruments has not changed, it does 
not include testing of the aperture current in 
aperture-impedance systems such as Coulter 
counters nor does it detect the sensing zone 
changes which occur as a result of blockage, 
protein build-up, or variation in vacuum. 
Temperature variations will affect the blood 
flow rate through the sensing zones. The pulse 
shapes created by cells passing through these 
zones will be complex and varied. Constant 
square wave pulses as produced by pulse 
generators would give totally misleading 
information (52,53). 
Most routine blood cell counting 
instruments are, in effect, comparators that 
can be adjusted arbitrarily (53,55) (Ch III, S 
3.2). This means that to obtain a true 
measurement on an instrument which will be 
comparable with that on another instrument or 
by another method, it is essential to calibrate 
the instrument; this requires ref preparations 
with assigned values of defined accuracy (55). 
However, apart from the official ICSH Hb 
standard, ref preparations do not exist. 
The urgent need for standardization and 
QA in haemoglobinometry was dramatically 
demonstrated in an international inter-
laboratory trial undertaken by the Dutch 
Institute of Public Health in 1962. 
Participating laboratories, including the most 
eminent in Europe, reported the Hb cone of the 
same blood specimen between ll and 18 g/dl 
(56). . 
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The classical work of Van Kampen and 
Zijlstra in the early sixties on the 
standardization of haemoglobinometry brought a 
fundamental change in this field (57). Their 
precise and accurate optical density 
measurements and iron analyses on purified Hb 
solutions led to the establishment of the 
millimolar extinction coefficient of 
haemiglobincyanide (HiCNl at 540 nm as 11.0, 
while the relative molecular mass of Hb was 
calculated by Braunitzer to be 64458. On this 
basis, ICSH established recommendations for the 
Hb ref method and ref preparations (58). 
In 1976 Van Assendelft et al. summarised 
the results of an inter-laboratory trial as 
follows: " In haemoglobinometry grave errors 
are still being made though an internationally 
accepted standardised method is available for 
the determination of the Hb content of blood " 
(59). They point out also that concentrated Hb 
solutions have become available recently, 
making it possible to control the dilution and 
conversion steps of the HiCN method. Using both 
HiCN ref solutions and concentrated Hb 
solutions, as well as checking the cyanide 
content of the reagent used, an acceptable 
intra-laboratory control programme may be set 
up. The within-run and between-laboratory im-
precisions obtained were 0.6-0.9% and 2.9-3.3%, 
respectively (CV's). The work of Van Kampen, 
Zijlstra and others has brought substantial 
improvement in the quality of Hb measurements. 
Even the CV from 2.9 to 3.3 % found in the 
inter-laboratory trial mentioned is for a large 
part assignable. The photometry error has been 
estimated to account for about one-half of the 
total error, diluting errors for the other 
half. Elimination of these assignable causes of 
erratic fluctuation is possible and after that 
the process is under control. In that case a CV 
of 1% is within reach. The progress made in 
haemoglobinometry shows that the application of 
26 
ref methods and ref materials in inter- and 
intra-laboratory QA trials produces a 
substantial improvement. The assignable causes 
of quality variation can be separated out much 
better if ref values are used than if only the 
all-method mean value is available. This makes 
the diagnosis and correction of difficulties 
easier and improves the quality. Moreover the 
second object of Shewhart's technique is 
achieved. By identifying certain quality 
variations as inevitable chance variations, we 
know when to leave an analytical process alone 
and thus prevent unnecessarily frequent 
adjustments which tend to increase rather than 
decrease the variability of the process (44). 
The beneficial effect of standardization and 
IQC was also shown in the remarkable reduction 
in CV for the measurement of Hb in succesive 
years by laboratories in the United Kingdom: 
when the UK external quality assessment (EQA) 
scheme was started in 1963 the cv for this 
estimate was 7 to 8% but this has been 
progressively reduced to only 1.3% in the 
period 1975 - 1979 (55). The same dramatic 
improvement was observed in the United States 
College of American Pathologists (CAP) Survey 
Programme: whereas Belk and Sunderman observed 
in Pennsylvania in 1945 that less than half of 
the laboratories could come within 1 g/dl of 
the "true" Hb value (35), in 1975 the time had 
come to set the performance limits for Hb at 
approx. 0.3 g/dl (0.2 mmol/1) for good results, 
thus approaching the limits of known accuracy 
and precision of the ICSH-method (43). 
The urgent need for calibration and IQC 
and EQA in cell counting and sizing was 
recognized during a workshop in cell counting 
instruments at the Physikalisch Technische 
Bundesanstalt (PTB) of the Federal Republic of 
Germany in 1981. Simultaneously, and under 
equal conditions, one fresh blood specimen was 
repeatedly (4x within-; 4x between-series) 
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analysed with different counters which were 
operated by manufacturers or service engineers. 
In contrast to the high precision of many 
instruments, the variation of the means is 
substantial (Fig. 2) (60). In a second series, 
control blood specimens from several 
manufacturers were analysed instead of fresh 
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concentration. Experimental workshoo in cell counting instruments 
(Berlin 1981) (Courtesy R. Thom, Calibration in haematolc.gy. !n: 
S.B.Rosalki. New approaches to Laboratory Medicine. SIT Verlag, 
Darmstadt, 1981) 
blood. The relative difference in % between the 
labelled value and the mean of measurements of 
all participants varied from -15 to 7.5% for 
wbc-substitutes and from -3 to 15% for MCV 
(60). The incompatibility between simulated 
wbc, stabilized rbc and reagents was apparently 
not recognized by several operators (cf Ch III, 
s 3.4.3.6). 
There are serious difficulties in 
preparing ref preparations, and no true ref 
preparation for blood counts is yet available. 
Ideally the material should closely resemble 
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blood in its physical characteristics with 
regard to cell numbers, size, shape, electrical 
conductivity, homogeneity, viscosity and 
rheology (55). Unfortunately, materials which 
are sufficiently stable to serve as a long-term 
calibrator do not have the physical properties 
of blood, while natural blood is not 
sufficiently stable to be useful for this 
purpose (55). Moreover, an instrument 
calibrated for counting blood cells of one 
size, may not properly count cells of another 
size, if it is not linear in its response to 
cells of varying sizes (55). Furthermore, 
different instruments may differ in 
measurements of MCV on the same blood specimen, 
if they use different principles CCh III) 
(55,66). This has been demonstrated in inter-
laboratory comparisons of counters which use 
light scattering CTechnicon Hemalogl, 
conductivity (Coulter) and laser light 
diffraction (Ortho-counter) (55,66). 
Materials which have been tried as 
potential standards fall into three main groups 
(55): 
a. biological materials such as pollens, mould, 
spores, yeasts. They tend to be too 
heterogeneous with regard to size and have 
never proved suitable. 
b. artificial materials such as polysterene 
latices and other plastic polymers. These are 
undergoing study by a number of Cinterlnational 
bodies (vide S 3.6). 
c. natural blood cells which have either been 
preserved or modified by fixation in glutar-
aldehyde or formaldehyde. Fixed cells have, for 
years, given consistently reproducible 
measurements of cell numbers and size 
distributions. Unfortunately, there is a major 
disadvantage in using these cells as a ref 
preparation. There is a tendency for fixed 
cells to clump and to adhere to the walls of 
the containers, so that unless the sample is 
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meticulously resuspended, non-homogeneity may 
arise and lead to loss of accuracy and 
precision. In fact, undiluted fixed cells are 
not suitable for use in fully automated systems 
(61). Furthermore, the rigidity of fixed cells 
results in erroneously high micro-haematocrit 
values due to increased trapped plasma.(cf Ch 
III). 
Preserved natural blood cells are not 
stable enough to be regarded as a long-term 
calibrator. However, these materials are useful 
as controls to check the precision and reliable 
functioning of a cell counting system over 
relatively short periods of time (55,61-63). 
Ch IV extensively deals with attempts to 
prepare control materials for IQC in hey. They 
serve three basic purposes of IQC. 
a.Process control, to be executed "ad hoc" by 
running the 
the results 
the technician by regularly 
material and instantly judging 
obtained (2,4). 
b.Retrospective IQC by 
the "Q.C. officer" 
proficiency attained 
between-day periods 
(2,4,8,30,46,48,50). 
the haematologist or by 
by evaluation of the 
both in within-day and 
(Shewhart charting) 
c.Blind controls to assure optimal IQC. This 
is done by regularly interspersing and 
evaluating results of other preparations of 
known composition, disguised as routine 
patient specimens within routine sample-
series. The t'endency to (solely) delegate 
this type of control to EQA schemes 
threatens the alertness and readiness of 
action of the laboratory (39,100). 
In short these materials are intended to 
contribute to the essence of IQC: continuous 
self-auditing and continuous---attempts at 
improving performance. 
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3.1.2 Specific problems of IQC of individual 
blood cell parameters 
3.1.2.1. Errors due to abnormalities of the 
blood specimen 
Cornbleet (22) has recently reviewed the 
sources of error in cell counting and sizing 
due to abnormalities of blood spec~mens. 
Serious rbc-count and rbc-parameter errors may 
be caused by specimens with a. cold agglutinins 
(4,22,64) b. positive Coombs' test (22,65) c. 
paraproteinaemia, opaque or strongly coloured 
plasma, d. haemolysis e. high WBC, f. giant 
platelets, g. microcytic rbc, h. clotting etc 
(22). The main sources of erratic results in 
wbc counting are a. cold agglutinins (22,64) b. 
aggregates (22,69,83,84) and c. the presence of 
nucleated red cells (22,83,84). Errors due to 
carry-over have been resolved in modern flow 
hey instruments (66). For the cause of brevity, 
we refer to References <22, 64, 83, 84) for a 
full account on the subject. Spurious 
elevations of electronicly determined MCV and 
Hct caused by hyperosmolarity have recently 
been reported in hyperglycaemia and diabetic 
ketoacidosis (70,71). An under-estimation of 6-
7% of Hct in polycythaemic patients was 
described for Coulter S and S-Plus instruments 
compared with micro-haematocrits corrected for 
trapped plasma and a radioisotope dilution Hct 
(72,73). This is in accordance with the 
observations of England and Down (74) and 
Arnfred et al. (75) that the MCV is not 
accurately measured by electronic counters when 
the rbc are hypochromic and microcytic (see Ch 
III). Spuriously elevated plt counts (mostly 
accompanied with abnormal MCV and/or instrument 
error code flagging) were described in cases of 
acute burns due to microspherocytosis (22), in 
haemolytic hereditary elliptocytosis (76-78) 
and in leukaemia due to leukaemic blast or 
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megakaryoblast fragmentation (22,78,79). The 
most frequent cause of spuriously decreased 
plt- counts is plt aggregation either due to 
difficult blood sampling or occurring 
spontaneously or due to plt to wbc adherence 
(platelet satellitism) (22,69,79-83). 
A particularly important source of error 
in plt (and wbc) counting is pseudothrombo-
cytopenia due to plt aggregation, although its 
incidence (predominantly in EDTA) is only 
approximately 1%. A falsely low plt count may 
lead to unnecessary treatment or to the 
unjustified withdrawal of needed drugs. 
Antibodies of all major immunoglobulin classes 
and all IgG subclasses can be found in EDTA-
dependent pseudothrombocytopenia (67). They are 
probably not directed against EDTA itself, but 
may be directed against a hidden antigenic 
determinant of plt membrane glycoproteins (GP) 
that are exposed in the presence of EDTA <67). 
This is strongly suggested by the fact that plt 
from patients with Glanzmann's disease (which 
are deficient in the GP-complex designated GP 
II b or III a, or both) do not react with the 
(aggregating) antibodies (67)~t is shown that 
EDTA dissociates the GP-complex. Thus EDTA may 
expose a neoantigen that is then the basis of 
the "pseudo" effect ( 67). 
Fortunately, plt aggregates can readily 
be detected in instruments such as the Coulter 
Models S-Plus II-V as a shoulder in the extreme 
left portion of the wbc distribution histogram 
(83). Current anticoagulants (EDTA, citrate, 
heparin) all result in plt aggregation, though 
at different times after sampling (68,82). 
Aggregation can be prevented (for at least 3 
hours) by drawing (4.5 ml of) blood into (0.5 
ml of) an acid citrate buffer of pH 4.65, 
resulting in a final blood pH of 5.50-5.60 
( 8 2). 
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3.1.2.2. Errors due to method or instrument 
deficiences or malfunctions. 
An extensive compilation of errors due to 
method or instrument deficiencies or 
malfunctions for Coulter S-Plus instruments has 
been issued C84l. 
3.2 Approaches to IQC. 
Because of the unsuitability of 
blood as a ref and control material in 
human 
hey, 
the 
the 
many IQC methods have been proposed in 
past. Methods primarily aimed at monitoring 
precision of the analytical process are 
summarized in Table I (57,85, modified and 
updated). 
Bull C87l was one of the first to show 
how the periodical determination of the mean 
MCV, MCH and MCHC could serve as a major 
contribution to IQC of automated analyzers, due 
to the approximate constancy of these patient 
parameters. 
There is general consensus now that no 
one IQC tool can provide all the information 
necessary for an effective IQC system. 
Consequently a combination of IQC materials and 
computation of patient values are to be 
preferred. 
Computatiryn oZ patients' data obviously 
can be best a~complished by computer. However, 
even in case where a computer is not available 
occasional off-line implementation of this 
valuable technique should be advocated, 
although it is time-consuming and has saveral 
inherent deficiencies (94). A large number of 
commercial IQC materials are in the market 
(97). Home-made IQC materials are less 
expensive and are to be preferred CCh IV). 
However, constant vigilance and judicious 
observation as to the quality of the IQC 
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Table I ti!§!gr!£~!_§~r~~Y-Qf-EQ~~£hg§c!g-'Lr@£!§iQD_£QD!ro_!-lD-D~~Y1~trt 
Control method 
co-rcial control materials 
!Ferro 1969) (8&) 
II patier,t rbc-indices 
(Bull et al. 1974) (87) 
truncated adult mean parameters; 
Ill combination with accurate Hb-deter-
mination (Rutten et al. 1975) (88) 
random patient duplicates 
co IV (Carstairs et al. 1977) (89) 
~ 
moving patient modes 
V (Pragnell-Johnson 1977) (90) 
(commercial) control plus patient rbc 
VI indices (Lappin et al. 1979) (91) 
Advantages 
well-known concept, easily 
implemented 
rbc-indices are an inherent 
"star~ard'; low cost 
as II 
simplicity, especially for 
random error detection; 
precision well docUIIented; 
low cost. 
less affected by abnormal 
results than II 
this and similar techniques 
give optimal information 
VII own preparation (Cavill et al. 1979)(92) inexpensive 
Disadvar.tages 
dependence on external source of 
material; large costs 
computer facilities necessary for 
optimal application; insufficient 
by itself;no check on WBC and PLT 
computer facilities r.ecessary; 
less suitable for WBC and PLT 
insufficient by itself 
as 11, more complicated 
calculations 
computer facilities r~essary 
for optimal applicatior, 
difficult to prepare 
COIIIK?rcial control + modified average 
VIII of normals technique 
more sensitive than average of as VI 
normals method; as VI 
(Talamo et al. 1981) (93) 
control materials, calibrator, and as VI as VI 
IX patient values (Bullet al. 1982)(941 95) 
materials is needed. This is best accomplished 
by having another IQC material constantly 
available. Provided HSLP requirements are met 
(seeS 3.3) precision in hey can be kept within 
narrow limits. 
A major problem, however, is the 
determination of assay values of blood 
preparations that are used as standards or 
calibrators. This will determine the accuracy 
of the measurements. 
The calibration of fully automated multi-
channel blood cell counting instruments has 
been approached in essentially three ways (98). 
a. Some have advised the use of fresh whole 
blood, analyzed by manual or semiautomated 
techniques, as the most valid method. Coulter 
advocated numerous repetitive measurements of 
fresh whole blood by routine manual procedures. 
The multiple assays (usually 20) are designed 
to absorb the inherent imprecision of these 
methods and to yield an acceptable average or 
mean value for use as a calibration point. 
Proponents of this technique, however, caution 
users to investigate manual procedures further 
if unlikely or unmatched results occur. The 
advantage of this approach is the ready 
availability of such methods because most 
technologist-operators are familiar with them. 
The disadvantages are the large quantity of 
blood required and time of the technologist, as 
well as the very real possibility that the mean 
value obtained may not be accurate (specific 
sources of potential error for individual blood 
parameters are discussed in S 3.1.2 ). 
b. An alternative approach to fresh whole blood 
calibration was described in 1977 by Gilmer et 
al. ( 9 9), whose practice is to perform a few 
repetitions (three to five) of carefully 
performed calibration techniques. They defined 
calibration methods as procedures performed 
with greater care and precision than routine 
manual techniques, yet differing from primary 
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ref methods, which generally require research 
facilities and instrumentation for proper 
execution. These procedures do require that 
quantities be directly measurable by materials, 
glassware, and instrumentation of known or 
verified accuracy. Although this approach has 
proved to be sound theoretically, it has been 
considered to be too tedious and time-consuming 
for practical use in the routine haem. 
laboratory. 
c. The third approach is probably the least 
well documented and yet by far the most widely 
used. It employs preserved whole blood cells 
prepared for QC and involves accepting the 
manufacturer's assay values as valid 
calibration points. This method is probably 
agreed generally to be the best approach for 
initial calibration of a new or recently 
serviced instrument. If a second, different 
control material is then run as a routine 
sample and results closely match its assay 
values, the instrument may be assumed to be 
reasonably well calibrated. This should be 
checked in one or more EQA schemes (see Section 
3.4). The advantage of this pragmatic approach 
is, of course, ready availibility and maximum 
savings of time and trouble. The disadvantages 
are the dependency on the manufacturer's assay 
values at the time of production and, even more 
important, the lack of assurance that these 
materials wil survive a wide variety of 
shipping hazards. An extension of this is that 
the user must also stringently follow 
manufacturer's directions for storage and 
handling. It also is a source of concern that a 
variety of preservatives and substitutes must 
be used to simulate samples of fresh whole 
blood, and this is compounded when routine 
manual techniques are applied to verify values 
of preserved control material (Ch III, s 
2.3.4). 
The problems described here could be 
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alleviated if substantial progress is made in 
value assignments, as undertaken by <inter)-
national agencies. These are considered in S 
3.6 and S 3.7. 
HSLP-techniques (cf S 3.3) and 
participation in EQA schemes will ultimately 
guarantee optimal laboratory results, in 
conformity with the present state of the art in 
QA. 
3.3. High-Standard Laboratory Performance in 
the analytical phase. 
HSLP in the analytical phase can be 
achieved if a single instrument has been 
evaluated according to the (tentative) ICSH 
protocol (140) and if the following operational 
requirements are met in the daily routine of a 
particular laboratory (2,4,8,14,46,50) 
- the presence of standard operational 
procedures, filed in an Instruction Manual. 
- thorough preventive maintenance and 
electronic checks of the instrument. 
Administration in a maintenance log book. 
- frequent instrument calibration and linearity 
checks. 
- continuous IQC with control materials 
preferably in conjunction with the use of a 
computerized patients' data programme 
(S 3.2). <process control). 
- technician's inspection of individual 
specimens and their measured results. 
(process control). 
- logging and graphing or plotting of the 
results to detect shifts or trends 
(preferably Shewhart-Levey-Jennings charting: 
retrospective IQC). 
- regular interspersing of blind controls and 
evaluation of the results (retrospective IQC) 
(39,100). 
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- regular participation in EQA schemes (S 3.4). 
3.4 External Quality Assessment (EQA) 
External quality assessment (EQA) is the 
objective evaluation by an external agency, 
under direction of a professional peer-group of 
the performance by a number of laboratories 
with respect to material supplied for specified 
tests. Interlaboratory trials play an important 
role in maintaining laboratory proficiency. 
They form the basis for EQA schemes by means of 
which the technical skill of individual 
laboratories and the efficacy of their 
equipment can be assessed (61). In addition, 
they provide data for assessing methods for 
identifying the limitations and faults of a 
particular method, type of equipment or reagent 
(61). The most important function of an EQA 
scheme is to provide a means for ensuring 
comparability of results between laboratories. 
(61) This is especially important for analytes 
for which there is no "absolute" reference 
material available. In this case, without an 
EQA scheme, the individual laboratory cannot 
judge the comparative accuracy of its 
performance, even if it has a well established 
IQC system. An EQA scheme provides specimens 
for inter-laboratory trials and values can be 
assigned to these by statistical analysis of 
the results of all participants. This provides 
comparability and standardization by consensus, 
even if it is not possible to establish and 
verify the results as being absolutely true (S 
3.1. ). (61) At this time several regional, 
national and international programmes are 
organized. In this Section we shall demonstrate 
some of the recent results of a regional 
scheme. Fig. 3 depicts the Youden plots of the 
5 basic parameters in the regional L~iden 
programme of October 1984. Fig. 3 shows that 
the spread in Hb, MCV and RBC is mainly due to 
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systematic errors, whereas the high CV's in WBC 
(9-10%) and particularly PLT <12-14%) are due 
to both systematic and random errors. The 
occurrence of relatively large systematic 
errors in the Hb determinations of the Leiden 
trial shows that even the existence of a ref 
method and a haemiglobincyanide ref solution 
does not guarantee optimal laboratory 
comparability. This was earlier described by 
Van Assendelft et al. (59) (S 3.1.) Even the 
simultaneous availability of stable Hb-
solutions for IQC (59) apparently has not led 
to optimal Hb results. Undoubtedly this can 
only be due to insufficient application of the 
basic elements of IQC, as described in S 3.1. 
Table II shows the order of magnitude of 
CV's of the different parameters in various EQA 
schemes. It reflects the state of the art of 
EQA in hey. In the clinical situation regional 
comparability seems more important than 
(interlnational comparability. Consequently, 
higher standards should be applied to the 
results of regional EQA schemes. In my opinion 
the results obtained in the two regions 
mentioned are unsatisfactory for WBC and PLT 
and rather poor for the other parameters. I 
feel that one or more of the following pre-
requisites should be met in order to improve 
the results in EQA schemes. 
a. The routine use of counting chambers should 
be abolished because of their poor repro-
ducibility and liability to negative bias. 
b. Ref materials should become available. 
c. IQC should be intensified along the lines 
described in S 3.1 (process control, 
retrospective IQC, blind controls, using 
materials such as published inCh IV). 
It should be re-emphasized, however, that 
the outcome of these programmes is not 
completely similar to that of clinical 
specimens encountered in practice. Obviously, 
an EQA scheme by itself is not a complete 
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Fig. 3. Youden plots of.the 5 basic parameters in the reQional Leiden EGA 
scheme <October 1984) <Courtesy J.F.v.d.Buryh, Central Clinical 
Haematoloyy Laboratory, Academic Hospital, Leiden, The Netherlands) 
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system of QA. The entire spectrum of pre-
analytical variability (S 2) escapes control by 
these schemes. Much of the variability in 
result reporting is not measured by them. Other 
objections to EQA surveys, especially applying 
to hey are : (102) 
a. the distributed material may behave 
differently from the biological specimens 
normally investigated by the laboratory, and 
hence give a misleading impression of the 
laboratory's normal level of performance; 
b. the distributed material may be handled by 
the participating laboratories in a way 
different from its routine practice, so that 
the impression gained in the survey bears 
little relation to the day-to-day level of the 
laboratory's performance. (ideally, EQA should 
be "blind", with the distribution specimen 
treated in exactly the same way as a routine 
specimen, but this is not always easy to 
arrange and/or may be impossibel; 
c. the distributed material may deteriorate in 
transit to a different extent for different 
laboratories; 
d. laboratories may consult one another about 
their results on the distributed specimen 
before submitting these to the organizer, 
thereby conveying a falsely favourable 
impression of between-laboratory consistency; 
e. there is considerable doubt as to whether 
either the consensus mean or the results 
obtained by ref laboratories constitute a 
scientifically impeccable base point for 
comparison with individual participants' 
results; this applies especially where a 
predominance of use of a particular apparatus 
in the region gives a "machine-bias" to the 
results (66,98; Ch III) and 
f. surveys can cover only a limited number of 
tests, which may be such a small fraction of a 
laboratory's range as to be unrepresentative of 
its total work. 
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Ways of overcoming or minimizing these 
and other difficulties in the survey method are 
suggested in a series of WHO recommendations 
(102). 
Taole II Typical average coefficients c•f variatior, of five basic parameters in 
2 regional !Dutch) and 3 r.ational EllA schemes !Compilation of method groups). 
EllA Scheme ,, nature of date/period WBC RBC Ho MCV PLT 
control material of analysis 
Lei den 28-42 or.e human mean of 12 8-10 4 2-3 4 13-15 
EDTA-blood trials (1983) 
Venlo 15 mean of 10 human 1980 - 1981 &-9 3-4 2 10-12 
!Ref. 101) EDTA-bloods 
Dutch 122 (mean of) 4 human August 1984 8-11 4 2 l!-13 
bloods 
human rbc;CPDA-
Ger;nan 392 plasma; fixed October 1984 &-12 3-8 2-4 3-7 10-35 
"Ringversuch" goose rbc; EDTA-
stabilized plt 
French November 1983 &-9 4-5 3 H 
'Etalonorme" 3400 
Although EQA is not meant to abandon 
rigorous IQC in the mistaken belief that EQA 
provides an adequate check on daily work, the 
time that elapses between analysis and receipt 
of the results should be as short as 
practicable. Rapid feedback enables the 
laboratory to investigate recent problems, if 
any, however difficult and sometimes impossible 
this turns out to be in practice. Too long a 
delay will not only dissipate interest but will 
42 
also diminish the possibility of identifying 
causes of inadequate performance. The ma~n 
value of EQA should be seen as educational, its 
aims should be to help participants to maintain 
and/or improve performance in their 
laboratories. Energy should be directed both 
within the laboratory and within regional 
discussion groups to endeavour to identify 
accurately means for improvement in performance 
and factors leading to divergence from the 
national norm or the ref results. The main 
purpose of these regional groups is therefore 
mutual education and training (24,102). 
3.5 Analytical goals. 
Although from the point of view of the 
analytical chemist precision and accuracy must 
be of the highest attainable standards, in· 
daily practice, there is considerable contro-
versy on the formulation of analytical goals. 
Some (103) assert that the precision 
performance of nearly all analyses, including 
hey, exceeds the medical requirements, as 
originally published by Barnett (1). Others, 
including IFCC (41), state that there should be 
varying levels of expectancy for analytical 
goals for different clinical uses, although 
p:~ctice indicated that such is not the case 
(41,104). Several studies (104-106) have 
alluded strongly to the very subjective quality 
of clinical opinion. One of them states that it 
is generally accepted that current goals are 
derived best from biological variation (105) 
(see S 4.2). The clinical view of analytical 
goals is, therefore, not easy to assess. 
Moreover, once defined, medically pertinent 
analytical goals must not be static or fixed. 
Goals must be modified according to clinical, 
scientific or analytical progress (104). Others 
state that it is scientifically unsound to 
monitor an objective process, such as an 
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analytical procedure, with subjective criteria, 
such as medical requirements (107). 
The fundamental question here revolves 
around the role of the clinical laboratory in 
patient care. Is it to provide quantitative 
data on patient specimens that is obtained by 
the most reliable "state of the art" analytical 
techniques, or is it to provide more crude data 
merely to confirm clinical impressions ? In my 
opinion, the clinical laboratory should serve 
as a scientific adjunct to patient care, 
available to physicians to screen for, 
diagnose, and/or monitor, disease processes in 
their patients. In this capacity, the clinical 
laboratory must provide the most reliable 
quantitative data possible Cas far as costs 
permit), monitored through objective QA 
procedures. 
Cell counts approximate to the Poisson 
distribution, so that it ~s possible to 
calculate the "ideal" CV of the number of cells 
from the square root of these counts (108). 
Haynes shows that in his experiments the 
observed CV approximates to this theoretical cv 
in plt counting, indicating that the precision 
is limited primarily by sample size and 
counting time (109). Coulter specifies the 
precision for the Model S-Plus II as CV's of <= 
2% for WBC, <= 1% for RBC and<= 3.3- 6.6% for 
PLT (all dependent on the particle cone). They 
are based on 31 determinations of the same 
sample and verified by numerous data sets in 
various locations (14). The established 
precision specifications for a normal patient 
sample in Ortho's ELT-8 are slightly greater: 
<= 3% for WBC; <= 2% for RBC; <= 3% for PLT 
COr tho Manual l . 
3.6. Value assignments by Cinterlnational 
bodies 
In previous Sections the need 
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for 
standardization in hey is extensively 
described. Establishment of ref materials and 
methods requires a collaborative study and 
consultation with experts from many countries. 
By universal agreement of national 
governments, the World Health Organization 
(WHO), acting through its Expert Committee on 
Biological Standardization is responsible for 
"establishing international biological 
standards, reference preparations and reference 
reagents for these biological materials used in 
prophylaxis, therapy or diagnosis of human (and 
some animal) diseases that cannot be 
characterized adequately by chemical and/or 
physical means alone" (55,110). Over the past 
decades an increasing number of other 
organizations have also become active in 
biomedical standardization. A recent meeting 
under the aegis of WHO identified at least 28 
such organizations (55). In haematology 
standardization has largely been undertaken by 
ICSH. Since its founding in 1964, ICSH 
published several "Recommendations" (111-112). 
The successful standardization in haemoglobino-
metry is a good example of ICSH-WHO 
interrelationship and cooperation (55). 
Recommendations for ref methods and ref 
preparations for blood cell counting and sizing 
are the subject of study by an expert panel of 
ICSH. The problems that they encounter are not 
easy to solve. It is Cup to now) not possible 
to develop ref preparations that behave in the 
same manner as fresh blood when analyzed by 
cell counters Cllll. Moreover, particle 
counting and sizing in general is a basic 
technological problem (60,109,139). Accurate 
counting can, among other causes, be seriously 
hampered by particle aggregation and/or 
adsorption or by count loss due to counting 
coincidence. Furthermore, Poisson statistics 
demand that at least 10.000 particles be 
counted, if precision is to be kept below 1%. 
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These and similar problems as well as those of 
the actual counting devices are discussed in Ch 
III. In haematology, the accepted ref count is 
produced by digital flow hcs e.g. a Coulter 
Counter ZBI, with manual large scale volumetric 
dilutions counted above or between specified 
size thresholds (14,60,97,114,139,140). The 
Coulter thrombocounter is now recognized as 
(one of the) plt ref counter(s) (139). In this 
type of digital instrumentation the cell cone 
is determined directly by counting the number 
of particles in a given volume. This volume is 
a calibrated liquid column between a start and 
a stop sensor (60). 
Of the many particles mentioned in S 
3.1.1., latex particles are the most promising 
potential ref preparations. Spherical poly-
styrene latex particles in a series of defined 
sizes, with a claimed CV of 2 to 3% have 
recently become available. These particles 
appear to be well-dispersed with little 
aggregation and preliminary studies have 
confirmed that at least some batches are 
relatively monosized (60,113). 
Particle s~z~ng can be performed with 
high accuracy by means of light microscopy 
provided the monosized latex beads are aligned 
in a long array (60)(Fig. 4), to prevent 
resolution problems (109). Electron microscopy 
values are said to be unreliable (60,109) due 
to size changes in sample preparation (109). 
Nevertheless, Coulter's ref material is a latex 
sized by independent workers using electron 
microscopy, but not certified by a competent 
independent authority (139). The values have 
been verified, inter alia, by techniques 
traceable to the American National Bureau of 
Standards material 1003, but there is still a 
great need for a certifying authority, e.g. 
ICSH, ECCLS, BCR or WHO, to produce a suitable 
ref material to which the commercial secondary 
ref materials can be related (139). 
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Fi2. 4. Jllonosized Latex beads (diameter= 7.0 um aligned) in S!Jeeial glass 
capillary tubes. Partial image of the array. The mean particle 
diameter can be determined with high accuracy by measuring the 
longitudinal displacement of the microscope mechanical stage under 
control of cross hair eye-piece and photoelectronic sensor (accuracy 
in the total range o-30 mm +/- 0.001 mm. (Courtesy R. Thorn, 
Calibration in haematolo2Y· In: S.B.Rosalki. New approaches to 
Laboratory Medicine. SIT Verlag, Darmstadt, 1981) 
Haemocytometry, International 
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Fig. 5. Flow sheet of scheme for assigning values to reference materials 
(Reprinted with permission from SM Lewis. The philosophy of value 
assigl'llllent. In: OW van Assendelft, J~ England. Advances in 
h!!llatological methods: the blood count. Copyright CllC Press, Inc, 
Boca Raton, Fl, USA; 1982) 
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Latex beads can be expected to become a 
certified ref preparation applicable to cell 
counting and sizing with the Coulter principle, 
the latter in consideration of the shape-factor 
of rbc. (spheres= 1.5; rbc = approximately 
1.1; see Ch III, S 3.4.3.2 <60)). 
A detailed scheme for assigning values to 
secondary ref materials has recently been 
.described (113). Fig. 5 shows the flow sheet of 
lsuch a scheme, based on a study sponsored by 
BCR, Brussels (113). To translate the primary 
ref preparation into a secondary ref material 
;for measuring blood specimens, it is proposed 
that fresh blood is used as an intermedium and 
preserved blood as the secondary ref (ll3)(Fig. 
5). 
A most important, in principle readily 
applicable scheme for assigning values to 
secondary ref materials has recently been 
published by the British Committee for 
Standardization in Haematology (BCSH) (114). 
The protocol is based on using an automated 
blood counter to compare WBC, RBC, Hb, Hct and 
rbc- indices of an IQC material ••ith those of 
<three) fresh bloods, whose values have also 
been measured directly in a Coulter Counter 
Model ZBI and by ICSH ref methods for Hb and 
Hct (114) (Table III). With the knowledge of : 
a. the directly measured values of the fresh 
bloods and 
b. the ratios o~ the automated counter (fresh 
blood value/IQC material value), it is then 
possible to precisely assign values to the 
IQC material for that particular automated 
counter. The Committee suggests that at 
least three institutions (hospitals) 
participate in order to average out 
inevitable inter-institution biases (114). 
In both schemes the standardization 
procedure will be repeated at regular 
intervals, the frequency being determined by 
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the stability of the secondary ref materials. A 
similar procedure can 
values to preparations 
ref materials for plt. 
be adopted 
intended as 
to assign 
secondary 
3.7 Proposals for calibration in daily practice 
In 
(initial) 
3.2, p.36 
pragmatic 
objection 
purposes. 
my opinion, the current practice of 
calibration with IQC materials (S 
approach c) should be maintained, for 
reasons, despite the theoretical 
to using IQC material for calibration 
As laboratory practice has 
Table Ill. BCSH scheme for assigning values to JQC materials 
Participants : 3 ir.stitutions (same automated counter) 
3 fresh bloods -direct values by Coulter ZBJ-counts, 
by JCSH-Hb method and by JCSH-Hct method. 
Same 3 fresh bloods) - 3 ratios blood/IGC material on 
and ) particular automated cour.ter 
roc material ) 
geometric mean of direct values 
Assigned value = 
geometric mean of ratios 
persistently shown, individual laboratories 
hardly have a realistic alternative (S 3.2,p.35 
approaches a and b). Counting chambers have no 
real place in accurately counting blood cells 
<Cf Ch III, s 2.1). As already mentioned inS 
3.6, in practice digital flow hcs have been 
recognized as the instruments of choice for 
counting blood cells <cf Ch III, S 3.2). 
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However, they are generally not available in 
hospital laboratories, since most routine flow 
hcs are analogue instruments (comparators). The 
ICSH-Hct method is too cumbersome for the 
individual laboratory <cf Ch III, S 2.3). The 
above mentioned objections would be obviated by 
the application of the BCSH protocol briefly 
described in s 3.6 and Table III. In my 
opinion, it is the only currently available 
method potentially able to improve 
interlaboratory comparability by further 
approximating "absolute ... values. However, this 
method requires intensive regional or national 
cooperation. 
4. Post-analytical phase 
4.1. Recording and reporting. 
Transcription error~ are avoided by 
printing the results directly on the request 
forms, as used with multiparameter instruments 
(66) or by on-line computer reporting. Normal 
blood count values are usually reported without 
any type of comment. Sta·t values are usually 
reported by telephone, by preference directly 
to the requesting physician. Nothing is gained 
by perfect laboratory performance, if the 
clinician does not make good use of the 
results. Considerable efforts must be made to 
communicate with the physicians on all aspects 
of laboratory performance, especially on the 
interpretation and significance of hey results. 
This is dealt with in the next Sections. 
Ideally, clinicians should list recently 
administered drugs on the request forms and/or 
bring up for discussion with the laboratory 
head any unexpected, contradictory, or 
otherwhise problematic results as well as 
unusual or unacceptable delays in reporting. An 
agreed procedure should exist for this purpose 
and should not be allowed to lapse or to be 
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replaced by the doubtful expedient of 
requesting repeat analyses without prior 
consultation (41). A Hospital Information 
System could play an important role in the 
promotion of communication (115). 
"It is not enough to have great 
qualities; one must make good use of 
them." La Rochefoucauld Cl613 - 1680) 
Maximes no. 159 (97) 
4.2. Aspects of the interpretation and 
significance of haemocytometric results 
4.2.1. Intra-individual variability: 
significance of successive counts 
(108; 116-118) 
Once methodological constancy has been 
ensured and quantitative knowledge has been 
gained of the precision of measurements in the 
modern very precise flow hcs, an attempt can be 
made to gain insight into the intra-individual 
variability of the various parameters in 
healthy individuals. This was first reported by 
Statland et al. (116) and more recently by 
Cavill et al. (117) and by costongs (118). This 
enables the laboratory to give the clinician an 
indication •~hen a difference between two 
sequential results is pathologically 
significant. This is unrelated to the better-
known concept of ref values (8 4.2.2) but 
concentrates on detecting haem. changes in a 
single individual. 
Despite small but significant differences 
due to sample techniques (8 2) evidence 
indicates that the Hb-conc in a single 
individual is remarkably constant, the maximum 
day-to-day cv being less than 3%. At a Hb-conc 
of 9 mmol/1, this means that two successive 
measurements should be within 0.25 mmol/1 of 
the mean and that the difference between such 
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measurements should not exceed 0.6 mmol/1. 
Variations less than that should not 
necessarily be attributed to pathological 
change. However, it is still possible for 
smaller changes to be pathologically 
significant, if a succession of specimens show 
a consistent trend (108). In contrast, Costongs 
(118) presents evidence that a month-to-month 
change in Hb-conc of 1.4 mmol/1, at the 8.5 
mmol/1 level, has a probability of being 
pathological of (only) 90%: the so-called 
critical difference dk90 = 1.4 mmol/1. I feel 
that this conspicuous finding requires 
confirmation before it can be generally 
accepted. 
The day-to-day CV for RBC is reported to 
be equally less tha£23%. Thus at a red cell count of 5.00 x 10 /1 no two counts should 
differ by more than 0.30 x 1012;1 unless the 
balance of the rbc production and destruction 
is disturbed. (108,117) 
On the other hand, the CV for wbc-counts 
may be of the order of 15%. This mgans that for 
wbc-counts in the region of 7 x 10 /1 the count 
fog any individual may very well vary by 2.2 x 
10 /1 between successive counts as a result of 
chance alone. Although exercise has been said 
to increase the wbc-count (5), a systematic 
study provided no evidence of any significant 
relationship between activity prior to blood 
sampling and the measured wbc-count (108,117). 
The stability of the rbc indices is well-
known and is used in analytical QA, as we have 
seen (S 3.2). The inter-individual CV's for 
MCV, MCH and MCHC are estimated to be 
approximately 4% (94). In a patient population 
of a typical, acute care, general hospital the 
variation is only slightly greater, in the 
order of 6% (94). 
In normal subjects there may be a CV of 
13% on plt-counts, although the hour-to-hour 
variation is generally less than 2%. Thus in 
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the region of a plt-count of 120 x 10 9;1 
results on successive da¥s might be expected to 
differ by up to 30 x 10 /1. When the count is 
made by a well controlled, automated method it 
would be unwise to attribute any difference of 
less than 30 x 109;1 between successive counts 
to pathological change. For manually counted 
plt it might be prudent to double that figure, 
in case the counts are not scrupulously 
performed (108). Costongs found a significant 
upward trend during one day for WBC, PLT and 
MPV (118). Furthermore, he observed a critical 
differenci2in dk90 during a six-wonth period of 0.83 x 109 /1 for RBC, 3.6 x 10 /1 for WBC and 93 x 10 /1 for PLT, all these values again 
being higher than those mentioned above. 
4.2.2. Inter-individual variability : reference 
values. 
The human organism is subject to variations 
caused by physiological processes, genetic 
differences, diseases and environmental 
factors. A rational interpretation of haem. 
results demands knowledge of these variations 
in the individual under study (S 4.2.1.) or in 
an adequately defined set of ref individuals. 
It will be evident that intra-individual ref 
values are more suitable than inter-individual 
ref values (118). However, the former generally 
are not (yet) available in daily practice. 
Alternatively, an important task for the 
laboratory is to provide reliable sets of 
inter-individual reference values. Customarily, 
laboratory test results are interpreted by 
comparison with traditional but inadequately 
defined "normal" values. This ref information 
too frequently is the weakest link between the 
laboratory and the clinician. W.Elion-Gerritzen 
extensively described the remarkable dispersion 
of "normal" range values, action levels and 
medically significant changes among physicians 
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(106). However, the proper interpretation of 
laboratory data depends, inter alia, on the 
quality of ref information available to the 
physician. Increasing awareness of the 
biological changes in physiological and 
pathological processes demands a more precise 
and comprehensive interpretation. A rational 
approach to providing a sound basis for 
interpretation of observed values calls for a 
theory which describes the principles and 
procedures for selection of ref populations and 
definitions of ref values. There is need to 
evaluate alternative approaches to the 
generation and application of ref values 
appropriate for various purposes (119). 
ICSH and !FCC are preparing a series 
joint recommendations on the theory of 
values (113,119,120). Nomenclature 
describing the relation of observed values 
ref values is unambiguously formulated 
proposed for universal acceptance (120). 
of 
ref 
for 
to 
and 
Establishment of "absolute" ref values is 
impeded by the lack of ref methods and 
standards. This is one of the main reasons for 
the great variety of published ref values. A 
practical approach to the calculation of ref 
values is the use of the hey results of an 
unselected (with respect to health 
characteristics) patient population, as 
routinely produced in a haem. laboratory. Using 
the bulk of hey data generated every day in 
laboratory routine practice is attractive for 
the following reasons: 
a. it obviates the great difficulty of 
selecting a ref population which is homogeneous 
with respect to certain health characteristics; 
b. analysing a great number of samples taken 
from members of a ref population is costly. 
Naus (121) describes and compares five 
different calculation methods using unselected 
patient data. From this comparison the method 
described by Bhattacharya appears to give the 
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best results and it is relatively simple. Naus 
et al. (121,122) extensively describe the 
concepts and techniques of the Bhattacharya 
plot. In another study (123) significant sex 
differences were found for all parameters while 
age differences were present in ref values of 
WBC, RBC, MCV and MCH. 
100 
25 
Low 
MCHC 
Low 
MCV 
Low 
MCH 
Increased lncreosed 
anisocytosis miaocytosis 
Fig. &. Sensitivity of various haematological parameters for detecting 
minor degrees of iron deficiency (Reprinted •ith permission from 
JM England et al. and Blackoell Scientific Publications, Oxford; 
Br J Haematol 1976; Ref 125) 
4.2.3. Clinical efficacy of haemocytometric 
tests. 
Two basic concepts are involved in the 
validation and implementation of a clinical 
test (124). The first step is to choose the 
best test from among the available 
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alternatives. This means establishing the 
relative ability of the tests to make correct 
clinical classifications, as reflected in their 
sensitivity and specificity. A simple example 
is given by the sensitivity of various haem. 
parameters for detecting minor degrees of iron 
deficiency <125) (Fig. 6). Note that the MCHC 
has lost its diagnostic sensitivity with the 
advent of flow hcs (126). With manual counting 
methods and a Hct derived by centrifugation (in 
Wintrobe tubes), the MCHC is low in iron 
deficiency and other conditions associated with 
small red cells and concomitant anisocytosis. 
This is caused by falsely high Hct's due to 
increased trapped plasma in anisocytosis; hence 
an apparent fall in MCHC is obtained from the 
ratio of Hb and Hct (127-129). The 
discriminatory function has been taken over by 
RDW ( 8 3 ) • ( c f Ch I II, S 3. 4. 3. 4 ) 
When the best test is selected, the second 
step is to choose the appropriate decision 
level for a particular clinical situation. This 
requires consideration of both prevalence of 
the disease (Table IV readily shows that a 
particular test has a higher predictive value 
when the disease occurs with a higher 
prevalence) and the medical (and economical) 
consequences of false-positive and false-
negative results. This concept, based on Bayes' 
theorem is exemplified by Fig. 7, that 
illustrates how sensitivity and specificity are 
altered by the selection of an upper limit of 
normal. Fig. 7 shows the classic overlapping 
distributions of WBC in patients classified 
into septic and nonseptic based on blood 
culture findings (130). At any decision level, 
one must sacrifice sensitivity for specificity 
and vice versa. Herein lies the major flaw of 
(laboratory) diagnosis, in that the tests are 
not sensitive and specific at the same time. 
Looking at multiple laboratory tests improves 
the predictive value somewhat, but the 
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Prevalence of disease (%) Predictive value (%) 
1 1~1 
2 27.9 
5 50.0 
10 67.9 
1s n.o 
20 82.6 
25 86.4 
so 95.0 
Table IV. Predictive value as a function of disease prevalence for a 
laboratory test •ith 95% sensitivity and 95% specificity. (Table IV 
and Fig. 7 <Legend slightly modified) are reprinted with permission 
from RS Salen, Blood Cells 1980; Ref 130; Springer Verlag, 
Heidelberg> 
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Fig 7. Overlapping distributions of WBC ir• septic and nonseptic patients 
(prevalence SO%). The selectior1 of the upper limit of normal (decision 
level> determines the sensitivity, the specificity and the predictive 
value of a positive result of wbc-counts as follaws: 
Decision level 
8x109fl 
10 
12 
14 
16 
Sensitivity (%) 
100 
95 
85 
70 
so 
Specificity <%> 
60 
75 
85 
95 
100 
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Predictive value (%) 
71.4 
79.2 
85.0 
93.3 
100.0 
fundamental trade-off between sensitivity and 
specificity always remains (seeS 4.2.4). 
4.2.4. Multivariate analysis. 
Solberg (131) was the first to illustrate 
graphically the benificial effect of multi-
variate analysis. Fig. 8 is a diagrammatic 
representation of a multivariate analysis with 
two variables. By combining the two tests we 
may be able to effect a greater degree of 
discrimination than could be achieved by using 
either of the two tests considered separately. 
It is possible to apply the same principle to 
more tests, although this is difficult to 
visualize. This approach has proven valuable in 
defining the combination of tests which will 
maximize the probability of a given diagnosis. 
Xz 
Fiy. 8. Discrimination between two groups in the bivariate case. (From 
Solberg HE, Scand J Clin Lab Invest 1975; 35: 705-12, •ith 
permission; Ref 131) 
Unfortunately, its diagnostic application 
is difficult for several reasons (132). Becket 
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al. (133) applied (computer assisted) multi-
variate analysis to iron deficiency anaemia to 
generate an efficient sequence of diagnostic 
laboratory tests. They constructed a three step 
diagnostic system: serum ferritin level and MCV 
as a screen in all patients, followed by serum 
iron and iron binding capacity in some patients 
and by erythrocyte sedimentation rate in a few 
patients. When compared to bone marrow iron 
stores, this system was found to have 96 per 
cent predictive value. 
5. Aspects of cost-effectiveness and QA 
In the present economy, much concern has 
been concentrated on the relationship between 
cost and medical efficacy of laboratory tests. 
It has been clearly shown that test ordering is 
fundamentally developed during internships and 
residential training (134). It is one of the 
paradoxes of contemporary medicine that there 
is a vague, but definite, malaise surrounding 
laboratory diagnosis at a time of unparalleled 
accomplishment in techniques and equipment. Too 
many available choices, especially if 
imperfectly understood, create confusion in the 
chooser. Laboratories have very little control 
of ordering and sequencing of the requisitions. 
Hovind (134) describes the realit~ of the 
present situation as follows:"Both in clinical 
and in laboratory practice, the junior doctor 
armed with the best intentions enters the 
laboratory super-market, whose shelves are 
increasingly filled with exotic and expensive 
tests and orders tests at will, regardless of 
cost rationale, and consideration of the 
patient". Galen and Gambino <135) formulate the 
situation as follows:"In the use of laboratory 
tests the physician does not sense any 
limitation. He considers the laboratory an 
infinite resource. A simple, effortless, 
painless stroke of the pen is all that is 
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required to command its use. It is not the 
physician's time that is used. It is not the 
physician's money that is consumed. It is not 
the physician's assistants who do the work". 
In the direct clinical care of the patient 
one of the objectives of QA is to reduce health 
care costs through appropriate test 
requisitions and avoidance of the necessity to 
repeat tests. There is little doubt that one of 
the most important ways of dealing with the 
"data explosion" is to further the 
communication and co-operation between the 
laboratory and the clinician. Much of the data 
might not be effectively converted into 
information of medical value. It is the 
significance that is assigned to data (S 4.2) 
which converts them to information (10). 
An example of how to possibly tackle the 
problem has been given by the American Medical 
Association since 1975, by publishing a series 
of publications "toward optimal laboratory use" 
in the JAMA (136). One of the most recent 
contributions in this series deals with the 
considerable misuse of tests in a teaching 
hospital, under the intriguing title "Ready! 
Fire! ..... Aim! An inquiry into Laboratory test 
ordering (137) (cf Fig. 1) 
Advances in technology have caused the 
unit cost of laboratory tests to decrease, but 
the variety of tests and gross expenditure for 
the total number of tests requested has 
increased drastically. This technology has also 
provided an alternative to selective testing in 
the form of multiparameter (panel) testing. The 
question is sometimes raised whether panel 
testing in case of a simple selective (e.g. Hb) 
request adds to the ever increasing expenditure 
on laboratory analyses. Lehman et al. (138) 
have shown in a comparable chemistry situation 
that panel testing resulted in substantially 
lower costs and fewer return visits to the 
laboratory than either selective or mixed 
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<combination of selective and panel) testing. 
Moreover, in every day practice IQC in 
multiparameter instruments is less time-
consuming and thus easier to perform. 
Serious studies are necessary as to 
whether the initial requisition by all 
physicians of standardized optimal protocols 
(chosen after careful consideration and 
literature studies) rather than the individual 
requisitions per patient and per physician for 
the diagnosis of a presumed disease, could 
fundamentally contribute to cost control 
without impairing the quality of the 
requisition. The three-step diagnostic system 
for iron deficiency anaemia described by Beck 
et al. (133) or the improved classification of 
anaemias based on MCV, RDW and rbc-histo-
grams (83) might be candidates for such a 
standardized, optimal protocol. 
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Chapter III 
BASIC PRINCIPLES AND PROBLEMS OF HAEMOCYTOMETRY 
1. Introduction 
The advent and widespread acceptance of 
flow haemocytometers (hcsl has markedly 
improved the precision of haemocytometry (hey). 
Accuracy on the other hand is still a source of 
major concern. This is brought about by several 
factors. In this review we shall discuss the 
basic principles and problems of hey. It will 
be shown that some of the classical manual 
techniques (microHct;Hbl still basically 
contribute to resolving accuracy problems. 
2. Principles and problems of manual 
haemocytometry 
2.1. Cell counting chambers 
For two reasons we shall not 
extensive descriptions of and 
counting chambers (c.c. l: 
indulge 
comments 
in 
on 
a. they have gradually been replaced by flow 
haemocytometers (hcsl; 
b. many detailed descriptions and critical 
reviews on c.c. have been published (1-5). 
Nonetheless, some remarks may be 
appropriate. Although counting precision and 
accuracy have always been a major source of 
concern, c.c. theoretically provide inherent 
primary calibration possibilities. Some authors 
(1,2) believe that this goal of absolute 
counting can be achieved by improving the c.c. 
as well as the counting technique. There are, 
however, major sources of error remaining in 
chamber counting (1-5), such as variable 
chamber depth mainly due to the positioning and 
bowing of the cover glass (this problem being 
reasonably well resolved), systematic 
differences existing between the results 
obtained by even experienced technicians (5l as 
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well as problems inherent in the counting of 
too few cells due to (near) Poisson 
distribution statistics (ll. For a full account 
on the subject we refer to the above-mentioned 
references (1-5). 
This implies that c.c. seem not (yet?) to 
be suitable for calibration of flow hcs, not 
even by (inter)national institutes for 
metrology, and despite modern possibilities, 
such as video display monitoring or 
photographing of the c.c., and accurate 
checking of the chamber depth by micrometers or 
interference comparators (1,2,5). This is 
substantiated by the fact that recent 
literature (4,6,7-9) and flow he Manuals (lOl 
generally describe cell counting calibration by 
comparison with values found in digital flow 
hcs (seeS 3.2.2.) (see also Ch II). 
2.2. Manual haemoglobinometry 
For the determination of haemoglobin (Hbl, 
the spectrophotometric method using 
cyanhaemiglobin (HiCNl has been accepted 
worldwide, and recommended by the ICSH (11-12). 
Comprehensive, detailed reviews (5,11-14) on 
the theory of and the experience with this 
method have recently been published. Although 
it is not our intention to repeat this 
information, again, it seems appropriate to 
comment on this method (11-18). 
Indeed, the HiCN-method has - as compared 
to other known methods - several significant 
advantages: 
(al only a single reaction has to be used; 
(b) all Hb species and derivatives are 
monitored, i.e. deoxy:-Hb_,_- oxy-Hb, carboxy"-Hb, 
fetal Hb and (at least in part) sulph-Hb; 
(c) the stable reaction product HiCN has a 
broad absorption maximum at 540 nm; 
(d) the Lambert-Beer law is valid within a 
wide range of absorption; 
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(e) stable standard solutions 
either from crystalline Hb or 
and they can be shipped 
problems; and 
can be prepared 
from washed rbc 
without severe 
(f) since HiCN is a stable derivative of Hb, 
measurements of the absorbance can be 
performed some min. or even some days after 
the addition of blood to the reaction medium 
without significant alteration of the values 
obtained. 
Nevertheless, the HiCN-method has also 
some disadvantages which cannot be neglected: 
(a) since the HiCN-reagent contains cyanide, it 
is toxic and therefore has to be handled very 
carefully; 
(b) the reaction solution is light-labile (even 
in the dark, it is not stable for more than 6 
months); 
(c) HiCN-solutions from patients with marked 
hypergammaglobulinaemia or paraproteinaemia may 
be turbid and must be clarified by 
centrifugation for 15 min (Turbidity can be 
prevented by the addition of NaCl, by 
increasing the cone of the phosphate buffer, or 
by adding a drop of ammonium solution (17)); 
(d) the cone of the reaction components, 
especially those of cyanide and the buffer have 
to be chosen and kept constant very carefully; 
(e) standardisation of the method is based on 
purified HiCN-solutions, the quality of which 
is controlled only indirectly by 
spectrophotometry (direct iron analysis is not 
possible because of the presence of K3 [Fe(CNl 6 J in these standard solutions); and 
(f) the reaction times of the different Hb 
species and derivatives differ markedly (3-5 
min for Hbl and at least in the case of 
carboxy-Hb the time for conversion into HiCN 
(90-120 min) is too long for rapid clinical 
use, giving rise to too high values (up to 6%; 
(14) (This period can be decreased to 15 min by 
increasing the ferricyanide cone fivefold (15) 
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or to 3-5 min by heating the reaction mixture 
to 56°Cl Cl5l. It should be realized that 
carboxy-Hb values for smokers (particularly 
those who inhale cigar smoke) may exceed 20%! 
(18 l. (Surprisingly, a negligible effect of 
carboxy-Hb on Coulter Model S readings 
(conversion time of some 20 sees!) was found 
(18). The broad-band-pass filter (495-555 nml 
of the Coulter S and/or the reagents used may 
possibly explain the phenomenon. (11,18)). 
Quite recently (15,16) a new method for 
the rapid and accurate measurement of Hb has 
been developed as an alternative to the 
conventional HiCN-method. This method is based 
on the conversion of all haeme, Hb and 
haemiglobin species into a stable end product 
by an alkaline solution of a non-ionic 
detergent ( "AHD reagent" l. The reaction 
product, designated as alkaline haematin D-575, 
is extremely stable and shows a characteristic 
absorption peak at 575 nm. As compared to the 
HiCN-method, the determination of Hb by 
alkaline haematin D-575 offers several 
advantages such as: 
(al extreme stability of the AHD reagent and 
the conversion product; 
(b) decreased conversion time of all Hb 
species into the end product; 
(cl decreased amounts of plasma and cell 
errors, and errors caused by delayed 
conversion of carboxy- and fetal haemoglobins; 
and 
(d) standardisation by a primary standard 
(purified crystalline chlorohaemin). 
This new method certainly deserves further 
studies. 
Finally, quite sensitive lib-determinations 
in plasma and serum have recently been 
described, obviating the potentially 
carcinogenic benzidine (19,20). 
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2.3. Centrifugal haematocrit (comparison 
with flow cytometric haematocrit) 
2.3.1. Macro versus microhaematocrit 
The haematocrit (Hct) is the ratio 
(expressed as a fraction or as a percentage) of 
red blood cell volume and whole blood volume in 
a particular whole blood specimen. Centrifugal 
(cf) Hct can be determined either by a 
macromethod or by a micromethod (21,22). ICSH 
have recently published "Recommended methods 
for the determination of packed cell volume" 
(21,23) or cf Hct. Although ICSH consider the 
terms Hct-value (Hct-ratio) and packed cell 
volume as synonymous, we prefer the term 
"haematocrit" (although the term "haematocrit" 
was originally defined as the tube in which 
blood is centrifuged or the centrifuge used for 
this purpose (7)), as, strictly speaking, the 
term packed cell volume is a misnomer in that 
it represents a volume ratio rather than a 
volume. (the correct terms relative or 
fractional packed cell volume are sometimes 
used in the literature (24,33)). In 1980 ICSH 
also published "Recommendation for reference 
method for determination by centrifugation of 
packed cell volume of blood" ( 25). This method 
recommends the macromethod as a ref method for 
the Hct determination, mainly on two grounds: 
a. "the potential lack of uniformity of the 
bore of many makes of microHct tubes" and 
b. even in the micromethod the amount of 
"trapped plasma may account for about 3% of the 
apparent red cell column in normal blood and 
even more in certain abnormal conditions" and 
"there is, therefore, no intrinsic merit in 
selecting a centrifugation method that has a 
relatively low plasma trapping correction". 
Radioactively labelled human serum albumin has 
been chosen as the indicator for determining 
the trapping correction since it is a well-
established method (26,27). 
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However, this macromethod is - like most 
ref methods - highly unpracticable for routine 
(calibration) purposes. Fortunately,recent 
studies have largely refuted the above-
mentioned arguments against the use of the 
micromethod, at least as a practical 
calibration method (28,29): 
a. It is recognized that some commercial firms 
put high-quality microHct-tubes on the market 
(27). Acceptable uniformity in bore <<2%) can 
be indirectly assessed by determining that the 
intra-assay CV of the microHct of blood samples 
meets certain criteria. Depending on the bore 
and the thickness of the wall of the tube as 
well as on the skill of sealing and melting the 
tube end, CV's varying from 0.2 to 0.8% can be 
achieved (8,27). Even tapered tubes can be 
successfully used, provided appropriate 
corrections are applied (27). 
b. Recent re-assessment of the amount of 
trapped plasma by Pearson and Guthrie (31) 
showed a degree of trapping amounting to 1.53 
+/- 0.33 (2 SD) %for normal blood (n=25), 
provided the centrifugation has been carried 
out at approximately 13,000xg (at the buffy-
coat interface) for ten min (in contrast to 
ICSH which recommend only five min). A further 
reduction of trapping is not possible even in 
an ultracentrifuge or with an excess of 
spinning time, if heating by air friction is 
avoided (8). /The non-equivalence of flow hey 
and cf (predominantly macro-)Hct's of rbc, 
serially diluted in their own plasma, as 
described by Fairbanks (32), is also (mainly) 
attributable to too high and variable 
percentages of trapped plasma in the (non-
corrected) centrifugation methods used in that 
study./ 
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2.3.2. Centrifugal haematocrit of normal 
blood. 
The corrected microHct of fresh, 
human blood approximates the true Hct 
taking into account the above mentioned 
following conditions: 
normal 
value, 
and the 
Fully oxygenated blood should be used as 
the Hct decreases by about 3% (1 Hct%) in 
oxygenating blood due to Gibbs-Donnan 
equilibrium changes (21,22,33). Moreover, di-K-
EDTA in excess of 2 mg/ml blood will cause cell 
shrinkage (25) and so does the use of tri-K-
EDTA instead of di-K-EDTA (27, 30). 
For all practical purposes, the mean of 
microHct values of, say, ten fresh, normal 
blood specimens is a very reliable calibrator 
for flow hey instruments, provided 1.5% 
allowance for trapped plasma is made (8). In 
our experience, this procedure can be 
considered as an excellent practical 
calibration method (28). Likewise, NCCLS (29) 
recommend their issued "approved standard 
procedure for determination of packed cell 
volume by the microhematocrit method" as an 
intermedium for the calibration materials for 
automated, multiparameter hematology analyzers 
( 2 9). 
2.3.3. Centrifugal haematocrit of 
pathological blood 
Pearson and Guthrie (31) found that the 
trapped plasma results for 127 specimens 
(including 25 normal specimens) ranged from 
1.18% to 2.25% (mean 1.61%; SD=0.213l, provided 
the MicroHct was performed at 13,000 x g for 
ten min. They found only six specimens which 
had trapped plasma volumes equal to or slightly 
greater than 2%. Of these, three were from 
patients with marked microcytic hypochromic 
changes due to iron deficiency anaemia. The 
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remaining three specimens were from patients 
with abnormal haemoglobins. In another paper 
(34) they describe their important findings of 
Hct-values in 17 polycythaemia patients: 
whereas the microHct's gave correct values, the 
amount of trapped plasma varying between 1.2 
and 1.8% (mean 1.55%), the Hct's were severely 
underestimated by Coulter's Model S and S-Plus 
instruments (6.4 and 7.4% at an MCH of 1.25 
fmol, respectively). This was earlier described 
by Penn et al (35) and Nosanchuk (36). (cf s 
3.4.3.3) 
Inaccuracies in the Hct's (MCV's), as 
measured by Coulter S, S-Plus and ELT-8 
instruments, of pathological rbc due to changes 
in deformability and ensuing shape factor (S 
3.4.3.3.) and due to changes in refractive 
index, respectively, lead to discrepancies with 
the corrected microHct method: Flow hey Hct's 
are too high at high, "true" MCHC (i.e. MCHC 
calculated via a corrected cf Hct) and too low 
at low, true MCHC (37 39),--although in one 
study--{37) Coulter s (Plus) Hct's agreed with 
microHct's at low MCHC values. 
Quite variable discrepancies among flow 
hey Hct's and between flow hey Hct's and cf 
Hct's occur in normal rbc, in a variety of 
disease states producing hyperosmolar plasma, 
namely hyperglycaemia and uraemia. An extensive 
background discussion on the underlying osmotic 
matrix effects giving rise to the spuriously 
elevated flow hey Hct's has recently been given 
( 4 0) ( cf Ch II, S 3 .1. 2 .1. ) . 
These findings have important implications 
for the diagnostic value of the MCHC, being the 
ratio of Hb and Hct. Whereas the MCHC, 
determined with the macro-Hct-method, decreases 
in iron deficiency due to increasing plasma 
trapping, MCHC generally remains constant when 
determined with the appropriately performed 
microHct. MCHC will also be constant in flow 
hey instruments, the more so as flow hey MCHC 
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generally is too high at low cf MCHC <true 
MCHCl and too low at high cf MCHC (37-39). 
Consequently, since MCHC, as measured with 
modern techniques, is generally constant, its 
diagnostic value is negligible (41-44), whereas 
it is very useful for IQC purposes (45). (cf Ch 
II, Fig. 6, p.55) 
2.3.4. Centrifugal haematocrit of artificial 
blood 
Artificial blood is designed primarily for 
use in flow hcs. Hct's produced in these 
instruments generally do not match those found 
by the cf (microlHct method. Consequently, this 
impedes the microHct of artificial blood to be 
used for calibration purposes. 
MicroHct discrepancies may occur in two 
ways: 
a. MicroHct values higher than flow hey values. 
This is mainly caused by the fact that the 
preserved or fixed cells do not pack evenly 
under cf force due to decreased deformability, 
resulting in a falsely high cf Hct (6). On the 
other hand flow hey Hct vatues may be too high, 
albeit less pronounced, due to the same 
decreased deformability and its resulting 
increased shape factor of the red blood cells 
(8, 39 l (see s 3. 4. 3. 3. l. An extreme example is 
given by the highly discordant Hct results of 
"Stabicell" (formaldehyde-fixed rbcl-
suspensions, their microHct values being 
virtually twice as high as the Coulter Model s 
He t-va lues ( 5 l. 
b. MicroHct values lower than flow hey values. 
This is clearly demonstrated in Table I, 
showing the discordant values of Hyland's 8 
parameter control material (unfixed rbcl (46). 
This representative example shows a ratio of 
MicroHct to Coulter-Ret of about 75%. we also 
measured the Hct of the normal control with the 
very accurate 131I-albumin method of England 
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c.s. (26) and found 50.2%. This strongly 
suggests that the MicroHct is too low. The most 
plausible explanation for the phenomenon is 
given by Halbhuber et al. (47). Using the 131!-
albumin method they showed 20% lower values for 
spun Hct's than for electronic Hct's in rbc in 
artificial media compared to these in 
autologous plasma. They showed that this was 
due to a medium dependent permeability of the 
rbc membranes, causing compression of rbc with 
concomitant H+ and H20 efflux (47). 
Finally, the effect of rbc storage lesion 
on the Hct, estimated by the ICSH ref method, 
the micromethod, and the Coulter counter S, has 
been recently described (48). 
Table I. 
Haematocrit values of Hyland's l'lO!'!la! al'ld abnormal 8 parameter 
oontrols !No 814 H2l with manual al'ld flow cytometric techniques. 
Values in parentheses il'ldicate the number of measurements. 
Control CS!a,cl B.T-8!b,cl Mhct !31!-Aib Mhct/CS 
Low 27.8 (5) 25.2 (2) 20.3 (2) • 75~ 
Normal 50.1 (2) 46.8 (!) 37.5 (2) 50.2 (2) '7~ 
High 60.0 (1) 55.6 (!) 46.5 (2) • 78% 
al. CS = Coulter Model S 
bl. Ortho Diagnostics, Westwood, ~a 02090, USA 
cl. Values in conformity with stated values 
3. Principles and problems of flow 
haemocytometry 
3.1. Introduction 
The basic concept of flow hey is that blood 
cells are made to flow at high speed through a 
sensing region where electrical or optical cell 
properties are measured. The cells are 
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suspended in a carrier 
isotonic buffer, which 
proper dilutions and to 
the measuring region. 
fluid, usually an 
is used to make the 
transport them through 
A knowledge of the principles governing 
this fluid flow is important for the 
understanding of the events that occur during 
measurements, and the effect of the flow on the 
data that is obtained. Important improvements 
in fluidics and electronics, such as 
hydrodynamic focusing, sweep flow and pulse 
editing, offering unsurpassed cell resolution 
and enabling simultaneous counting of plt and 
rbc, shall be described (S 3.3.2. ). 
3.2. Classifications of flow 
haemocytometry instruments 
Coulter's instruments are the first and 
foremost in electrical ("aperture-impedance" 
or "resistive particle") flow hey (50,51) (S 
3.4. ). Optical (light-scattering) flow hcs are 
represented by Technicon's H-6000 series and 
Ortho's ELT-instruments (S 3.5). 
In the measuring region the cell cone is 
determined either directly with a digital 
method by counting the number of cells in a 
given volume (e.g. Coulter A, ZBI etc), or 
indirectly with the analogue method by counting 
the number of cells per unit time (routine flow 
hcs: Coulter S-Plus series, ELT series, H 
6000(Cl (8). Common to both counting principles 
is the discriminator for threshold setting and 
the transducer, a device that generates 
electrical pulses when cells pass the 
electrical or optical sensing zone. 
3.2.1. Analogue instruments (8,49-58) 
In analogue instruments, the number of 
pulses per unit time, the counting rate, is 
measured. This rate is converted into a 
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proportional but otherwise arbitrary voltage 
which can continuously be read. An adjustable 
amplifier is employed to amplify the voltage 
into an appropriate value for display of the 
cell cone. This displayed value has to be 
calibrated to the assigned value of the 
calibrator. This means that the zero intercept 
and the slope of the amplifier have to be 
adjusted by means of a particle-free sample and 
a ref suspension with a well-defined cell cone. 
(Ch II, S 3). 
The major routine flow hcs are analogue 
instruments. We shall not describe them but 
rather refer to their Manuals and descriptions 
and/or evaluations in the literature: Coulter's 
ModelS-Plus series (49-53), Ortho's ELT 
instruments (51,52,54,55) and Technicon's H6000 
series (51,56-58) 
3.2.2. Digital instruments (5,8,59,70) 
With the digital method, the cell cone is 
determined directly by counting the number of 
cells in ~ given volume. This volume is a 
calibrated liquid column between a start and a 
stop sensor (5). The accuracy of these 
instruments is mainly dependent on the 
accuracies of this measuring volume and the 
counting device as well as of the cell 
dilutions, threshold settings and coincidence 
and background corrections (5) (SeeS 3.4.2.) 
Examples of these digital instruments are the 
Analys 134, Contraves 800, Coulter Models DN, 
ZB and ZF, Sysmex CC 108, 110 and 800 (60) and 
the Ultra Logic 800 (59). Detailed accuracy 
studies on these instruments are currently 
being performed by Helleman (59) (SeeS 3.4.2.) 
Digital counters are often used for primary 
calibration (cf. s 2.1 and Ch II, s 3.6). 
Important remarks and recommendations on 
accuracy in cell counting for use in 
calibration, are given by Thorn (8) and Barfield 
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(9), using a. Coulter counter of the ZB-type. 
3.3. Hydrodynamic properties of flow 
haemocytometry instruments 
3.3.1. Flow of fluids in the sensing 
(impedance) apertures (Courtesy 
V.Kachel and M.L.Mendelsohn, Refs 
61,70). 
Flow in tubes is either laminar or 
turbulent. In flow hey instruments, the 
suspending medium must transport the cells 
along well-defined paths through the sensing 
region. Thus, since accurate cell transport 
trajectories are required, laminar flow 
conditions must be established and turbulence 
avoided. For flow in tubes, this requires that 
the Reynolds number (Rcl be below the critical 
value of 2300. That is, 
vdp/z < Rc = 2300 
where v is the average flow velocity, d is the 
tube diameter, p is the fluid density, and z is 
the fluid viscosity coefficient. For water in a 
100 urn tube, this leads to laminar flow below 
23 m/sec. Above this velocity, turbulence tends 
to occur. The possibility of turbulence 
increases with distance along a tube or with 
the presence of surface irregularities. Just 
inside the tube entry of a laminar flow system, 
the velocity profile of the fluid is flat, 
with a sharp drop to zero very close to the 
wall (i.e. the boundary layer). There is a 
gradual transition from this distribution to a 
parabolic distribution with increasing distance 
into the tube. In the parabolic velocity 
distribution, the maximum velocity is on the 
axis, the velocity at the wall is zero, and 
the average velocity is one-half the axial 
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velocity. For water flowing in a 100 urn-
diameter tube at the critical velocity of 23 
m/sec, little progress toward the parabolic 
velocity distribution occurs in the first few 
hundred micrometers into the tube; hence, 
practical flow channels usually found in flow 
systems generate essentially flat velocity 
distributions, with a core region of linear 
velocity distribution. The radius of the core 
region is a function of the Reynolds number 
(usually in the order of 300) and the distance 
from the inlet of the aperture. 
3.3.2. Basic fluidic (and electronic) 
improvements enabling 
high-resolution cell analyses. 
3.3.2.1. Hydrodynamic focusing 
Both the ELT and the H-6000 (optical) 
instruments apply a technique called 
hydrodynamic focusing, a key fluidic 
improvement. In these flow hcs a particle-free 
sheath fluid is used to constrain the cells to 
be measured in the center of the sensing 
region, eliminating artifacts caused by pulses 
from off-axis cells (see below), thus greatly 
improving cell resolution (62). The cells are 
forced into a single-file array and intercept 
the light beam, which is focused to a very 
small sensing zone. In the ELT instruments the 
passing cells scatter the laser light and the 
low angle forward light intensity data is 
processed (54-55). In the H-6000 a dual 
detection system in the peroxidase channel 
measures light scatter and light absorption due 
to peroxidase stain (58). Additional claimed 
benefits of sheath fluid technology include 
virtual elimination of clogging and minimal 
cell transit time, which reduces coincidence 
error and increases analysis rate C62l. Ccf S 
3. 5) 
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In "aperture-impedance" or "particle-
resistive" (Coulter-type) counters <39,49,60-
67), cells in fluid suspension flow through a 
small orifice or aperture, causing a change in 
the electrical resistance across the aperture, 
as they are essentially non-conductors of 
electricity. This change produces a voltage 
pulse, the signal height of which is not simply 
proportional to the volume of the cell, but 
rather to the volume of the electrolyte 
displaced within the sensing zone, and, more 
importantly, to the changes of electrical lines 
of force, the so-called "electrical shadow" 
(49,67). In other words, the pulse height is 
also dependant on the orientation and shape of 
the sensed cell <see s 3.4.3.2. l as well as on 
the current and fluid densities along the path 
taken by the cell through the aperture. Because 
the electrical and hydrodynamic fields along 
and across the aperture are not uniform, even 
identical (latex) spheres having different 
trajectories give voltage pulses of different 
shape and duration. Orientation and shape of 
(flexible) cells are altered near the wall by 
the unbalanced shear forces there. 
Consequently, it will be obvious that the 
residence time in the aperture for a cell 
travelling near the wall will be longer than 
that for a cell passing through the center, 
because of the smaller fluid velocity near the 
wall (boundary layer, see S 3. 3. 1. ) . 
Consequently, duration of the signal created by 
a cell travelling near the wall will be 
correspondingly greater. 
Ejection of cells from the tip of a 
focusing tube placed approximately 1 mm in 
front of the aperture, has repeatedly been 
shown (39,61-67,70) to align the cells in axial 
aperture flow. This procedure is also called 
hydrodynamic focusing. It produces dramatic 
improvement in pulse resolution by preventing 
aberrant pulse shapes and artifactual pulse 
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heights, thus enabling simultaneous rbc and plt 
counting and sizing. However, probably for 
pratical reasons (e.g. analysis speed, 
technical problems) this focusing technique is 
not applied in routine flow hey. Instead, other 
procedures such as pulse editing and sweep flow 
are applied to achieve sufficient cell 
resolution. 
3.3.2.2. Nonaxial cell flow and pulse 
editing (9,49,53,62-64,66-68) 
Since coulter-type counters generally do 
not have hydrodynamic focusing (49,68), pulses 
are allowed to be sensed from cells travelling 
through various parts of the sensing apertures. 
As by choosing optimal aperture dimensions only 
a fairly small portion of the cells will be 
nonaxial, there will be a relatively small 
artifactual right skew of the cell 
distributions. In routine flow hey, electronic 
circuits edit rbc and wbc pulses to exclude 
those produced by nonaxial cells (10). The edit 
circuits select only those pulses coming from 
one by one central passage through the sensing 
zone. Such pulses have width to height ratios 
for single cells within tightly definable 
limits (53). 
3.3.2.3. Sweep flow (9,49,61,62,67,70) 
At the outlet of tubes (apertures) flow 
transition from a small-diameter tube to a 
large-diameter tube occurs. The divergence 
angle at the widening tube is not allowed to 
exceed some 8° to prevent flow separation with 
formation of turbulence. So-called fluid eddy 
currents and a backflow of part of the fluid 
and cells ejected by the aperture occur, 
producing distorting pulses (70). In modern 
eight-parameter Coulter counters the so-called 
sweep flow (49), a steady stream of diluent 
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that flows behind the rbc apertures during the 
sensing period, prevents cells from re-entering 
the sensing zone and being counted as plt. The 
sweep flow technique provides many of the 
advantages of hydrodynamic focusing, enabling 
the simultaneous counting and sizing of rbc and 
plt. (49,67) 
3.4. Electrical (aperture-impedance) 
counting and sizing (Coulter 
principle) 
3.4.1. Introductory (Courtesy V.Kachel and 
M.L.Mendelsohn, Ref 70) 
The issuance of a patent for an 
electrical resistance technique for high-speed 
cell counting to W.H.Coulter made the year 1953 
EXTERNAL 
ELECTRODE 
APERTURE 
CURRENT 
APERTURE 
VACUUM {6"Ho) 
APERTURE 
Tl!BE 
Fig 1. Coulter Method of Counting and Sizing (Reprinted with permission of 
Coulter ElectronicS Ltd, Luton, l.IKl 
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a landmark in the development of flow hey 
systems. Over the next few years this brilliant 
invention was developed commercially into the 
"Coulter Counter", now well known for its 
successful application in clinical haem. 
laboratories (70). Coulter's idea is'~asy to 
comprehend but its simplicity is deceptive. 
Imagine a dilute suspension of cells in saline 
being drawn through a narrow aperture (50-100 
urn in diameter typically). At the same time a 
constant current, i, flows through the 
aperture. (Fig. 1) (70) 
Since cells are poor electrical 
conductors due to membrane resistivity, a cell 
traversing the aperture causes the electrical 
resistance, R, to be momentarily increased, ~ 
R, thus generating a voltage pulse of amplitude 
i x /\ R. These electrical pulses can easily be 
amplified and counted; at the same time the 
volume of cell suspension flowing through the 
aperture is measured, yielding the number of 
cells per milliliter of suspension. This rather 
simple measurement turns out to be extremely 
useful in clinical haematology and biological 
research. It is widely used for counting blood 
cells. (70) 
In addition, by measuring the voltage 
pulse it is possible to determine the cell size 
and thus obtain size distributions of cell 
populations - important information very hard 
to get any other way. Although easy to verify 
qualitatively, the quantitative relationship 
between cell volume and pulse height turns out 
to be complex, especially for human rbc around 
which was centered most of the early work and 
controversy. We now have a much clearer 
understanding of the important variables such 
as cell shape and orientation, shape changes 
under the hydrodynamic forces in the aperture, 
the cell trajectory through the aperture, the 
electrical field distribution in and near the 
aperture, the aperture dimensions, coincidence 
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effects, and electronic instrumentation 
effects. ( 70) 
3.4.2. Blood cell counting 
3.4.2.1. Counting accuracy with special 
reference to red blood cell 
counting 
The difference between analogue and 
digital counting has already been described in 
s 3.2. 
In Ch II, Fig. 2 and S 3.1.1. we already 
mentioned the substantial variation in the mean 
counts of the same blood specimen produced by 
different instruments, as described by Thorn 
(8). Similarly, Helleman (59) found differences 
in results varying from 3.5 to approx. 5%, when 
comparing a number of digital instruments. 
Harfield (9) describes a scatter of values 
around the average ranging from -11.8 to +16.4% 
from 10 individual laboratories using several 
different Coulter counters. 
Accuracy of count results is dependent on 
the correctness of the following items 
(5,8,11): 
a. the counting volume 
b. the counting device 
c. the discriminator setting 
d. coincidence correction 
e. background pulses correction 
f. blood sample dilution factor 
g. integrity of the blood sample (absence 
of count loss due to lysis and/or 
adherence of cells to the wall of the 
container and/or due to cell clumping; 
absence of count gain due to 
contamination) 
h. absence of other interfering causes, such 
as leaks, plasticizers, abnormal cells 
etc ( 11). 
We shall briefly discuss some of these 
80 
accuracy items. 
a. The counting volume. Digital instruments 
have--a controlled displaced liquid volume 
(5,67). In a Coulter Counter this displaced 
volume is factory calibrated to at least 0.25% 
of the stated volume by procedures traceable to 
the u.s National Bureau of Standards (67). In 
analogue instruments accuracy is highly 
dependent on the accuracy of the calibration 
(Ch II). 
b. The counting device. Proper electronic 
instrumentation is essential for accurate 
counting and sizing. The counting device can be 
tested by aid of the voltage pulses generated 
by a Particle Simulating Instrument (PSI) (5) 
or other pulse generator (11,70), such as those 
built in the latest Coulter Models to perform 
"ramp" and precision tests. For other tests 
necessary for optimal performance we refer to 
the various instruments' Manuals (See also Ch 
II, S 3.1.1. ). 
c. The discriminator setting selects wanted 
from---unwanted pulses. This setting is 
particularly important with regard to cell 
counting accuracy, as improper setting causes 
count loss or count gain. Moreover, the setting 
accounts for the degree of coincidence loss 
(see below). Last but not least, accurate 
setting is vital to the appropriate 
differentiation of cell types e.g. plt and 
microcytic rbc or lymphocytes and granulocytes. 
Helleman (5) comments on the calibration of the 
setting of Coulter type counters. By aid of the 
PSI the necessity of recalibration can be 
explored and zero setting and linearity of the 
discriminator can be tested; moreover it is 
possible to compare the response to pulses of 
two similar counters. Provided zero settings 
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and linearity of the discriminator are correct, 
the value of the "critical discriminator level" 
can be calculated from the relative change of 
the value of the mode or the counting plateau 
of the frequency distribution curve of a 
suspension of stable particles of the relevant 
size (e.g. approx. 35 fl. to discriminate plt 
from microcytic rbc) (5). 
d. Coincidence correction and 
f. blood sample dilution factor (5,70). 
Coincidence is the phenomenon occurring when at 
the same moment two or more particles appear in 
the sensing area of the detecting device, and 
when two or more pulses follow each other so 
closely, that they cannot be discriminated by 
the discriminator device, and also when two or 
more count pulses follow each other at such 
short time intervals that the counter is not 
able to count these pulses separately (5). If 
the identical cells move through the aperture 
as if stuck together, a double-sized pulse 
results and the two cells are incorrectly 
measured as one cell of double volume. If they 
move through the aperture in tandem sequence 
then a double-humped pulse results and again a 
false value is recorded. The latter effect can 
be recognized electronically and rejected. (70) 
Coincidence error is dependent on the 
length of the sensing zone and on the cone, 
flow rate and size of the partirzes <61,67,70). 
For a nominal rbc-count of 5xl0 rbc/1 counted 
at a dilution of 1 in 50,000, the error will be 
12% in an aperture which is 100 urn in length; 
of the 12% loss, 10% is the result of geometric 
cell coincidence and 2% is caused by electrical 
time constants (the time constant of the 
amplifier will affect the ability of the 
detector to recover from a pulse in time to 
respond to a following one). (67) Although the 
magnitude of the error diminishes with 
decreasing cell cone, the error cannot be 
brought down by increasing the dilution of the 
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specimen from 1 in 50,000 to, say 1 in 
1,000,000. Such an approach is undesirable 
because dilutions as great as 1 in 1,000,000 
pose problems of volumetric accuracy (8,67), 
they downgrade precision from 0.5% to 2% and, 
more importantly, these high dilutions 
generally are not stable, because of the 
adhesion of cells to the wall of the tube or 
the container (8,11). There is a loss depending 
on the properties of the material, the shape 
and size of the cells and the surface 
properties of the container (8,11). Adhesion 
could even be increased by agitation of the 
filled container on a roller-mixer (8). 
A more effective alternative is to 
replace the standard aperture with one that has 
a diameter of 0.030 mm and a length of 0.050 mm 
(67,70). The reduction of the sensing zone 
volume achieved by this arrangement results in 
a reduction of coincidence error by a factor of 
at least 20 or to a level of 0.6% for normal 
blood diluted 1 in 50,000 (67). Furthermore, 
the error is now virtually a linear function of 
count and its magnitude can be confirmed by 
performing an additional count at a dilution of 
1 in 100,000 (67). This simple approach to 
extracting the full-potential performance from 
a single counter is not without penalty, since 
the time it takes liquid to pass through the 
smaller aperture is considerably greater than 
in standard (routine) counters and the chance 
of aperture obstruction is increased (67). It 
will be clear that routine cell counting 
instruments are without exception optimized in 
speed by sacrificing accuracy (8). However, 
when a counter is to be used in a ref method, 
the coincidence error should be removed rather 
than corrected after the fact (67). 
For a mathematical elaboration on 
coincidence theory, we refer to Helleman 
(5,59). 
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3.4.2.2. Platelet and white blood cell 
counting 
Thanks to the various fluidic and 
electronic improvements described ins 3.3.2, 
plt can be counted simultaneously with rbc (61-
70). Instruments not equipped with these high-
resolution devices, require prior separation of 
plt from rbc, usually by differential 
centrifugation, yielding so-called platelet-
rich plasma (lll. 
A particularly important source of error 
in plt counting due to anticoagulant-induced 
pseudothrombocytopenia has already been 
discussed on inCh II, s 3.1.2.1. 
All methods used for wbc counting 
necessitate a haemolysing reagent to eliminate 
the rbc which exceed the wbc numbers in normal 
blood by approx. 1000:1. Wbc are counted in 
separate counting apertures, the dimensions of 
which are different from those of rbc apertures 
(10). It is a matter of course that incomplete 
rbc lysing will lead to falsely high wbc 
counts. On the other hand, improper 
discriminator setting will generally cause 
count loss. As wbc counting and sizing are 
closely connected, we refer for further details 
toS3.4.3.6. 
3.4.3. Blood cell sizing 
and after the biologist and 
the .chemist had completed their 
descriptions of the horse, the 
physicist began: "Now let us first 
assume that the horse is a sphere" 
Kerker et al (71) 
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3.4.3.1. Primer of aperture-impedance 
theory 
Kachel 
signal from 
and aperture 
where 
(70) shows that the electrical 
a Coulter sensor depends on cell 
parameters as follows 
/\ U - Vpif/r4 
1\ U = amplitude of voltage pulse 
v-= particle volume 
p = electrolyte resistivity 
i = aperture current 
f = cell shape factor 
r = aperture radius 
The equation applies to "long" apertures 
(length-diameter ratio between 1 and, say, 2) 
such as in the Model S-Plus II, where rbc 
apertures length and diameter are 60 and 50 urn, 
respectively. As can be seen, the output 
voltage is strongly dependent on the aperture 
radius r, showing the importance of small 
apertures for measuring small objects 
While pulse height is essentially 
proportional to the electrolyte resistivity p, 
particle resistivity has very little effect on 
the voltage response, unless it is quite close 
to the resistivity of the liquid. If the 
particle resistivity changes from one million 
to 100 times that of the electrolyte, there is 
less than 1% change in the response (67,70). 
The distribution of current density i in 
and near the aperture is important. The 
equation shows that the voltage pulse is also 
proportional to i, which is dependent on the 
position in the short aperture commonly used, 
especially near the edges where the current 
density is maximal. As a result, pulse shape 
and amplitude vary with the cell trajectory, 
causing inaccurate cell-volume distributions. 
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As we have seen, this problem can be partly 
solved by electronic editing or, preferably, by 
hydrodynamic focusing. (S 3.3.2). 
Finally, ~ U is linearly proportional to 
f, the cell shape factor. This is dealt with in 
the next Section 
3.4.3.2. The shape factor. 
In an aperture current field the lines of 
force around a rigid sphere follow a fusiform 
shape, creating an electrical "shadow" in the 
field that is very nearly 1.5 times the volume 
of the sphere itself. It is the volume of this 
"shadow" that determines the height of the 
pulse (49,63,67,70). A sphere is said to have a 
shape factor 1.5. Particles with other shapes 
produce more complex shadows, but it is not 
difficult to get an intuitive grasp of the 
relationship between the volume of the shadow 
and the shape and orientation of the particle. 
Electric Field 
Elongated Object 1.0 Sphere 1.5 Disk 2.8 
Fig 2. Shape fa~tor for some geometri~ shapes with the same volume 
(49,63,67, 70) 
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For instance, a disc oriented with its plane 
normal to the current field, will produce a 
shadow that is large in relation to its 
geometric volume (shape factor approx. 2.8). 
Position the disc with its plane in the axis of 
the current flow and the electrical volume 
becomes a better representation of the 
geometric volume. A long, slender body with its 
long axis moving parallel to the current field 
will have an electrical space volume only 
slightly greater than its geometric volume: its 
shape factor approaches 1.0. Thus the shape 
factor could be defined as the ratio of the 
signal pulse height produced by a given 
particle to the minimum pulse height that can 
be produced by a particle of the same volume 
(see Fig. 2). 
3.4.3.3. Flow-induced (red) cell shape 
changes 
Bagge et al (69) and Kachel (70,73) 
presented photographic evidence of the shape 
changes that rbc undergo when they are 
subjected to hydrodynamic stresses in 
apertures. They showed that normal rbc 
suspended in saline took on an ellipsoidal 
shape in fast liquid streams such as those 
found in Coulter apertures. This shape conforms 
very closely to the lines of current force that 
flow around it, causing the electrical shadow 
volume and the geometric volume of rbc to have 
nearly the same value. They found shape factors 
in the 1.06-1.12 range (mean 1.09). Similarly, 
they found a shape factor of approximately 1.5 
for human lymphocytes and granulocytes as well 
as for fixed, shrunken rbc, lacking the ability 
to deform into a fusiform shape. 
These facts can seriously 
accuracy of cell volume (MCV) and 
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affect the 
indirectly 
RDW, Hct and MCHC-determinations (37). several 
detailed papers and reviews have been written 
on techniques of measuring rbc deformability of 
both normal and pathological subjects (39,74-
79). Deformability is a basic characteristic of 
rbc; its regulating factors are presently well 
known: surface-volume ratio, internal viscosity 
and viscoelastic properties of the membrane 
(75,78,79). Herrera et al (75) have recently 
studied the deformability of 64 hereditary 
haemolytic anaemia rbc, using the 
Ektacytometer, a laser-diffraction viscometer 
(74). They found that deformability is always 
decreased (and consequently the shape factor is 
increased) in rbc membrane diseases and in 
haemoglobinopathTeS: on the other---hand 
deformabilities were found normal in all the 
enzymopathies studied. The deformability 
decrease could be either due to one regulation 
factor (increase of internal viscosity easily 
demonstrated by ektacytometry in hereditary 
xerocytosis and haemoglobin CCl or to several 
parameters: increase of internal viscosity and 
decrease of surface-volume ratio in hereditary 
spherocytosis. 
Bator et al. (39), using a novel method 
enabling monitoring of the deformability of 
individual cells, demonstrate that the measured 
MCV of 114.3 fl of a (homogeneous) sickle cell 
sample, actually would be 90.3 fl, if 
appropriate allowance would have been made of 
the shape factor of 1.38 instead of using a 
fixed factor of 1.09, since 114.3 x 1.09/1.38 = 
90.3 fl. 
Since, as we have seen, impedance-sizing 
flow hey uses a constant (mean) rbc shape 
factor of 1.09 <39l for pathological or 
artificial rbc with decreased deformabilities 
(and consequently increased shape factors) the 
impedance signal over-estimates the rbc volume, 
that is the MCV and the Hct, and consequently 
underestimates the MCHC (37). The opposite 
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applies, albeit to a lesser degree, for rbc 
with increased deformabilities: the MCV and Hct 
will be underestimated and the MCHc--will be 
overestimated (37). This-was already mentioned 
inS 2.3.3. for polycythaemic patients with low 
MCH (p. 68). 
The overall conclusion is that in 
impedance-sizing MCV and Hct will be found 
erroneously more extreme than the "true extreme 
value" at either extreme side of the mean, 
whereas the MCHC tends to be erroneously 
blunted, leading to erroneous constancy <cf S 
2.3.3., p. 68). 
3.4.3.4. Red blood cell sizing: MCV (Hct, 
MCHC) and RDW 
3.4.3.4.1. MCV (Hct, MCHC) 
All the main features pertaining to MCV 
(and consequently Hct and MCHC)-measurements 
have already been described, viz: 
a. The mean of the micro-Hcts of several fresh, 
normal blood specimens as a reliable MCV 
calibrator for flow hey instruments, provided 
1.5% allowance for trapped plasma is made (S 
2.3.2, p. 68). 
b. MCV-errors due to abnormalities of the blood 
specimen such as hyperosmolar plasma, cold 
agglutinins, haemolysis etc. (Ch II, S 3.1.2.1). 
c. MCV dependency on fluidic and electronic 
improvements (S 3.3.2, p. 75). 
d. MCV dependency on flow-induced shape changes 
(deformability) (S 3.4.3.3, p. 87). 
3. 4. 3. 4. 2. RDW 
It will be evident that factors 
influencing MCV will generally also have their 
impact on the Red cell Distribution Width (RDW) 
and vice versa. As described ins 3.3.2., the 
fluidic and electronic techniques employed in 
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the different instruments and the shear 
stresses applied during the measurements can 
greatly affect the height and shape of the 
generated pulses and hence rbc size 
distributions. However, if artefacts can be 
avoided, these distributions, visualized in 
histograms, reflect the native non-discrete 
heterogeneity of rbc (80,83) and the RDW is an 
index of this natural variation in rbc size; it 
is a quantitative analogue of what is termed 
subjectively "anisocytosis", or heterogeneity 
of size, on the peripheral blood smear. Bessman 
et al (81) have recently described their 
important "Improved classification of anemias 
by MCV and RDW". Nutritional deficiency, 
whether iron, folate, or vitamin Bl2, always 
causes an increased RDW, the RDW being more 
sensitive than the MCV. In contrast, normal RDW 
accompanies pure hypoproliferative anaemias, 
resulting from chronic disease, marrow 
toxicity, or aplasia, independent of the MCV. 
Among the hereditary haemoglobinopathies there 
is a Telation between anaemia and RDW: RDW is 
normal unless concomitant deficiencies are 
present (81,83). In increased rbc destruction 
from any cause and with any MCV, nonanaemic 
compensated disorders are homogeneous (normal 
RDW), whereas anaemic disorders are 
heterogeneous (increased RDW). Johnson et al 
(82) confirmed these findings in microcytosis 
for heterozygous thalassemia and chronic 
disease on the one hand (normal RDW) and iron 
deficiency on the other (increased RDW). 
Moreover, Bessman et al (81,83) show how rbc 
histograms identify rbc fragmentation or 
agglutination, dimorphic populations (e.g. by 
transfusions or iron therapy) and artifactual 
counting of lymphocytes as rbc. 
An important feature of the RDW is the 
confusion brought about by the various 
prevailing RDW definitions and the ensuing 
potential pitfalls in RDW interpretation (84). 
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The RDW definition differs not only among the 
various Models of the Coulter Counter (53), it 
also differs among manufacturers. Whereas in 
the Coulter S-Plus-I the mean of the RDW values 
was equal to 10 (ten) by definition (53), 
thanks to the improved technology in the Model 
S-Plus-II (and subsequent Models) RDW could 
represent a final CV and is expressed as a 
percentage, the reference range being in the 
order of 13.3 +/- 1.5% (53,84). By a special 
computational technique the latter RDW is 
totally unaffected by artefacts (large plt, plt 
clumps or electrical interference on the left, 
and doublets, triplets, agglutinates, and 
aperture artefacts on the right) and 
consequently more precise and very sensitive to 
distribution variations (53,67). The Sysmex 
instrument CC-800 defines RDW as the 
"distribution width measured 10 percent of the 
distance from the base to the highest peak" 
(85), being only a direct measurement of the 
rbc distribution width, not divided by MCV to 
give a CV. With such a measurement when MCV is 
low, either a heterogeneous or homogeneous 
distribution will produce a normal RDW. When 
MCV is high, any rbc-distribution will yield a 
high RDW by this technique (84). Thus, use of a 
ROW-definition that is not a CV will not allow 
the important distinctions described by Bessman 
et al. (80,84). ICSH have issued proposed 
recommendations for the standardisation of cell 
size analyses to further comparability of 
results (86,87). 
Although, perhaps, less suitable for 
routine clinical purpose~, these RDW-problems 
can be avoided by us~ng the actual rbc 
distribution histograms rather than their 
descriptive statistics. Moreover, these 
histograms can give a superior impression of 
the actual situation compared to figures alone. 
This is beautifully exemplified in several 
recent papers (81-83,88,89). Bessman et al 
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(81,83) and Scholda et al (89), using the 
Coulter Model S-Plus II, found valuable results 
in microcytic and macrocytic anaemias for 
diagnoses as well as for monitoring the 
therapy. They show that the mechanized volume 
distribution analysis is superior to the 
microscopic cell size estimation, except in 
spherocytosis (which, as we have described, is 
generally not appropriately sized by automated 
instruments due to deviating shape factors; s 
3.4.3.3). Moreover, rbc histograms are 
quantifiable in contrast to blood smear 
analyses. This is the more important since 
individual people have their own rbc histograms 
(83), that can be reproduced very precisely 
(83). 
3.4.3.5. Platelet sizing, MPV, PDW, Pet 
Since the literature on plt sizing is 
proliferating, it is impossible to cover 
the subject in detail. Timely reviews and 
papers on the techniques, biological 
significance and clinical applications of plt 
sizing have recently been published (11,49,90-
95). The major features will be briefly 
highlighted here: 
a. Shape changes and MPV 
Similar considerations about fluidic and 
electronic improvements (62,66) and about 
deformability and shape factor, as described 
for rbc (see above), apply to plt, although plt 
are much less deformable than rbc under shear 
stress (90,91). On the other hand, there is a 
substantial influence of the specimen 
temperature and of the type of anticoagulant on 
the MPV (94,98,99). EDTA, in contrast to 
citrate, causes plt to transform from an 
ellipsoidal shape to a sphere, resulting in 
EDTA/citrate-MPV ratios of 1.26-1.50 (90,94). 
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EDTA appears to cause a time dependent increase 
in MPV, probably due to 2 factors: shape change 
and, after a variable period of time, actual 
swelling due to water uptake (90,94-99). This 
phenomenon makes standardization in pit-
analysis time and temperature imperative if 
reproducible and comparable MPV-values in EDTA-
anticoagulated blood are to be expected (94-99) 
(MPV are constant after 2-4 hours). On the 
other hand, both plt count and MPV remained 
stable in blood collected in ACD/di-Na-EDTA 
anticoagulant for up to eight hours at room 
temperature; moreover this anticoagulant 
provided the best overall conditions of 
anticoagulation (98). 
b. Platelet distribution and PDW 
Plt volumes approximate a log-normal 
distribution <85,90,92,96), their heterogeneity 
being expressed as Platelet Distribution Width 
(PDW) (88). In order to avoid interference 
(e.g. due to microcytic rbc, electrical noise, 
megakaryocytes etc) in the Coulter S-Plus 
counters, stringent distribution criteria must 
be met for curves to be fitted and accepted 
(10,53). Different criteria are established in 
Sysmex instruments (85). Analogue to the ROW-
situation, PDW definitions differ among the 
various Coulter S-Plus Models (53) and among 
different manufacturers: its reference value 
being 10 for Coulter's S-Plus I and 17-19 for 
Coulter's S-Plus II-V (53), whereas Sysmex 
defines PDW (identical to RDW) as the 
"distribution width measured 10 percent of the 
distance from the base to the highest peak 
( 8 5). 
c. Inverse, non-linear relationship between MPV 
and plt-count 
In normal subjects there is an inverse, non-
linear relationship between MPV and the plt 
count (88,94), necessitating the use of a 
nomogram for practical applications (Fig. 3) 
( 9 4). 
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Characteristic departures from this 
relationship have been described for several 
diseases (88,94,100). Taking into account the 
nomogram, MPV is normal in hyperdestructive, is 
low in hypo-proliferative and is high in 
myeloproliferative diseases as well as in 
splenectomy (94,100). The inverse relationship 
implies that the "normal" Pet-value is also 
dependent on the plt count. Although the above 
0 100 200 300 400 500 
Platelets(" 10 9/L) 
Fig 3. i'!PV-r10mogram (Reorinted with permission of Coulter 
Electronics Ltd, Luton, ll<l 
shows that important clinical information can 
already be gained from MPV, the routine use of 
EDTA and the ensuing requirement for carefully 
controlled conditions impede the practical use 
of MPV in diagnoses (90). Problems are further 
compounded by the lack of comparison of MPV-
values in different instruments due to both 
different MPV-definitions and different 
instrument responses to the available MPV QC-
materials (101,102). 
d. Platelet Rich Plasma (PRPl 
If only older-generation routine instruments, 
not capable of simultaneous counting and sizing 
of rbc arid plt, are available, plt will have to 
be separated from rbc. The most common method 
94 
used has been low-speed centrifugation, 
yielding so-called Platelet-Rich Plasma (PRPl. 
However, centrifugation leads to variable plt 
counts and can lead to non-random exclusion of 
larger plt (90). This problem may be further 
aggravated in pathological conditions (90). 
Increasing g-forces progressively deplete PRP 
of its larger plt with a concomitant fall in 
MPV and PDW (103). Anticoagulants also affect 
these parameters (103 l. So strict 
standardization of PRP preparation is needed 
( 103). 
e. Overall conclusion 
EDTA is less suitable for optimal routine 
determination of plt counts and MPV, because of 
time-dependent plt swelling and a relatively 
high incidence of aggregation (Ch II, S 
3.1.2.1). The promising characteristics of low-
pH citrate (or citrate/EDTAl should be further 
explored in order to reliably benefit from 
valuable MPV data that flow hcs could provide 
in daily routine (97,98). 
3.4.3.6. White blood cell sizing: partial 
differentiation 
Under the controlled conditions of lysis 
in the Coulter Models S-Plus II-V, partial 
differentiation of wbc by volume analysis has 
been accomplished: lymphocytes and granulocytes 
can be differentiated (10,49,67,88). In 
Coulter's Model S-Plus IV-D a third population, 
called monocytes, also includes blast and 
plasma cells, Cpostlmyelocytes, promyelocytes 
and promonocytes, while granulocytes also 
encompass metamyelocytes, eosinophils and 
basophils (49,88). However, these histograms do 
not represent the actual volumes of wbc, in 
contrast to the rbc and plt histograms 
(10,49,88). The lysing reagent acts on the wbc 
membrane and cytoplasm, causing differential 
shrinkage of the wbc types, allowing the wbc to 
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be classified by their relative sizes (49,88). 
Richardson Jones (67) and Gibson (104) give a 
full account on the historical development of 
this method over the last two decades. 
In several recent papers good correlation 
is described between lymphocyte counts given by 
the Coulter Models S-Plus II-IV and microscopic 
counts (105-108). Likewise, these coulter 
Models correlated well with three other 
automatic wbc analyzers (Hemalog D, H 6000, 
Diff 3) (106). Consequently, applying this in 
daily practice, could substantially reduce the 
number of conventional differential counts by 
carefully prescreening by automatic wbc 
counting and sizing (105-108). However, it 
should be taken into account that high 
rejection rates and often considerable 
underestimation of the lymphocyte percentages 
were observed in neonates and infants as well 
as in infectious mononucleosis and in 
lymphoproliferative disorders. (108) 
It will be obvious that adequate 
threshold setting is vital to the appropriate 
counting, sizing and (partial) differentiation 
of wbc. It should be remembered that these 
settings are dependent on the particular lytic 
agent, diluent and aperture tube used (8,11). 
Furthermore, it should be realized that QC 
materials invariably contain simulated rather 
than native wbc, being either fixed (human or 
avian) rbc, fixed wbc or latex particles (8). 
Thorn (8) beautifully depicts threshold curves 
which manifest the discrepant behaviour to 
diluents and lysing agents between non-lysable, 
osmotically inert, wbc simulators and native 
wbc, which are liable to lytic and osmotic 
influences. consequently, totally different 
pulses can be generated by originally equally-
sized simulated and native wbc. In practice, 
adequate threshold setting is only possible 
with native wbc (8,11). 
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3.5 Optical (light-scattering) blood cell 
counting and sizing 
Under carefully controlled experimental 
conditions light scatter signals from cells can 
give practical data on cell number and size. 
The signals can also contain much additional 
morphological information, but they are often 
difficult to interpret because the scattering 
process is a complex phenomenon. This process 
is a function of many cell characteristics such 
as size, shape, orientation, (relative) 
refractive index and properties of the nucleus 
and organelles, if any (109-117). For particles 
such as blood cells whose size is greater than 
the wavelength of the incident light, most of 
the scattered light is concentrated within a 
narrow angular region in the forward direction: 
the so-called Mie-scattering (109,113,114). The 
extent of this region is defined by the angle 
for which the intensity of scattered light 
reaches its first minimum. As the angle of 
observation increases beyond this minimum, the 
intensity of scattered light varies in an 
alternating sequence of maxima and minima 
produced by interferences of the reradiated 
waves from various portions of the cell (109). 
Due to the complexity of the scattering 
phenomena, practical results have come from 
empirically determined relationships between 
the scatter signals and cell characteristics 
(109-117). 
The main representatives of light 
scattering instruments are Ortho's "ELT"-series 
(51,52,54,55) and Technicon's H-6000 and its 
predecessors (51,56-58) (cf S 3.3.2.1). In 
many respects their accuracy and precision are 
affected by factors common to all flow hcs 
irrespective of their detection system. 
a. A 
be 
Special features of optical systems are: 
relatively small sensing volume that can 
obtained by employing a hydrodynamically 
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focused sheathed sample stream and by 
focusing the incident light (cf S 3.3.2.1). 
For optical systems volumes as small as 2-3 
pl are commonly obtained as contrasted with 
aperture-impedance sensing volumes that 
typically exceed 100 pl (113). 
b. Although optical sensors have relatively 
small sensing volumes, it is generally 
necessary to apply a correction for 
coincidence, especially if the system is to 
be used to count both rbc and plt at the 
same dilution (113). 
c. Cells are counted in laminar flow and hence 
undergo only a very small radial shear force 
that is zero at the center of the stream. 
Consequently, cells in laminar flow are free 
from longitudinal acceleration (37,113) in 
contrast to cells in aperture-impedance 
systems (S 3.4.3.3: flow-induced (red) cell 
shape changes). However, the typical 
mammalian biconcave-shaped rbc show <large) 
orientation-dependent variations in signal 
size (115,116). Both these differences as 
well as the dependency of optical sizing on 
cell refractive index can cause discordant 
MCV (Hct, MCHC) values of the same rbc in 
both systems (37-39, 54-56, 118,119). 
d. Laser-illuminated systems have greater 
potential for resolution of the structural 
details of the cells than (incoherent) 
light-illuminated systems (113). 
e. In Ortho's ~LT-instruments discrimination 
between rbc and plt depends upon three cell 
variables : volume, refractive index 
(MCHC;37,120l and "time of flight" (114) 
through the sensing zone. Moreover, by using 
a dual detection system in the so-called 
"three-part" version, the light scattered in 
the forward direction can be used for 
counting the various cells, while the laser 
light collected at right angles to the 
incident beam can be used to probe the 
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cellular granularity of wbc. This enables a 
wbc population to be segmented into 
granulocytes, lymphocytes and monocytes (51, 
52, 54, 55, 114, 121). 
f. In Technicon's H-6000 and some of their 
older-generation instruments wbc differen-
tiation is accomplished in a dual detection 
system where light scatter (depending on 
cell size) and light absorption due to cell 
peroxidase stain are simultaneously mea-
sured. In the XY-representation of scatter 
and absorption characteristics, movable 
thresholds divide the display into wbc 
subpopulations (51, 56-58, 113). 
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CHAPTER IV 
PREPARATION AND EVALUATION OF INTERNAL QUALITY 
CONTROL MATERIALS FOR FLOW HAEMOCYTOMETRY 
1. Prologue 
As emphasized inCh II, S 3.3, p.37 on 
HSLP in the analytical phase, control materials 
should play an essential role in the process of 
continuous self-auditing in daily hey routine. 
The extreme cost of commercial controls 
generally is a serious impediment to their 
frequent use in daily practice, a basic 
requirement for optimal IQC (S 2.4). This 
important disadvantage was one of our main 
incentives to this study on QA in hey in 
general and to the preparation of IQC materials 
in particular. 
We describe the possible approaches to 
the preparation of IQC materials and 
conclude that for rbc QC, native rbc are 
required (S 2.3). In the course of our 
investigations reported below, we gradually 
gained insight in a basically different 
behaviour to haemolysis of electrical and 
optical hey counters. As we describe in 
S 2.5 below, optical (light-scattering) 
instruments in contrast to electrical 
(aperture-impedance or resistive-particle) 
counters are sensitive to haemolysis, 
leading to decreasing rbc counts and increasing 
pseudo-plt counts. Since prevention of 
haemolysis appears to be a major problem in rbc 
preservation, preparation of IQC materials for 
electrical counters has been found much easier 
than that for optical instruments. The first 
five papers (S 2) deal with the descriptions of 
preparations and evaluations of IQC materials 
suited for electrical and to a lesser extent 
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for optical counters. The next two papers (S 3) 
are spin-offs of our ongoing research on the 
improvement of IQC materials for optical 
instruments. Since commercial 8-parameter IQC 
materials for the ELT-8 instrument do not yet 
exist (with one recent exception: Hyland's 
Lasercheck), a simple material for the 
instrument's plt counts is described (S 3.1). 
In the framework of our research on the further 
reduction of haemolysis, a sterile method for 
the age fractionation of rbc (S 3.2.) was 
developed. In S 3.3. a "comparison of the 
degree of haemolysis of young and old human red 
blood cells during storage" has been described. 
Although a highly significant difference 
between the degree of haemolysis of the 
fractions is found, the separation technique, 
unfortunately, does not yield a better starting 
material for IQC controls in optical 
instruments. Ongoing research on further 
reducing rbc haemolysis and pseudo-pit-
formation is quite promLSLng, but the 
procedures and results shall not be described 
here. 
Finally, the rheological behaviour of 
patient and control bloods is shown to be 
comparable at shear rates probably occuring in 
hey, provided their Hcts are taken into account ( s 4). 
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Introduction 
Adequate quality control (Q.C.) of white blood cell (WBC) channels of automated 
hematology instruments remains a major problem. Due to their extreme lability [1] 
and their great biological variability [2] native WBC are insuitable for most Q.C.-
methods as recently reviewed by Koepke and Protextor [3]. Therefore. the only 
pragmatic approach is using (commercial) controls containing stable WBC-sub-
stitutes [4]. preferably in conjunction with the use of a computerized "average of 
normals" Q.C. program [5]. 
WBC-substitutes used in commercial controls consist either of latex particles or of 
fixed human or avian RBC [6]. However. these substitutes of potentially long-term 
stability are seldom offered separately. but rather as so-called multiparameter 
controls (perhaps for commercial or practical reasons). The stability of these controls 
generally does not exceed 2 months. due to the presence of (stabilized) RBC andjor 
platelets. Consequently. there is a continual need to employ new multiparameter 
controls. which almost invariably come from different lots of material. Hence. these 
may differ in composition and subsequently the continuity of control might be lost. 
In this paper we describe the use of commercially available fixed human RBC as 
WBC-substitutes of long-term stability. To our knowledge. this is the first docu-
mented report on WBC quality control material exceeding 10 months" periods of 
stability. 
Methods and results 
Fixed human red blood cells (2.5 ml vials of "Stabicells") can be bought from the 
Rijksinstituut voor de Volksgezondheid (RIV). Bilthoven. the Netherlands. A box of 
6 vials (order No. 8011) costs about Dfl 95.00. equivalent to about S 35.00. The red 
blood cells were fixed with formaldehyde by the (slightly modified) method of 
* To whom correspondence should be addressed. 
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Benedek [7] (Dr. P.W. Heileman. personal communication). 
We did not attempt to make quantitative dilutions. After vortexing for 5 min, 
about 1 : 500 dilutions of Stabicells in lsoton or Isoton-Plus were made. For 
preservation 10% merthiolate was added in a final concentration of 1 : 2000. The 
suspension was divided into 30-ml glass injection bottles. that were kept at room 
temperature. Before use, the bottles were vigorously shaken by hand to suspend the 
cells then left undisturbed for at least 5 min to clear the foam and the air bubbles. 
(Persisting foam, if any, does not invalidate the results, provided the instrument's 
aspiration nozzle is kept below the foam.) Prior to aspiration the bottle was placed 
on a roller mixer or carefully inverted a few times to homogenize the suspension. 
Measurements were originally made in a Coulter Counter Model S and more 
recently in a Model S-Plus II. The WBC channels of both models were monitored 
with the commercial controls Ortho Normal and Abnormal (Ortho Diagnostics, 
Beerse, Belgium). Moreover, Haem C control (Baker Diagnostics, Bethlehem, PA, 
USA) was used in the Model S and Hyland 8-parameter Hematology control 
(Hyland Diagnostics, Lessines, Belgium} in the Model S-Plus II. Accuracy was 
checked in a monthly regional Q.C.-survey and in the Ortho Quality Control 
Program. Recalibration was performed if judged necessary by the accuracy checks. 
Table I shows the results of (I) one representative lot (Lot I) of the four lots of 
suspensions measured on the Coulter Model S over the past 6 years: (2) the most 
recent suspension measured on a Model S-Plus II: and (3) the lymphocyte per-
centages as generated by the Model S-Plus II. 
TABLE! 
RESULTS OF THE WBC MEASUREMENTS l:-1 THE COULTERS AND COULTERS-PLUS II AS 
WELL AS THE LYMPHOCYTE PERCENTAGES AS GENERATED BY THE COULTERS-PLUS 
II. 
n X SD CV(%) Lymphocyte(%) 
(X 10°/1) 
n X CV(%) 
CoulterS 
Lot 1 
first 8 weeks 20 I !.08 0.18 1.7 
total 19 months 99 10.98 0.31 2.8 
last 9 weeks 20 10.99 0.23 2.1 
Coulter S~Plus II 
Lot 2 
first 10 weeks 20 7.02 0.15 2.2 4 86.3 1.4 
total 10 months 92 6.97 0.16 2.3 35 86.7 2.0 
last 6 weeks 44 6.98 0.15 2.1 II 85.8 1.8 
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Discussion 
Table I shows overall coefficients of variation (CV's) of 2.8 and 2.3% in the stated 
periods. These CV's compare favourably with an inter-assay CV of 3-6% for WBC 
as stated by Gilmer and Williams [4]. The differences in the means between the first 
weeks, the last weeks and the total periods are neither statistically ( p > 0.05) nor 
clinically significant. Good linearity was shown by a I: I dilution of Lot No. 2 in 
Isoton-Plus giving a mean value of 3.45 (n = 8). 
Initially quantitative dilutions were made to check the accuracy of the measure-
ments. The discrepancies between the experimental results of lot 2 (mean value= 7.0) 
and the theoretical value of 7.6 (1.85 ml of Stabicells - concentration 4.12 X 1012 
RBC/1 - in 1.0 I of Isoton-Plus) can be explained by the suggestions of Thorn [2]. 
He states that exact WBC counting. employing WBC-substitutes and using counters 
with a fixed threshold value calibration, is more or less a matter of luck, due to 
'incompatibility' between simulated and native WBC. ('Incompatibility' meaning 
that patient blood and control blood cannot be measured with the same threshold 
level due to generation of different pulses in relation to frequency. shape and 
amplitude distribution [2j.) 
Discrepancies of results of WBC-substitutes can also be due to differences in 
measuring principles, notably the Coulter principle versus the laser principle. This is 
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Fig. 1. WBC-Histogram of single aperture 2 (SA 2) showing total WBC and lymphocyte percentages 
display. 
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very pronounced with latex particles and fixed avian cells like chicken red blood 
cells (RBC). With Hyland's Normal 8-parameter Blood Control containing fixed 
avian cells. we found 6.6 (n = 5) in the Coulter Model S-Plus II against about 27 
(n = 5; bad reproducibility) in the ELT-8 (Ortho Diagnostics). The histogram of 
these ellipsoid cells with round nuclei was found to be bimodal (not shown) due to 
their random orientation as they pass through the laser beam. as described by Loken 
et al [8] for forward angle light scattering. On the other hand we found 12.5 (n = 2) 
in the ELT-8 against 11.0 in the CoulterS for the fixed human RBC used in our Lot 
No. l. Latex particles may also be used as WBC substitutes. However, apart from 
being very expensive~ they bear the least resemblance to native cells. leading to very 
different responses in different instruments [9]. These examples clearly demonstrate 
that the values obtained from the two instruments. of the fixed human RBC (used as 
WBC substitutes) are in much closer agreement (12.5 and 11.0) than those of avian 
RBC (27 and 6.6) and latex particles [9]. 
There is no commercially available reference control material suitable for moni~ 
toring the performance of the lymphocyte percentage (ly %) function in the Model 
S-Plus II [10]. Therefore, this function should be evaluated at least daily by 
comparing the conventional differential results for all samples with the results 
reported by the ModelS-Plus II [10]. Generally, after analysis of our suspension a ly 
% print-out is not automatically obtained. but. the percentages of the individual 
channels can be printed out instead (Fig. 1). Although the suspension cannot be 
used to check on the proper functioning of the shrinking process of lymphocytes. it 
can be used to monitor the proper ly % calculation (Table I). 
In conclusion, we show that Stabicells are a simple. inexpensive Q.C. material for 
monitoring long-term WBC reproducibility. They are. however. pot suitable for 
absolute WBC calibration. 
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Summary 
The preparation and evaluation of a human platelet-white blood cell control of at 
least 5 months' stability, as measured in the Coulter Counter Model S-Plus II. is 
described. In some preparations minor departures from log normal platelet (PL T) 
distributions were found, impeding the generation of values for mean PLT volume 
(MPV) and PLT distribution width (PDW). In many cases, however, excellent 
linearity for PL T and white blood cell (WBC) counts and low coefficients of 
variation for PL T and WBC counts and PDW were found. Some possible factors 
causing the large coefficient of variation found for MPV values are mentioned. 
Introduction 
Once the calibration of platelet (PL T) channels of the Coulter S-Plus II has been 
performed [1-6], stable (and preferably inexpensive) materials are needed to monitor 
the instrument's performance and drift [7]. Human PLT-counts in normal EDT A-
anticoagulated blood are stable for a few days, provided the blood is intermittently 
mixed [8]. As a consequence of this short-term stability, EDT A-blood is not suitable 
as a control. 
PL T-control samples have always proven to be most difficult to manufacture [9]. 
Hence PLT-substitutes are employed such as human and animal PLT (stabilized or 
fixed). animal red blood cells and plastic particles [1,3-7,10]. However, there are 
problems encountered with these materials [l-7.10]. These include: (1) clumping of 
PLT [1,2]: (2) non-matching of PLT substitute distribution with the actual human 
PLT distribution [3-5]: (3) cumbersome fixing procedures [6]: (4) discrepancies 
between the results obtained from two types of instruments: resistive-particle 
"' To whom correspondence should be addressed. 
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(Coulter-type) instruments and laser-based instruments. These are brought about by 
differences in measuring principles [10]. 
The above suggests that human PLT are very labile. Nevertheless. in this paper 
we describe a simple method for the preparation of a stable. unfixed human 
PLT-control used in a Coulter Model S-Plus II. Furthermore. we show that this 
PLT-control exerts no adverse reactions with the stable white blood cell (WBC) 
control we recently described [11]. thus providing a human PLT-WBC control of at 
least 5 months" stability. 
Materials and methods 
Preparation of a P LT-concentrate from buffy-coats 
Human PLT-concentrates are made from fresh buffy-coat layers within 24 h and 
kept at room temperature to preserve the normal. discoid PLT shape [12]. All 
preparations are made under sterile conditions. Four buffy-coats. each about 70 ml. 
left over from the routine processing of red blood cell concentrates, are pooled into 
an empty. 600-ml transfusion bag. Acid citrate dextrose (ACD; NIH formule A) is 
added until the bag is fulL The bag is centrifuged at room temperature for 15 min at 
400 X g. After centrifugation. the bag is carefully placed in a plasma extractor that is 
routinely used in any blood bank (Fenwal. Travenol Laboratories [13]). The platelet 
rich plasma (PRP) is carefully transferred into a double transfusion bag via a 
transfer tube until a 2-cm PRP layer is left with the WBC-precipitate. The PL T are 
concentrated by recentrifuging the PRP in a double bag at room temperature for 
5 min at about 2000 X g. The centrifuged bag is placed in a Fenwal plasma extractor 
and the supernatant (ACD) is transferred into the satellite bag until some 50 g of 
PLT-precipitate with ACD are left over in the primary bag. After sealing. the 
transfer tube is broken and the satellite bag is discarded. The PLT-precipitate is 
easily resuspended in the ACD solution by agitation. The suspension should be very 
fine at this stage (indeed no aggregates should be seen at microscopic inspection). 
The suspension is kept at room temperature before processing, which preferably 
should be done within 24 h [12]. 
The preservation medium 
The preservation medium consists of ACD plus the following substances: al-
bumin and gentamicin in final concentrations of about 2.5% and 400 J.tg/ml or 
more. respectively. Distilled water is added until the osmolality is about 300 
mOsmjkg. Since it is one of our goals to combine this PLT-control with a 
WBC-control. Stabicells acting as WBC-substitutes (in a final dilution of about 
I : 500) are added as well [II]. This preservation medium can be made beforehand in 
a separate transfusion bag. Appropriate dilutions can be made by connecting the 
two bags via their injection ports using Fenwal site couplers and a transfer tube [13]. 
A I : 4 dilution of the PLT-concentrate described above will result in approximately 
200 X 10 9 PLT/1. indicating a high yield (as we produced the PLT-concentrate from 
four buffy-coats). 
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Instruction for use 
During storage the control is refrigerated in 6-ml glass bottles. Before use the 
bottle is shaken to resuspend the PLT and left for at least 10 min (allowing the 
suspension to come to room temperature and to clear it of air bubbles and foam). 
When needed, the suspension is carefully inverted to ensure homogeneity. Residual 
foam. if any. does not invalidate the results. provided the suspension is aspirated 
from below the foam layer. 
Quality control of the Coulter S-Pius 11 
The Coulter S-Plus II was routinely monitored with three levels of Hyland 
8-parameter control. (Travenol labs, Deerfield, IL 60015, USA). Accuracy was 
checked once a month in a regional quality control survey. Recalibration was 
performed if judged necessary by the accuracy checks. 
Results 
Several controls were prepared and were found to give reproducible PL T, platelet 
distribution width (POW) and WBC results. Table I shows the results of the 
PL T-count, the mean platelet volume (MPV) and the POW of a representative 
control during a 5-months period. Since the WBC results are comparable to those 
previously described [ 11]. they are not listed. Our preparation gave similar CV's for 
PLT and POW values to those of the Hyland Normal Control. This is displayed in 
Table I. However, the CV of the MPV in our control is very inferior to that of 
Hyland. 
Table II shows non-significant differences ( p > 0.10) between several measuring 
periods of PLT-counts and PDW indicating their perfect stability during a 5-months 
TABLE I 
THE PLT-NUMBER. MEAN PLATELET VOLUME (MPV) AND PLATELET DISTRIBUTION 
WIDTH (PDW) MEASUREMEKTS OF THE HYLA:-!D NORMAL 8-PARAMETER CONTROL 
AND OUR CONTROL IN THE COULTERS-PLUS II 
Tho;;: total measuring period is 5 months. 
PLT-count 
X' 
Hyland Normal Control. Lot 823 H;: 
Stated value: 
(n ~ 66) 
Our control 
(n ~ 66) 
Mean value. 
225 
228.1 
168.2 
Coefficient of variation. 
CV '"'" 
5.1% 
3.8% 
3.8% 
MPV PDW 
X cv X cv 
8.1 2.5% not stated 
8.4 2.7% 16.7 2.4% 
9.1 12.8% 17.3 0 'C -.:>tO 
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TABLE II 
THE MEANS OF THE FIRST to MEASUREMENTS, THOSE OF ALL 66 MEASUREMENTS AND 
THOSE OF THE LAST 4 MEASUREMENTS FOR PLT-COUNTS AND PLATELET DISTRIBU-
TION WIDTH (PDW) 
The non-significant differences between them indicate perfect stability of PL T and PDW over the 
5-months period. 
First 12 days 
Total period of 5 months 
Last day 
Mean value. 
"'"' Standard deviation. 
200 
~ 100 
• 
n PLT-counts 
x• 
10 168A 
66 168.2 
4 172.0 
100 150 200 
PLT q:JNCENTR EXPECTED 
10.0 
2.0 
2.0 '0 ,, "·0 
WBC CONCENTR EXPECTED 
PDW 
SD "'"' X SD 
4.7 17.6 0.3 
6.4 17.3 0.4 
5.0 I7.3 0.2 
Fig. 1. Dilution of the 8-week-old control in lsoton Plus shows excellent linearity for both PLT and WBC 
counts. 
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TABLE lii 
MEASUREMENT DURING 5 CONSECUTIVE DAYS OF THE 8-WEEK-OLD PLT SUSPENSION 
After 8 weeks in the refrigerator the PLT-suspension was brought to room temperature for this 5-day 
measuring period. 
PLT 
MPV 
PDW 
* Mean value. 
n 
5 
5 
5 
"'"' Standard deviation. 
""""' Coefficient of variation. 
RE 
NO 
x• 
163.4 
7.96 
17.48 
SD "'"' 
4.0 
0.3 
0.16 
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Fig. 2. Histogram of the 1 : 7 dilution of the 8-week-old control in Isoton Plus. 
CV(%) **"' 
2.4 
3.8 
0.9 
period. However. these comparisons are not meaningful for MPV due to the very 
poor CV found for MPV in our control. 
Measurements were made for 5 days after the 8-week-old refrigerated PLT-sus-
pension was brought to room temperature. Table III displays the results suggesting 
that storing the suspension at room temperature is also possible. 
Fig. l shows excellent linearity of the 8-week-old control of both PLT and WBC 
counts with the dilution. 
Fig. 2 reproduces the histogram of the l : 7 dilution of the 8-week-old control with 
Isoton Plus. 
Discussion 
There are several arguments for the preparation and description of a home~ made 
PLT-control: 
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( 1) the high costs of commercial quality control (Q.C.) materials inhibit their 
frequent use necessary to assure optimal intralaboratory Q.C.: 
(2) a thorough search of the literature reveals no simple methods of preparing a 
PLT-control [1.4-7]: 
(3) patent literature is less accessible. Our enquiries with some commercial firms 
revealed that, for respectable reasons, they were not prepared to disclose to us any 
patent numbers or details relevant to their Q.C. materials. Moreover, a search in the 
Dutch Patent Office revealed that patent literature is lagging behind [14.15]. Fur-
thermore, the invention described may well only be part of a procedure. and 
follOwing it gives no guarantee of a successful product. Last but not least. the 
information is patented and consequently not publicly applicable: 
(4) the (sole) use of commercial Q.C. materials contributes to the ever growing 
dependency of medical laboratories on commercial firms: 
(5) sophisticated home-made intralaboratory Q.C. materials might be used to-
gether with commercial controls and Bull's algorithm on patients' data [16] to 
optimize intralaboratory Q.C.: 
(6) due to the ever growing demand for transfusions with pure red blood cell 
concentrates. buffy-coats often have to be separated from red blood cells. Although 
there are several useful applications for buffy-coats (e.g. therapies with fresh PLT 
concentrates: interferon preparations). in blood bank practice they are sometimes 
left over and discarded. 
Some of these buffy-coats. harvested from blood anti-coagulated with citrate 
phosphate dextrose-adenine (CPO-A) (pH about 7.2 at 20°C). were used as starting 
materials in our preparations. However, the PL T were diluted with acid citrate 
dextrose (ACD) (pH about 5.5 at 20°C). a crucial material for the successful 
preparation of the PLT-control. (It has long been known that acidification of 
PLT-concentrates results in aggregate-free suspensions [17]). Similarly. fine PLT-sus-
pensions (as viewed under the microscope) were obtained, whereas PLT-clumps were 
prevalent in the more alkaline CPO-A. Indeed. when the CPO-A suspensions were 
employed for the PLT-controls non-reproducible results were obtained (not shown). 
Albumin could also be an important ingredient in the preservation medium as it 
is known to provide the PLT with a 'protective coat' which diminishes the loss of 
PLT-constituents into the surrOunding medium [18.19]. Moreover. albumin has a 
complex influence on the glass-adherence of the PLT [!9]. In fact. we believe that 
albumin should be added to the PLT before bringing them in contact with any glass. 
The results show an excellent CV for PLT-counts indicating that our WBC-sub-
stitutes of long-term stability [II] do not exert any adverse effects on the human 
PL T. notably no adherence of the PL T to the WBC-substitutes. This enabled us to 
prepare a human PLT-WBC control of at least 5 months stability. 
The results also give an excellent CV for POW. The CV for MPV. however. is 
very unsatisfactory. PL T swelling possibly is the main reason for this phenomenon 
[20]. The primary cause of such swelling is possibly the inability of the cell to 
maintain its volume in response to the continuing influx of sodium and water which 
results from the colloid osmotic effect of cellular macromolecules [20]. In a separate 
experiment (not shown) we attempted to prevent this swelling by adding mannitol 
112 
101 
(2% final concentration) to the preservation medium. As mannitol is known not to 
penetrate PLT. its presence could counterbalance the colloid osmotic pressure of the 
PL T. However. this still did not result in MPV stability. 
Many other factors, such as the storage temperature. the type of anticoagulant .. 
the pH and the resulting PLT-shape changes appear to affect the (apparent) MPV 
[20-23]. However. the handling of this most complicated matter is beyond the scope 
of this paper and would require further extensive investigation. 
Unfortunately. about one-third of our PLT-preparations did not show a perfect 
log normal distribution, giving rise to error code 10. Further studies will be necessary 
to clarify this phenomenon. We observed this same departure from log normality 
with the most recent Coulter platelet controls CTC-4 (Lots 32A and 32B). despite 
strict adherence to the instructions for use. The same disadvantage applies to the 
recently described PLT-control material PlasCon [7]. 
The availability of this control offers the possibility of implementing the internal 
quality assurance protocol advocated by Gilmer and Williams [24]. Once the 
calibration of the instrument has been performed according to one of the approaches 
described in this paper and/or those in the literature [1-6.24]. an inexpensive. 
independent source of stable cell control is available in sufficient amounts to check 
the 'primary calibration material' for any deterioration or vial variances, to fre-
quently monitor instrument drift and other gradual malfunctions and to promptly 
trace any instant instrument failures. 
In conclusion, we propose a solution to some of the problems of PLT-manufac-
ture mentioned in the introduction. We have described a simple preparation of a 
human PL T-WBC control with at least 5 months stability. suitable for the Coulter 
S-Plus II. 
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2.3. 
Preparation and evaluation of a ?-parameter 
intralaboratory control blood of 4-month stability 
.-\ J p F LOMBARTS AND B LEIJNSE* 
From the Dt•partm,•llf of" Clinical Chemistry ami Hacmarofo;.:y, L'·yt•n/mrg Hospital, Leylt't'K 275, The Hague. 
Tht• ,\'dher/wuls ami rht• •Department (~(Chemical Pathology, Era.\'11/11,\' Unil't'Y.I'ity/Dt•partmelll of Clinical 
Chemistry, Dijk=~::t Hmpitaf. Rotterdam. Tin• .''kther/ands 
Sl:~n.tARY Sterile. fre~h concentrates of human red blood cells suspended in <t specially designed 
sterile preservation medium have :1 St<tbility of all six red blood cell purameters of over four month:. 
<tS measured in the Coulter ModelS-Plus II. Substitution under :.tcri!c conditions of the unstable 
\\'hitc blood cells for (commercially available) liXed (human) red blood cells is a well-e~t:tblished 
method 10 obwin simubted \\hite blood cell su~pensions of long-term stability. 
ln !low haemocytomctry there arc two ditl'ercnt 
approaches to intral:tboratory quality control (QC"'): 
either the analyses of patients' data or those of 
c~mtrol sample.; may be used. 1 A.; these approache~ 
ha\·e their advant:tgcs and disadv:J.ntages. a conlbina-
tion of both is:J.dvantageous. 1· :l U;,e of pati~nts' dat:J. 
requin .. -s computer fadlitk.-s to c:J.kulate the patients· 
mean p:J.rameters, moving a\·eragc~. moving modes, 
ctc. 1 -~ In this paper we will conccntr:J.te on the 
prermrution and evaluation of a human bl~1odcontrol. 
As the haematological pa1·ameters in EDT A-
l:llood ar~ ~table for only a few day;.:' :J.rtificial QC 
material~ have to be u~'d. A thorough search of the 
literature shows an amazin-:; paucity of data on the 
characteristicsr· 7 kt alone on the preparation of QC 
matcria!s. 1 ~ x Data on the preparation of Q(' 
materials may pcrhap~ be found in the lc~s aecc;.sible 
patent litcraturc.t' 101 The (sok) u;.e of commercial 
Q(' m:.t.tcrials contributi..'S to the ever growing 
dependency of medical laboratories on commercial 
firms. Moreover. the high cost of commercial 
controh inhibits their frequent u;.e to a'>.<.ure optimal 
QC. 
In thb paper we describe :J.nd di"cuss :J. ~implc 
blood prOCi..'SSin~ procedure to prepare :J. blt1od QC 
material and evaluate the result~ a~ mca~ured in a 
Coulter counter ModelS-Plus 11. 
•.-tl>l>r<'l·iati"n·'' \\h.: "hite t>lutH.l .:ell,: rh..; red hluuU .:ell': 
WB(' White BlnoU Cell C<'Unt": RB(' Red Blnt><..l C'cll 
..:oum'; flh Hacm<'gl1>hin: MCV Mean Cell V1'11.1me; 
VICH Mean Cell flacnwgluhin: MC'HC' Me:111 Cell 
11o~cmul!l<'l>il1 ('un~·entratiun: Rr>W R~·d ~·dl J)i,tril>utiun 
Width: ~h..:tl'l Mi..:r<>hacmaln;;rithl: Chct Cnuh1.·r hue-
m.nu..:rit; 0<" Qual it} Contn>l. 
Mat('rials and ffi('thods 
Mt::ASURt::~~STS 
Mhcts were determined· after ~pinnin):! the blood in 
c:J.pi!laries for 5 minutes :J.t about l::?:OOOg in a 
Hettich Mikro Rapid centrifuge. In the supernatant;, 
of spun blood. ~pectrophotometric ultramicro-
dcterminations of Hb (:J.s cy:J.nmethaemoglobinl 
were performed ac<.!ording to Rice.11 Blood pH wa~ 
measured in a Radiometer ABL-::?: ithtrumcnt and 
osmolality in a Knauer osmometer. Met haemoglobin 
was determined according to Fairbanks. 1 ~ 
('ALJBI{Ar101" A:-J() (.1(' 0~ rH~. CoL:L1~.K 
S·I'Lt'S II 
Hb was calibrated with the international st:J.ndard. 1:1 
The other parameters were calibrated again~t the 
means of the Coulter counter value~ in the Ortho QC 
programme (0rtho Diagnostic~. Bccrsc. Belgium). 
These means were ~hown to ~ valid by the finding 
that the means of 100 normal outpatient valui..~~ 
closely corri..-spondcd to the n1cans of the Jabora-
torii.."' • t'cfcrcncc values of these parameters. Th~ 
Coulter counter was monitored with Hvland 8-
par:J.mctcr control (Travenol Laboratoric~. i 1) 
HLOO() l'KO("J:SSl"l(; 
Blood wa~ colk'<.:tCd in 75 ml acid citrate dcxtro~ 
(ACDl-anticoagubnt in a regular double plastic bag 
sy;.tem. After centrifugation for 5 minutes ~t 5000 g 
the rlasma and butl'y coat were carefully prt.-ssed out 
in a Fcnwal bag cxtractor. 11 
Rcm:J.ining wbc and platelets were then removed 
by filtration through cotton wool in a closed sterile 
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:-\:-otcm. We u:-:.ed the lilter column from the Ccntr.tl 
laboratory of the Netherlaitds Red Cross Blood 
Transfusion Service (POB 9190). Amsterdam. This 
routine technique ha" bo..>cn shown 1:. to be the method 
of choice for the preparation of wbe-free and 
platelet-poor rtx concentrat1..'S. After centrifuging 
and ro:moval of the saline, the sterile prCSI!rvation 
medium (sec below) was added through a port in the 
hag using a standard connecting tube and site 
couplcr.11 The final pH was 7·0. Under ~lCcao;;ional 
mixing. otliquots of about 5 ml of the 'wbc'- rbc~ 
suspension were aseptically filled ·1hrough the 
connecting tube into sterile 6-ml screw-capped glas~ 
b0ttlcs in a laminar flow cabinet. Blood cultures were 
found to be negative in a r<~.ndomly chosen bottle. 
THE !>RESioRVATJ0:-.1 '-HOlUM 
All chemicals used were of analytical !;rade. The next 
preservation medium was prepared and steriliS~.-'<1 at 
120 C for 30 minutes: 5 mM Na~HPO,. 30 mM 
K~HPOJ. 15 mM K2-EDTA. 2H"O. mannitol 2·2",;. 
gentamicin 1 g/1. 4:-.1 NaOH until pH 8·5. After 
cooling. sterile albumin and glucose solutions were 
added under sterile conditions in a final concentr..t-
tion of about 3",', and 0·5~\;. respectively. After 
\IOrtexing for a few minutes about I ml/1 ofStabicells 
(sterile. aldehyde-fixed rbc) were aseptically added to 
simulate wbe.u1 The final osmolality was measured 
(about 315 mOsm(kg) and set at approximately 300 
by the addition of sterile di..;tillcd water, 
WBC ill . z~ ... 31~ •• • • • . . 
• 
S8 
57 0 0 
Results 
Figure I dcpi-:ts thcex1..'Cllcnt Stability ofWBC. RB(', 
and rbc primary parameters and Mhct during a four~ 
month period. auwmatieally resulting in stability of 
the calculated parametersChct(RBC · MCV). MCH 
(Hb/RBC). and MCHC (Hb/Ch-:t). After this time 
the MCV gradually incrca'\Cs. WBC. 101 RBC. and Hb 
value..; arc unchanged even after eight months. All 
the parameters remained constant after mixing the 
4-month~old blood on a roller mixer for 6 hours. 
showing good mechanical resistance and stability of 
the control. 
Figure 2 shows the supernatant Hb·COncentrations 
in MhcHubcs after centrifugation of a represcnta~ 
tivc. normal EDT A-blood (kept at 4 C) (curve A) 
and of the described control (curve C) at ditTercnt 
stages of the i1..-st period. Curw B represents super· 
natant Hb-conco:ntrations as depicted by Spaethe.'1 
A yellow supernatant colour corresponded to a Hb-
concentration of aboLit 0·3 mM. a yellow~brown 
colour to approximately 0·6 mM Hb. a brown-red 
colour to about ! ·3 mM Hb. Higher concentrations 
of Hb showed r1..-d :-:.upernatants with progressively 
less sharp interfaces with the packed rbc due to 
increasing haemolysis. We consider supernatant 
Hb-concentration a good and practical criterion for 
rbc-stability. as the degree of haemolysis reflects 
the ability ofrbc·membrancs to withstand the trauma 
of high centrifugal forces. Figure 2 unambiguously 
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Fig. 2 Su[N.•matalll HIM·otln'fllralitm,v in ,\/lu·t·llllws aft<'r 
cemrifitKation of a n•prl!,\'l'llfUIIh: normal J:'DTA·hlood 
(kl.'pl at 4°C) (CIII'f<' A) mu/ ofr/u: dt•.\·criht•tl t'OI/Im/ kul'\'£' 
C) 01 dijji.'rt•nt .WaKt',l' of the 11':>1 {Jf'riod. Cun•e B rt•pn•st•n/.1' 
supernatam Hh--<•onct:l/lralion.~ as tk.\(·riht•d h.r Spaelht•." 
Tit<' /i;ture sltow.v tltt• MlfJ<..'rior rt•si,l'f(IIIC<' to llat•mo~\-,l·is of 
tire descrilx•d t·omrol. 
shows th~: superior mechanical resistance of the 
described control. 
Due to the gradual loss of2,3-DPG. which occur.. 
during storage of blood, 17 the oxygen affinity of our 
control was markedly incrcascd,17 leading to a light 
red colour of the blood during the whole four-
month period. However, methaemoglobin was 
gntdually formed and amounted to about 7~" after 
four months in our control. After this period the 
colour of the control gradually darkened due to 
increasing met haemoglobin formation, 
Discussion 
Commercial intcr~ts and the many problems 
encountered in blood cell prcscrvation 1 7 ,. arc 
probably the reason for the surprising scarcity of 
literature on the subject. 
J•ROHLE,MS P£RTAININli TO THE !'RESERVATION 
OF BLOOI) CELLS 
The main problems pertaining to the pn .. 'Scrvation of 
blood <.:ells arc: 
I wbc and nlatclcts d\..'Crca.,c in a few day:>:' and 
Lomharr.~ and Ldjtr.w: 
cause microaggregatc:>.111 Formation of micro-
aggregates can be avoided by removing wbc and 
nlatclets by filtr.ltion. as dt.-scribcd in this paper.1;' 
2 It i:> common practice 10 store transfusion blood 
at 4 C. However. at this temncrature the Na-K-
ATP-asc pump is insufficiently active to maintain 
the normal cation-gr.J.dients in the rbc_l~· Con!'oe-
qucntly. K-ions arc expelled and Na-ions and water 
arc taken up. resulting in rbc-swelling and thu:-. a 
MCV (and haematocrit) increasc. 1 ~ 
3 Stor.J.gc at 20 C or 37 C r\..-sult:-. in e"en quicker 
:-.welling of rbc~ accompanied by a rapid darkening 
of the colour due to mcthaemoglobin formation 
(own experiments. not shown). 
4 Accumulation of lactate due to glycoly:-.is. 
resulting in a pH decrease, Lactate lcav\..-:. rbc only 
slowly through a carrier-mediated proccss 1 ~' and 
therefore exerts an osmotic ctlCct. 
5 Gradually complete los."' of ATP and 2.3-DPG. 1 ~ 
0 Substitution of chloride ions for 2.3-DPG. also 
causing an osmotic cff..:ct since chloride ..:xens about 
3·7 times the osmotic efTect of 2.3-DPG. 1 ~' 
7 ATP-dcplction lead"' to discocytc:..;.."Chino\..;.·tc tran:v-
formation, and u!timatdv t.-chinocvtc bleb:-. ":<>tan to 
bud olfasspectrin-free v~iclcs.~11 ~~-
AI'I'KOACHI:S 10 'IH~ I'K~I'AK,\'!H~;-.: 0~ (,f{' 
M,\TI:KIALS 
At first sight S(!vcral material:-. might be suitable h' 
check the mca:;urcmcnts of rbc and thdr raramctcr-.. 
I Arrijicial parrich·.~ 
None of the artificial spheres tried in the past. such 
as pollens, mould spOr\..~, Yl!a."'t· polystc:rene latex or 
other plastic polymers. have p"rtW\..-d suitable.; 
Moreover, it is ncct.-s...,ary for SI!\'Cral reasons that rbc 
in multiparameter quality control materials can be 
lysed. In blood flow eytomet..:rs the: enormous mas:-. 
of unlysable rbc-substitutes of approximately the 
S<~.me size a."' wbc would make measurement of wbc 
impossible. Hb determination of an added haemoly-
sate would be seriously biased by light scattering. 
Furthermore. there would not be a ch\..'Ck on the 
proper functioning of the lysing process. The \Cr;. 
high cost of the artificial particles m.'Cded in such high 
quantitb if they are to replace rbc is also disad,·an-
tageous. Finally, there might be a danger of dumping 
and nossibly dogging of the apertures. This imrlic:-. 
that the usc of rbc i:; practi~.11ly unavoidable. 
2 Aklt!hyd<·-jixed or glyceroli.~<·d rhc 
There arc a number of disadvantag~'S It) the u:-.c lit' 
aldehyde-fixed rbc1 ~ such a"' a tendency w dumr 
and to adhere to walls of containers, rbc-ri~idit;. 
resulting in crroncmtsly high Mhcts. and the danger 
llf il1cllmrlctc hacnu1lysi:-.during th..: \Cr~ :-.l1lwt 1~:-.ing 
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TheSe:: fact'> may kad to los'> <.\f accurac;· and rrcci-
-.ion. In fact undiluted li\cd cell-. :tre ll1H -.uitahk (~\r 
usc in fully :lllwmatc<.t countcr .... 1 Low tempcrawrc 
pr~.--servation of dx: in gl)ccrol leads to rrog:r~.-"osivc 
lysis~ and an unphysiolog:kally high and incon ... tant 
MCY (own experiments. not shown). 
3 Outdated h!uod 
The usc of outdated bank hl(\()d ha:-. lx.-cn :td,-ocatcd 
in the literature.~ ~:t Washed. outdated rbc su:-.pended 
in lsoton"'' and substituted with aldehvdc-thed rbc 
to :;'m1ulate wbclH were sttCI..'\.~s.fully em-ployed in the 
first author"s laboratory for many years. allowing for 
the usc of unlimited volume:-. of ine'i.pensive dail) 
QC' material {unpublished). There arc. however, 
some disadvantages to the usc of outdat~.-'d blo<.ld. 
Firstly, expired hlood is more labile to the high 
<..~mrifug:al forces during a Mhct dctermination. 
causing considerable haemolysis and dccrca..;ing 
Mhct valu<..'S. 51.-condly. after -.omc thrt.-c week... the 
MCY of outdated rbc becomes progr<..-ssivcly more 
sensitive to temperature intluenccsand to mechanical 
stress during prolong:cd stay on a roller mixer. 
Thirdly. in modern so-called 8-par..t.metcr flow 
cytometers (which measure platdcts simultaneously 
with wbc and rbc parameters) outdated blood is less 
suitable as a QC material due to interferences of rbc 
fragments in the platdet range. Studb on the addi-
tion of human platclcl':i 10 the described 7-paramct~r 
(fresh) blood control arc currently being performed 
in our !aboratori~.--s. 
Because all the m:.Hcrials described above have 
more or k-ss serious disadvantages. we studied the 
possibility of preserving fresh rbc without fixation. 
THl: J>RESI:RVATJO)'.: M~.DlliM 
In this :-.tudy we report the results of experiments in 
which monovalent cation exchanges due to gradients 
and concomitant MC'Y changes are avoided by 
suspending the freshly drawn rbc in a high potassium. 
low sodium mcd'tum of approximately the same 
concentrations as potas..;ium and sodium conr.:cntra-
tions inside the rbc. Preliminary tt.-sts show~.--d that an 
impermeable osmotic substan<..~ in a fairly high 
concentration was necessary to counterbalance the 
imrcrmeable Hb and other osmotically active 
-.ubstances such as lactate. Several substances arc 
known to be impermeable to rbc (sucrose. mannitol. 
dtrate~ 1 ::.· •• etc). We chose mannitol l:x.'Cause of its 
neutrality. 
Figure 3 shows the oncotic dl"cct of mannitol and 
the relationship between the final mannitol rcrcen~ 
ta,:e and the change of M("Y; it can be concluded 
that a concentration of about.!·.!";, mannitol will 
lead w a constant M("Y during at least .!5 days. 
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He:. J Om·llfi<" <'/kt·f r~( mumt{IIJ/. lc'.wm{lll' of .\/(")' 
chunK<'.' w ufmwtion of.,tm'liK<' till!l' a/ 4·'C am/the jiulll 
munnirol {l<'tn'ulaKt' in tit(' {ll"<'.''"n'atfon tlletlium. The nm-
l"lusiou cull Ill' tlrmrn tltat u <'mtcelt!rlltion ofaho:ll ::!·::!" .. 
mwmirol •l'i/1 !nullo tt ('0/t.,lult/ ,\/CJ · dur"iiiK m I<'U\1 ::!5 
day.'. 
Three per cent albumin was added for two reason~: 
firstly, to provide rbc with a prot<..-ctive coating;~'1 
s...-condlv, to simulate the viscositv of fresh blood. 
It is ge~crally acceptt.'d that the idCal control should 
mimic the patient samph.: a..; closely as rossihle. 7 
EDT A was added in a final concentration of 
15 mM because this concentration is said to inhibit 
7s:· .. of v~.--sicle-formati(lt1.~11 However. there is a 
disadvantage in the usc of such high concentrations 
of EDTA. It has long bcr:n known~~ that high 
conccntr.ttions of EDT A cause shrinkage of rbc in 
proportion to the excessive concentration of the 
anticoagulant. It is of practical interest that this 
phenomenon leads t(l crron~.-·ously low Mhcts but 
doc-s not produce an error in Chct. The C'hct is the 
com:ct value because the hig:h dilution of blood in 
isotonic mt.'dium restores the shrunken r<..'d ~.-~Its 1\l 
their initial sizeP This discrcraney prevents the 
Mhct being used as a primary method (lf calibration. 
We found a Mht."t of about .!.! ~·., against a Chct of 
26",,. Subsequent \'itudk-s (not shown) strong!~ 
sugg<..'St that high EDT A ctmccntrati(ms arc not 
ncct."\sary to yield stable contnll valu'"-s in the 
CoulterS-Pius II. 
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In tim~! gradualllxidation of Hb cvcntuallv lead~ to 
dttrk-colourcd blood due to increasini met-Hb 
fMmation.~~ Hov.e\Cr, Hb values remain constant 
t\1r at lca~t eight months as both Hb and the met-
Hb!'. arc cmwcrtcd to ..:vat,nwt-Hb. 1 ~ ..:~ Likewi..;e. 
haemol}sis gradually inc;·e:.L-..;e~ both 'pontane,lusl:,. 
and after high-~peed ..:cntrifugati,ln. Anal<lgou~ to 
Gcar·s~1' obscn·ations in a Ccll,ls..:opc ..:<luntcr, we 
1\)und that under the gcomctri.: and dc.:tric current 
.:ircumstan.:cs in the measltrit1!:! apertures d the 
Coulter S-Piu~ Jl. rbc !,!hosts (!y~ed rb..:J !:!ivc MCY-
valucs considerably snwllet· than those of intact rbc. 
We fllUnd (not sl10wn) MCV·\·a]ucs i11 the 50 70 !l 
ranl!.c in watct·-induccd rbc-1l~.a:molv~ut<.~ HowC\L'r 
uddition of (solidJ sodium chl~ldde. (9 mg·ml; 
r<-'Sulted in a MCV-shift to the right of about I?. 11. 
conlirming that MCV i..; abo depc11d~:nt on the 'alt 
concentration of thc suspending mcdittm.~:• A~ 
·pulses from the rbc-bath rcprcsenting cclls 36 :1.111:~ 
and grcatcr arc dassi1icd as red cdb.':~, hucmol:,.~is 
docs not ~~11~-ct RBC. This explain~ \\hy RBC arc 
constant for eight month~ and probably mw.:h lllll):!cr. 
The above re~ult..; slww that the prorosed high 
rotassittm,low sodiummcdittt11 in combinati<m with 
2·2", mannitol for osmoti~o: balance i-. a ~uitablc 
rn .. -scrvation medium for fr~,.-:-;hly drawn rlx:. rarticu-
larly for maintaining a ..constant MCY. To the best of 
our knowlcd!;C this has never been dcscr'1bed before. 
Thus fresh rbc rrovidc a suitable 7-r~tr:unctcr 
control blood in combination with tixcd rbc. which 
had already been ..;hown w be st!.iblcY.bi.:-Sllb~titutL..,. 1 " 
('ALlllRATIO)'; ,\:-.;[) (,fC 
The availability of the d~.~critx:d contn1l mak~.-s it 
possible to imrlemcntthe internal quality a~surancc 
protocol advocated by Gilmcr.:11 Once the ca!ihrati0n 
of the instrument has lx.-cn performed accord in),! to 
the method used in this rarer or to one of the 
procedures des~.:ribcd by Gihncr.:u an incxrensivc. 
imlependel/1 source of ccll C()ntrol of medium-tcrlll 
stability is available to check the ·primary calibration 
111atcriul' for any dct~rioration or vial vurianccs. 
After removal of the rlasma proteins from dill'crent 
blood units. rbc with dilfcrcnt antigenic makc-ur 
can be mixed with no apparent damage to the cell 
membranes.~ This provide.; quantities of control 
blood large enough to minimise the frcquen..:y of 
handovcr from old butchcs t·o new ones. w n1onitor 
(i'eqm·utly drift and other gradual malfunctions. and 
to trace rromptly any ahrupt instrument f:dtur~. .... 
We thank Dr JA van dcr Do~o.-s, dircctm. and Mr J K 
Jug:dc.,~ing:. chief technician. of the rcg:ion:tl blood-
bank · ':-.-Gravcnhage en ~lm-.trcken' for their 
ho-.ritality. Without their heir and advice the 
l.omharts ami Ldjf/.\1' 
experiment!'. rrcscnted here ~;ould not ha\c been 
ac<.:omp!i~hed. The skilful tcchnic:tl a~sistancc of 
Ms Anita Robers and Mrs Angela in 't Veld i' :tl'o 
gratefully acknowlcdg:cd. 
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Summary 
A protocol for the laboratory preparation of a multiparameter hemocytometry 
control is given. Human platelets. stabilized by a basically simplified and inexpen-
sive fixation procedure. are added to our previously described white and red blood 
cell control. Evaluation of this multiparameter control shows good precision char-
acteristics and acceptable mechanical stability for at least 7 weeks. as measured in 
the Coulter counter Model S Plus-II. The control can basically contribute to the 
realization of the essence of internal quality control: continuous self-auditing and 
continuous attempts at improvement of performance. 
Introduction 
Perusal of the recent literature has shown that protocols for the laboratory 
preparation of so-called multiparameter quality control (QC) materials. including 
platelets (plt), for flow hemocytometry have never been published [1-5]. In a recent 
"' To whom correspondence should be addressed. 
Abbreviations (and dimensions if applicable): ACD =acid citrate dextrose: AP =aperture: AVG = 
average: CPD-A =citrate phosphate dextrose-adenine: CSP-II = Coulter counter Model S Plus-II: 
CV =coefficient of variation(%): GA =glutaraldehyde: Hb =hemoglobin (nunoljl); Ht =hematocrit 
(%): LY% =lymphocyte percentage: LY# =lymphocyte counts: MCH =mean cell Hb (fmol): 
MCHC =mean cell Hb concentration (mmoljl): MCV =mean cell volume (,u.m3 = fl); MPV =mean 
pit volume (,u.m3 = fl): Pet= plateletcrit (%): PDW =pit distribution width: pit= platelets; PLT =pit 
counts (10 9jl): PMTR =parameter: (I)QC =(internal) quality control: rbc =red blood cells: RBC = 
rbc counts (1012/1): RDW = rbc distribution width(%): wbc =white blood cells: WBC = wbc counts 
(10 9/1): X= mean value. 
0009-8981/84/$03.00 ® 1984 Elsevier Science Publishers B.V. 
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report we have described the preparation of a seven-parameter blood control of 
medium-term stability [4]. These 'seven' parameters were white blood cell counts 
(WBC), red blood cell counts (RBC), hemoglobin (Hb) and the four red blood cell 
(rbc) parameters mean cell volume (MCV). mean cell hemoglobin (MCH). mean cell 
hemoglobin concentration (MCHC) and hematocrit (Ht). Additionally. red blood 
cell distribution width (RDW) was monitored [4]. 
In another paper [5] we described a human platelet(plt)-white blood cell (wbc) 
control for the Coulter counter Model S Plus-II (CSP-II). In this article we report 
our studies on the development of a multiparameter QC material for the CSP-II. 
combining the seven-parameter QC material with (fixed) human pit. 
Materials and methods 
Blood processing 
Blood was routinely collected in a standard blood bag containing 75 ml of citrate 
phosphate dextrose-adenine (CPD-A). Plasma, wbc and pit were removed by centri-
fugation and sterile column filtration was performed as described before [4]. 
The sterile preservation medium containing wbc-substitutes and fixed human pit 
(for details see below) was added through a port in the bag using a standard 
connecting tube with two spikes. For rheological reasons a Ht equal to that of 
normal blood should be chosen, as it is recommended that control blood be as 
similar to patient blood as possible [6]: it is well known that Ht has a decisive 
influence on blood viscosity [7]. Spikes allow for faster blood flow rates than narrow 
gauge needles; the former should be preferred in order to speed up the blood 
processing and to avoid the application of considerable pressure and concomitant 
possible hemolysis due to too high shearing stresses [8]. 
Under occasional mixing portions of about 8 ml of the suspension were asepti-
cally passed through the connecting tube (using a Kocher clamp) into 10-ml 
polyethene bottles (Tamson. Zoetermeer, The Netherlands. Order Nos. 420F 1 and 
420F 11 (caps)) in a laminar flow cabinet. Although these bottles are not claimed to 
be sterile, blood cultures always proved to be sterile in a randomly chosen bottle 
filled with the control blood. (The plastic bags containing the bottles and caps were 
opened and closed only in the cabinet.) The filled bottles are stored in the 
refrigerator. 
The preservation medium 
Apart from the addition of fixed pit, the medium was essentially the same as the 
one described earlier [4]. The slight modifications involve: 
(1) the EDT A-concentration was decreased from 15 mmoljl to 5 mmoljl for the 
reasons mentioned before concerning the Ht determination [4]; 
(2) 5 mmoljl adenosine was added because of its well-established benificial effect 
on membrane stability [9]; 
(3) the final K-concentration was higher by 10 mmoljl: 
(4) the final pH of 7.9, instead of 8.5, was achieved with HCI instead of NaOH 
(tripotassium phosphate was used instead of dipotassium phosphate). (Modifications 
(3) and (4) are not essential.) 
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The exact composition of the final medium used is: 5 mmoljl NaH 2 P04 • 2 H 20, 
30 mmoljl K 3P04 • 3 H 20, 5 mmoljl K 2-EDTA · 2 H 20, 5 mmoljl adenosine, 2.2% 
mannitol, 1 g/1 gentamicin, 4 moljl HCl to pH 7.9 (20°C). After autoclaving at 
120 ° C for 30 min and cooling, the solutions or suspensions were added under sterile 
conditions (final concentrations in parentheses): albumin (3%), glucose (0.5%), 
Stabicells (5-15 X 109 /1) [4] and fixed human plt (100-400 X 109 /1). The final 
osmolality was set at approximately 300 mOsmjkg by the addition of sterile distilled 
water. The preservation medium can be kept for several months (we do not yet have 
sufficient experience of keeping fixed plt). It is important initially to make higher 
concentrations than stated by leaving out enough water to compensate for the 
volumes to be added after autoclaving. 
A practical protocol for a final volume of 300 ml preservation medium is 
(M, =relative molecular mass in parentheses): 145 rni distilled water, 235 mg 
NaH 2 P04 • 2 H 20 (M, = 156), 2400 mg K 3 P04 • 3 H 20 (M, = 266.3), 606 mg 
K 2-EDTA · 2 H 20 (M, = 404.5), 390 mg adenosine (M, = 267.3), 33 ml mannitol 
20%, 300 mg gentamicin, approximately 1.5 ml 4 moljl HCl. After autoclaving and 
cooling: 45 ml albumin 20%, 15 ml glucose 10%, approximately 1 ml Stabicells, 
20-60 ml fixed human plt, distilled water to 300 ml and a final osmolality of 
290-310 mOsmjkg. 
Platelet fixation 
A pit concentrate, prepared from buffy-coats [5], was transferred to a sterile 
100-rnl glass injection bottle and diluted, if necessary, with ACD until a final 
concentration of approximately 2.1012 pltjl (for reasons of standardization). While 
gently swirling, 200 1-d glutaraldehyde (puriss., 25% in water for electronmicroscopy, 
under argon, photosensitive - Fluka, Buchs, Switzerland, No. 49625 - store 
frozen, see 'Discussion') was carefully added. Fixation was allowed'to proceed on a 
roller mixer for at least 2 h. The suspension shoutd remain very fine~ indeed no or 
very few aggregates should be seen on microscopic inspection. After fixation 20% 
albumin was added in a final concentration of approximately 3%. Depending on the 
plt concentration desired in the control. a certain volume of this fixed plt con-
centrate is added to the preservation medium. 
Instructions for use 
Before use, the bottle is carefully inverted by hand and allowed to warm to room 
temperature on a roller mixer. There is no need to return the bottle to the 
refrigerator. The bottle may be left ready to hand on a roller-mixer for 8 h or even 
longer (see 'Results'), facilitating frequent use [4,6]. 
Calibration and QC of the CSP-11 
The calibration and QC of the CSP-ll were basically performed as previously 
described [4], and the CSP-ll was monitored by Bull's algorithm, as used in Coulter's 
QC computer program [10]. 123 
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Results 
Table I shows the results obtained for the eight primary parameters of a 
representative blood control preparation over several weeks. Since the derived 
parameters Ht, MCH, MCHC and plateletcrit (Pet) are calculated by the CSP-II. 
their values are dependent on those of the primary parameters and consequently 
they are not given. Table I shows non-significant differences between the values of 
the described control in the three test periods, indicating perfect stability of all the 
parameters during the entire test period. The Table also shows that the CV's of the 
described control are slightly higher than those of Hyland's eight-parameter control. 
It should be recalled, however, that Hyland's control was measured once every 
morning under standardized conditions, whereas the described control was used at 
random while rocking and rolling on a mixer for up to 8 h and sometimes even 
longer. 
Fig. 1 reproduces the composite display of the 7-week-old control on the CSP-II. 
The arrow in the WBC-area points to a small shoulder due to pit aggregation. This 
shoulder is sometimes much larger in commercial controls. The L Y% and L Y # 
(counts) are not automatically printed out, but single aperture values can be 
recorded. This is shown in Table II for a different, representative control. 
Table II also shows the excellent average intra-assay CV' s of all the parameters 
(n = 10). Furthermore, this type of test enables one to judge the inter-aperture 
agreement. In this case highly discordant CV's of aperture 2 for WBC. LY% and 
TABLE I 
The means (X) and coefficients of variation (CV's) of the first 20 measurements. those of all 49 
measurements and those of the last 13 measurements for the 8 primary parameters of the control 
described and Hyland's 'normal' 8~parameter control 
The non-significant differences between the mean values of the control described in the three periods 
indicate perfect stability of all the parameters in the entire 7-week test period. CVs of the described 
control are slightly worse than those of Hyland's 8-parameter control (see text). 
Control described Hyland"' 
1st week 6th+ 7th week*"' Total period ** Total period 
(n ~ 20) (n ~ 13) (n ~ 49) ( n ~ 21) 
X CV X cv X cv x cv 
WBC 14.4 2.1 14.3 2.0 14.3 1.9 7.8 1.5 
RBC 5.10 1.9 5.11 1.8 5.12 1.7 4.55 1.2 
Hb 10.5 1.5 10.5 1.8 10.5 1.7 8.3 1.2 
MCV 96.7 1.1 94.7 1.1 95.9 1.4 87.3 1.0 
RDW 13.5 3.6 13.5 5.4 "'"' 13.6 4.2 "'"' 18.9 1.4 
PLT 167 3.0 176 5.6 *"' 172 4.9 "'"' 232 4.7 
MPV 8.0 2.2 8.1 1.5 8.2 3.1 7.2 1.4 
PDW 17.0 1.9 17.2 3.0 "'"' 17.1 2.3 "'"' 14.6 1.6 
"' Lot No. 838 YN. 
"'"' Including the results of a control that was mixed on a rolleNnixer during 3 days (see Table III). 
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Fig. 1. Composite display of the ?·week-old control on the CoulterS Plus-II. The arrow in the WBC-area 
points to the relatively small shoulder due to platelet aggregation. The double arrow in the RBC-area 
indicates slight skewing to the right, most probably due to swelling of some red blood cells. 
TABLE !1 
Intra-assay reproducibility of a representative control as generated in Coulter's QC program 
Excellent (average) results are found. Single aperture (AP) values for LY% and L Y # are displayed. The 
highly discordant CV's of AP 2 for WBC. LY% and LY# indicate aperture malfunction (*** ). 
Startup 
Reproducibility /calibration Date 26~10-83 OPR 123 
Mean CV 
PMTR"' AVG* AP1 * AP2 AP3 AVG AP1 AP2 AP3 
WBC 12.25 12.57 11.77 12.05 1.3 1.3 11.0 """* 1.7 
RBC 3.952 3.931 3.982 3.944 1.2 1.4 1.5 1.1 
HGB 8.12 8.12 8.12 8.12 1.1 1.1 1.1 1.1 
HCf 37.21 36.93 37.55 37.15 1.4 1.7 2.1 1.1 
MCV 94.1 93.9 94.3 94.1 .4 .8 .9 .7 
MCH 20.51 20.63 20.37 20.56 .9 1.0 1.1 .7 
MCHC 21.80 21.96 21.58 21.83 1.0 1.4 1.5 1.0 
RDW 13.46 13.58 13.42 13.35 1.2 2.1 1.4 2.0 
PLT 283.0 286.3 275.6 287.1 2.1 4.7 2.4 1.9 
PCf .2269 .2322 .2186 .2297 2.3 3.6 3.0 4.3 
MPV 8.02 8.11 7.91 8.01 2.5 2.9 2.7 3.8 
PDW 16.83 16.80 16.81 16.87 1.0 1.6 2.5 3.0 
LY% 
.0 "'"' 74.9 71\3 75.9 .8 14.0 "'"'"' 1.4 
LY# .00 ..... 9.44 8.51 9.12 1.0 20.8 ....... 2.8 
n =10. 
"' See list of abbreviations. 
*"' Backlighted. 125 
.,. ,.. .. Aperture~2 malfunction. 
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TABLE 111 
Mechanical stability testing of the control 
Comparison of means and CV's shows acceptable stability. 
n WBC RBC Hb MCY RDW PLT MPY PDW 
After 5 min mean 2 13.9 5.07 10.5 94.8 13.9 186 8.0 18.0 
Total period mean 6 14.1 5.15 10.4 94.4 !4.3 180 8.1 17.5 
(51 h) CY(%) 6 2.1 2.3 1.2 0.5 4.3 6.9 1.6 3.6 
After 51 h mean 2 14.5 5.28 10.3 94.6 !5.0 186 8.3 17.5 
Inter-assay CV(%) 20 2.1 1.9 1.5 1.1 3.6 3.0 2.2 1.9 
(Table I. 1st week) 
L Y # are found. indicating aperture malfunction ( * * * ). 
Table III gives the results for the mechanical stability testing. In order to 
investigate mechanical resistance and stability, the 7-week-old control blood was 
allowed to come to room temperature and remain so over the total test period of 51 
h. During daytime the control was rocked on a roller-mixer for 3 h on the first day 
and for 6 h on the second and third days. The Table shows that the total-period-CV's 
are generally comparable with those of the interassay CV's of Table I. indicating 
acceptable mechanical stability of the control. In fact. Fig. 1 shows the histogram of 
the '51-h-old' control, which is nearly identical to that of the 'fresh' control (not 
shown). The only departure from a fresh control pattern consists of a slight skewing 
to the right of the RBC-histogram (as indicated by double arrows in Fig. 1), which 
probably indicates swelling of some rbc. This may be reflected by an increased 
RDW (Table III). Slight deterioration of rbc-stability is also indicated by the fact 
that the rnicro-Ht of the '51-h-old' control was only 43.8% (n ~ 2), whereas that of 
the CsP:II was 48.7% (n ~ 6) and that of the freshly prepared control 7 weeks before 
was 49.1% (n ~ 2). The rnicro-Ht supernatant had a brown color due to hemolysis. 
but a sharp interface with the packed rbc was obtained (see 'Discussion'). 
Discussion 
Mechanical stability testing 
Mechanical stability testing is described to corroborate the statement made in the 
subsection 'instructions for use' that there is no need to return the bottle to the 
refrigerator. This enables the user to leave the control ready to hand on a roller-mixer. 
greatly facilitating frequent use (vide infra). As shown in the 'Results' slight 
deterioration of the control occurs. However, Table III demonstrates stable values as 
measured in a CSP-IL Clarification of this phenomenon is given in the discussion in 
one of our previous papers [4] under the subheading 'Constant Hb and rbc-values 
despite gradual oxidation and haemolysis'. (Our experience has shown that it is 
necessary to stress that this applies only to Coulter-type (resistive-particle) counters 
and consequently not to 'optical' instruments [11], which are sensitive to hemolysis.) 
Last but not least, it should be noted that the Ht of the described control is fairly 
high (50%, see Fig. 1). Hoegman et al [12] have shown that 'mechanical traumatiza-
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tion (centrifugation or shaking) caused considerably more damage to red cells when 
they were highly concentrated than when they were diluted' and that ·this tendency 
was clear-cut, irrespective of how the red cells had been stored and in which medium 
they were suspended during shaking'. This explains why the hemolysis in the 
described control is higher than that in our previously described control with a Hi of 
only 26% [4]. 
Platelet fixation 
In an earlier publication [5] we showed that pit-counts are stable for at least 5 
months (in fact we later found a stability remained for at least 12 months) provided 
they were kept in a medium of low pH (5.5 at 20 ° C). Unfortunately, many 
subsequent attempts to keep pit-counts constant failed when plt in ACD were added 
to rbc suspensions. One of the possible reasons is the higher pH's of the rbc-suspen-
sion, although pit-counts were generally constant for about 18 days. Many attempts 
to avoid aldehyde-fixation with its 'inherent' aggregation disadvantages [5] were 
made by adding several substances separately or in combination: (1) prostaglandin 
E1, a well-known aggregation inhibitor [13,14]: (2) theophylline, a phosphodiesterase 
inhibitor, that prevents cyclic AMP breakdown [15]; (3) apyrase, which converts 
ADP, a potent aggregation inducer, which is released by rbc [16,17]: (4) taxol, a pit 
microtubule stabilizing agent, that was claimed to protect plt microtubules from 
disassembly in the cold and to preserve the discoid shape of most plt [19]. None of 
these substances solved the problem of pit swelling and instability. 
Consequently, aldehyde fixation seems necessary to obtain stable plt. Eventually 
we found that 'inherent' aggregation, the main problem of plt fixation, can be 
almost completely prevented by fixation at a lower pH. We used ACD with a pH of 
approximately 5.5 (20 ° C). The fixation was carried out with colorless glutaralde-
hyde (GA) that had been stored in the freezer (approximately -20°C) for several 
years to slow down GA polymer formation [20]. The possible importance of using 
GA solutions of high purity has been demonstrated by data indicating that the 
monomeric and polymeric forms of GA do not affect tissue in the same way [21 ]. 
The basis for these differences has not yet been fully clarified [21]. We used the ratio 
of the solution's absorbances at 280 and 235 nm (polymers) to assess the purity of 
the GA [20]. We found a ratio of 0.30 in a 0.5% dilution in water. Knowledge of the 
purity of GA used might be important to reproduce the described fixation process. 
Fig. 2 shows a histogram of a 1 : 2 dilution in ACD of a fixed pit suspension. This 
histogram reveals that at pH 5.5 aggregation is indeed almost completely prevented. 
This is demonstrated by the relatively small shoulders in the wbc and rbc areas and 
by the fairly low apparent wbc, rbc and Hb-values. This is further substantiated by 
the data given in Table IV showing non-significant differences ( p > 0.05) between 
pit-counts in fixed and in non-fixed plt suspensions. 
The major advantage of low-pH fixation is that it enables unprecedented high 
concentrations of pit (2-8.1012 plt/1) to be fixed without substantial aggregation 
[5,22-23]. This greatly facilitates the preparation of the multiparameter control. 
Studies are in progress to optimize further the fixation conditions in order to try and 
completely prevent aggregation. 127 
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Fig. 2. Histogram of the 1:2 dilution of fixed platelets with acid citrate dextrose (pH approximately 5.5 at 
20°C). 
Optimization of internal quality control (IQC) 
The objectives of this paper are 
(1) to describe a simple protocol for the fairly inexpensive preparation of a QC 
material for Coulter-type blood cell counters; 
(2) to provide QC blood in sufficient quantities to optimize !QC. This QC 
material can basically contribute in several ways to optimization of IQC. preferably 
in conjunction with the use of some computerized 'average of normals' program 
[4,10]. Firstly, the availability of a fairly inexpensive, independent source of cell 
control of medium-term stability makes it possible to check the 'primary calibration 
material' for any deterioration or vial variances [4]. Secondly. by frequently monitor-
ing drift and other gradual malfunctions and promptly tracing any abrupt instru-
ment failures [4]. Last but not least. to contribute basically to the application of 
Shewhart's pioneering, brilliant IQC philosophy: to differentiate 'some stable system 
of inherent chance causes' from 'assignable causes of error' [24-26]. In other words, 
TABLE IV 
Relevant mean data ( n = 3) of fixed and non~ fixed platelet suspensions both diluted 1: 2 in ACD 
Note the non~significant differences between the PLT and the significantly higher apparent WBC~ and 
Hb-values. For conunents see text. 
Fixed 
Non~ fixed 
WBC 
0.8 
0.2 
RBC 
0.01 
0.02 
Hb 
0.3 
0.1 
128 
PLT 
588 
603 
MPV 
7.7 
8.1 
PDW 
17.0 
17.3 
!53 
these materials serve three basic purposes of IQC: 
(a) Process control. to be executed 'ad hoc• by the technician by regularly 
running the material and instantly judging the results obtained. 
(b) Retrospective IQC by the hematologist or the 'Q.C. officer' by evaluation of 
the proficiency attained both within-day and between-day (Shewhart charting) [26]. 
(c) Blind controls to assure optimal IQC. This is done by regularly interspersing 
and evaluating results of other preparations of known composition. disguised as 
routine patient specimens. The tendency to delegate this type of control to external 
quality assessment schemes threatens the alertness and readiness of action of the 
laboratory (27]. 
In short. these materials are intended to contribute to the essence of IQC: 
continuous self-auditing and continuous attempts at improvement of performance. 
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Summary 
Outdated, huffy-coat depleted, CPDA-1 blood and redundant huffy-coats were 
used as sources for the laboratory preparation of controls for Coulter-type 
(resistive-particle) hemocytometry. Deteriorated white blood cells and platelets and 
potentially interfering microaggregates with volumes not exceeding 400 fl are shown 
to be virtually completely removed by centrifugation and filtration. Addition of 
fixed red blood cells as white blood cell substitutes and of isolated. fixed platelets 
enable the preparation of multiparameter controls of short-to-medium-term stability. 
The availability of these simple, inexpensive controls can contribute significantly to 
optimal internal quality control in hemocytometry. 
Introduction 
In our previous papers on the laboratory preparation of hemocytometry controls 
[1,2] fresh blood was always used as the starting material. However. several consider-
ations prompted us to study the potential of using outdated, huffy-coat depleted 
blood as the source for these controls. Moreover, the addition of platelets, isolated 
from huffy-coats and fixed as previously described [2,3] allows us to produce 
"' To whom correspondence should be addressed. 
0009-8981/84/$03.00 © 1984 Elsevier Science Publishers B.V. 
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mu!tiparameter controls of short-to-medium-term stability. This is demonstrated by 
measurements in a Coulter Counter Model S-Plus II, equipped with a (standard) 
Coulter Video Data Terminal (VDT) and matrix plotter [ 4]. The low cost and easy 
availability of these starting materials together with the simple methods of prepara-
tion of these controls enable laboratories with Coulter-type (resistive-particle) coun-
ters to use these controls frequently along the lines previously described [2]. thus 
contributing to internal quality control [2]. 
Materials and methods 
Centrifugation and filtration of outdated. huffy-coat depleted blood 
Outdated, buffy-coat depleted, CPDA-1 blood, as routinely stored in The Hague's 
blood bank, is used as one of the starting materials for our controls. After 
centrifugation in a Christ 8.6 or 6.4 S centrifuge at 22°C for 15 min at about 
4,200 X g, the supernatant plasma, containing most of the remaining buffy-coat and 
probably also most of the formed microaggregates [5], is pressed out in a plasma 
extractor [1,2]. The red blood cells (rbc) are filtered under sterile conditions through 
a cotton-wool filter column to remove the great majority of the remaining white 
blood cells (wbc), the platelets (pit) and probably also the microaggregates (micro-
aggr) [1,2]. All these prooedures are performed with simple, routine blood bank tools 
and methods. After the blood has been processed in this way, the bag is weighed (the 
weight of empty bags being known) to estimate the volume of the blood. Moreover, 
after mixing, a sample is run through the Coulter Counter to evaluate whether the 
wbc, pit and small microaggr are sufficiently removed and to determine the 
hematocrit (Ht). From the total volume and the Ht the volume of the wash (saline) 
solution, which may vary in different filtrates, in the rbc suspension is calculated. In 
previous papers [1,2], we failed to stress the importance of this volume for the 
calculation of the amount of mannitol to be added in order to arrive at the 
appropriate final mannitol concentration. 
Preparation of the controls 
Fixation of platelets, harvested from fresh huffy-coats Isolation and fixation of pit 
in high concentration (2-8 X 1012/1 pit) were performed, exactly as previously 
described [2]. 
Artificial preservation medium The same high-K, low~Na medium as previously 
described [2] (including fixed human pit) was used. The amount of mannitol to be 
added was calculated, taking .into account the volume of the remaining saline 
solution, in order to assure a final mannitol concentration of 1.6%. In one of our 
previous papers [1], we mentioned a final concentration of approx.imately 2.2% as 
optimal for achieving a constant MCV. To prevent possible confusion, we wish to 
draw attention to the fact that in that paper we gave the concentration of mannitol 
in the preservation medium, not taking into account the volume of remaining saline 
in the filtered rbc suspension to be added to the preservation medium; generally the 
Ht of the filtered rbc suspension amounts to approx.imately 70%. 
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Compatible CPD(A) plasma As an alternative, compatible stored CPDA-1 plasma 
or factor VIII-depleted plasma was sometimes used instead of the artificial preserva-
tion medium. Stabicells (ca. 0.3 ml/100 ml) [1,6], gentamicin (some 400 l'g/1 or 
more) [1] and fixed pit [2] were added through a port into tbe plasma bag. Moreover, 
mannitol was added, again taking into account the volume of the remaining saline of 
tbe rbc suspension to be added, to achieve a final mannitol concentration of 0.55%. 
Since both citrate and mannitol are impermeable to rbc [1] and consequently both 
exert an oncotic effect [1], the required final mannitol concentration is lower tban 
that in the artificial preservation medium. Notice, however, tbat tbe citrate con-
centration in the various anticoagulants varies substantially [7]. 
Actual preparation of the control The actual combining of the filtered rbc 
suspension with either the preservation medium or with compatible plasma as well 
as the filling of the control bottles were performed in exactly tbe same way as 
recently described [2]. 
Calibration and quality control of the Coulter Counter 
Calibration and quality control of the Coulter Counter Model S-Plus II were 
performed as previously published [2]. 
Instructions for use 
The instructions for use are the same as previously described [2]. It might be 
useful, however, to reiterate tbat tbe control may be left ready to hand on a roller 
mixer for 8 h or even longer (depending on its quality and age), facilitating frequent 
use. 
Contraves 
A Contraves Haemocell400 H. coupled to a Contraves Digicell 3100 H. as well as 
a Dilutor 4020 were used (Contraves AG, Zurich, Switzerland). 
Results 
Figure 1 shows a facsimile of a matrix plot of a typical VDT-display of outdated, 
in this case 4-wk-old, huffy-coat-depleted, CPDA-1 blood after centrifugation and 
filtration. Note tbat the Ht (Hct) is 64.7%. The successful removal of wbc, pit and 
relevant microaggr by tbe described procedure is amply supported by the following 
facts: (1) tbe wbc and pit counts are virtually zero and the corresponding histogram 
areas are practically 'clean'; (2) tbe rbc histogram is fairly normal (remember tbat no 
or very few rbc-coating proteins are present [1]); (3) the histograms exhibit no 
evidence of remaining microaggr of interfering size. 
Table I shows the results of the primary parameters of a representative control 
prepared in tbe described artificial preservation medium as measured in a Coulter 
S-Plus II and in a Contraves blood cell counter. The counters were not cross-
calibrated. The measuring periods were 7 wk (November-December 1983) and 3 wk 
(December 1983) for tbe Coulter and Contraves counters, respectively. The table 
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TABLE! 
Mean (X) and CV for the primary parameters of a representative control prepared in the described 
artificial preservation medium as measured in two resistive-particle counters 
The counters were not cross-calibrated. The measuring periods were 7 and 3 wk for the Coulter and 
Contravcs counters. respectively. The outdated blood was 4 wk-old before preparation. Values for the 
commercial control 'Hyland eight-parameter Normal'. measured in the Coulter Counter once every 
morning during approximately the same period, are added for comparison. 
Counter WBC RBC Hb MCV RDW PLT MPV PDW 
Coulter X 7.55 3.77 7.18 91.8 15.2 122 7.3 17.8 
S..Plusii 
n =-117 CV(%) 2.2 2.1 1.1 0.6 3.1 4.5 1.6 2.8 
(7 wk) 
Contraves x 8.20 4.06 7.60 93.7 
n = 26-29 
(3 wk) CV(%) 5.3 * 2.2 1.6 1.1 
Hyland's x 7.3 4.38 7.79 86.0 19.6 215 7.2 14.9 
'Normal' 
control CV (%) 2.5 1.3 1.5 0.4 1.3 5.2 1.2 1.0 
(Coulter 
Counter) 
n = 31 
"' Upward trend with time. 
exhibits CV values comparable to those described for fresh blood in one of our 
previous papers [2]. Furthermore, the table contains values for the commercial 
control 'Hyland eight-parameter Normal', measured in the Coulter Counter once 
every morning during the period mid-November-end December 1983 (n = 31). The 
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Fig. 1. Facsimile of a matrix plot of a typical Video Data Terminal display of outdated (in this case 4-wk 
old). huffy-coat-depleted. CPDA-1 blood after centrifugation and filtration. For comments sec the text. 
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table also shows acceptable CV values (apart from that for WBC, which underwent 
an upward trend) for the control in a Contraves counter. 
Figure 2 represents a time-based collage of some histogram plots of the control. 
The figure shows comparable plots for A (0 wk) and B (7 wk after preparation), 
although the rbc histogram in Fig. 2B exhibits the first signs of rbc swelling (arrow). 
However, Fig. 2B was made after 6 h of rocking and rolling on a mixer, showing 
' 
~L 
c 
' 
. " 
Fig. 2. Reduced collage of four hlstograms (A-D) of the control, suspended in the artificial medium (cf. 
Table I), plotted at different stages of the 4~mth observation period. The ages (wk) after preparation and 
the primary parameters at these ages of the control are as follows: 
Plot Age WBC RBC Hb MCV RDW PLT MPV PDW 
A 0 7.4 3.63 7.2 92.4 14.5 120 7.1 17.7 
B 7 7.1 3.68 7.0 91.7 15.5 119 7.4 19.0 
c 10 8.1 3.97 7.4 95.3 16.2 122 7.6 17.5 
D 16 7.5 3.73 6.9 96.0 17.8 128 7.4 18.4 
Note that WBC, RBC and PLT are stable throughout the period, although in stage D minor departures 
from log normal PLT distribution were sometimes found, in contrast to the case shown in plot D. 
impeding the generation of values for mean PLT volume (MPV) and PLT distribution width (PDW). For 
further interpretations sec the text. 
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TABLE 11 
Mean (X) and CV for the primary parameters of a representative control prepared in 0.55% mannitol-con-
taining. compatible CPDA-1 plasma as measured in two resistive-particle counters 
The counters were not cross-calibrated. The measuring periods were 6 and 4 wk for the Coulter and 
Contraves counters, respectively The outdated blood was 4-wk-old before preparation. Values for 
Hyland's control were of the same order of magnitude as in Table I. 
Counter WBC RBC Hb MCV RDW PLT MPV PDW 
Coulter X 6.35 3.98 8.20 96.9 * 13.1"' 275 8.4 17.4 
S-Plus II 
n =127 CV(%) 2.8 1.6 1.8 0.9"' 4.1 .. 4.5 1.8 1.0 
(6 wk) 
Contraves x 6.88 4.22 8.49 97.8 
n -34 
(4wk) CV(%) 5.2 "'"' 3.0 2.1 1.3 
"' Slight, gradual increase with time. 
Upward trend with time. 
fairly good mechanical stability of the control. The constancy of the rbc parameters 
MCV and RDW are only acceptable for about 7 wk. Notice several gradual changes 
occurring during the 4-mth-period: (1) MCV (after 7 wk) and RDW are increasing; 
(2) The right rbc-tail is decreasing, indicating diminution of 'cell coincidence, 
aperture artefact, doublets, triplets andjor agglutinates' [4]; (3) Skewing to the right 
is increasing due to the rbc swelling; ( 4) Skewing to the left (most pronounced in 
Fig. 2D; arrow) due to ghost (hemolyzed rbc) formation. As we pointed out before 
[1], hemolysis gradually increases leading to rbc ghosts which give MCV values 
mainly in the 50-70 fl range (depending on the salt concentration), at least under 
Fig. 3. Histogram of a water-induced red blood cell hemolyzate. 
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the geometric and electric current circumstances in the measuring apertures of the 
CoulterS-Plus II [1, 8]. This is demonstrated in Fig. 3 which shows the histogram of 
water-induced ghosts. We found extreme constancy of such ghost histograms and of 
their apparent MCV and rbc counts for a period of over 2 yr (not shown). This 
finding and the fact that 'pulses from the rbc bath representing cells 36 p.m3 and 
greater are classified as red cells' [4] explain why hemolysis most probably does not 
affect rbc counts during a long period. 
Table II compiles the results of a representative control prepared in CPDA-1 
plasma, containing 0.55% mannitol. The CV values are largely comparable with 
those of another control, prepared in our artificial preservation medium as shown in 
Table L Both MCV and RDW exhibit a gradual, albeit slight, increase with time, 
possibly indicating that the mannitol concentration should be slightly increased. 
Again the table shows acceptable (except for WBC) CV values in the Contraves 
counter. 
Discussion 
Objections of The Hague blood bank to using fresh blood for the routine, 
medium-scale preparation of hemocytometry controls (in contrast to usage for 
small-scale experimental goals) as well as the fact that a number of blood bags 
inevitably get outdated in any blood bank (approximately 2% in The Hague's blood 
bank, yielding several hundreds of bags per year), prompted us to investigate the 
potentials of using outdated blood as the source for the preparation of our controls. 
For a clear appreciation of the matter it seems useful to recall that blood donations 
are performed on a voluntary basis in several countries, including Canada, Great 
Britain, France and The Netherlands; consequently fresh blood cannot be simply 
bought [9]. 
Outdated bank blood was successfully employed in one of our laboratories for 
some eight years, allowing for the use of unlimited volumes of inexpensive quality 
control material for the Coulter Counter Model S. Several disadvantages of the use 
of outdated blood have been previously mentioned [1]. The major difficulties 
included MCV problems and, especially for so-called 8-parameter flow hemocytome-
ters, interference of microaggr and cell fragments in the wbc and pit range. 
In this paper, the MCV problem was shown to be partly overcome by the 
addition of an appropriate amount of mannitol. Although we did not yet systemati-
cally investigate the issue, it is hard to avoid the impression from numerous 
experiments that MCV constancy in the artificial medium is superior to that in 
mannitol-containing plasma. 
Microaggr with volumes ranging from 2 to far over 1,000 fl, consisting mainly of 
aged pit, wbc and strands of fibrin, are known to develop in blood during storage at 
4 ° C [5,10-13]. However, their formation will be prevented for the greater part when 
the concentration of pit and wbc is low at the beginning of storage [14]. On average, 
< 20% of the pit and < 40% of the wbc remain in 'buffy-coat-free' rbc concentrate 
[14]. As described, our starting material consisted of buffy-coat depleted blood. We 
generally found 1-3 X 109 jl particles in the wbc-range and some 100 X 109 jl 
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particles in the pit-range in such blood after 4-8 wk of storage (not shown). Further 
removal of microaggr from stored blood was recently described by Linko [5]. He 
found that centrifugation (5 min, 6,900 X g) and filtration of blood (stored > I wk) 
through a standard 170 p.m transfusion filter removed most of the microaggr. We 
found excellent results after centrifugation for 15 min at 4.200 X g. removal of the 
plasma and part of the remaining 'buffy-coat' and filtration through a standard 
cotton-wool filter column, at least for microaggr with volumes not exceeding 400 fl. 
as is shown in Fig. 1. Linke [5] showed that 'centrifugation caused the small 
aggregates to firmly adhere to each other and form larger ones so that aggregates 
ranging from 10 to 80 I'm virtually disappeared'. Microaggr with volumes exceeding 
400 fl will not interfere with the Coulter measurements. Furthermore, in practice we 
never experienced any increased tendency to clogging or increased protein build-up 
of the measuring apertures due to high-volume microaggr, if any. So microaggr 
> 400 fl are likely to be largely or totally removed together with the plasma and 
buffy-coat after centrifugation and/ or during the filtration process. 
Stored packed cells (Ht approximately 80%) could also be used as starting 
materials. However, they are known to be inferior to huffy-coat-depleted blood (with 
normal Ht) because of their greater sensitivity to mechanical damage and hemolysis 
during storage and handling [15]. 
As Fig. 2 shows the addition of plt, isolated from buffy-coats and fixed as 
previously described [2,3], enable us to produce multiparameter controls with 
virtually complete absence of a shoulder in the wbc area, indicating that pit 
aggregation is almost completely [1,16] prevented, thus yielding multiparameter 
controls of short-to-medium-term stability. It should be emphasized, however, that 
this applies only to a lesser degree to instruments making use of optical measure-
ments, as these are sensitive to hemolysis, causing decreasing rbc counts [17] and 
increasing artefacts in the pit-range (own experiments, not shown). 
The results obtained by measurements in a Contraves counter show that the 
control is suitable for intralaboratory quality control in another resistive-particle 
counter, although substantial differences in the mean values of several parameters as 
measured in both instruments were found. It should be recalled, however, that the 
instruments were not cross-calibrated. We are currently investigating whether the 
control is suitable for low-budget, regional quality control cooperation andjor for 
interinstrument comparability studies. 
Prevention of ethical objections, if any. to the use of fresh blood, low cost, the 
simple methods of preparation as well as the easy availability of the starting 
materials are the main assets of the described procedure. Large-scale intralaboratory 
implementation of these controls is bound to improve dramatically internal quality 
control in hemocytometry. 
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A simple, inexpensive quality control material for 
Ortho EL T -8 platelet counts 
A J P F LOMBARTS 
From the Departmelll of Clinical Chemi:;try and Haematology. Leyenhurg Hospital, 
Leyweg 275. Tlu: Hogue, ThC' Netherlands 
SUMMARY Dilutions of I : 600 and I : 3000 of I fJ.ffi diameter polystyrene latex suspensions are 
simple. inexpensive materials for quality control ofOrtho ELT-8 platelet counts. The coefficient of 
variation (CV) for a 12-weck period at the 350>: JQll/J level was 2·2%. comparable with that of a 
commercial control. The CY at the 70:-: 101'/llevel was 3·5%. 
The automation of platelet counting is essential in 
laboratories that analyse a large number of samples. 
However. accuracy and precision of the automated 
platelet count are continual challenges and even 
more difficult to achieve than for the erythrocyte or 
leucocyte counts.1- 3 
The ELT~8 (Ortho Diagnostics. Westwood. Ma 
02090. USA) is a fully automated haematology 
instrument which utilises 100 !J-1 quantities of blood 
to determine the standard seven-parameter blood 
count plus platelet (Pl T) count. Cell-counting is 
based on the principles of laminar flow hydro~ 
dynamic centering of cells before one~by~one 
counting using a helium-neon laser optics system. 
Real-time relative-size frequency distribution curves 
(histograms) for red blood cells. white blood cells. 
and PLT can be seen on the CRT display screen.~-.:. 
The proper method of calibrating a platelet or 
multiparameter counter is to perform multiple 
manual platelet counts with a phase-contrast 
microscope.1 ~·~The calibrating medium should be 
fresh human blood. preferably having high and low 
counts. Once properly calibrated. instrument drift 
can be monitored with a stable suspension of platelet 
control or latex spheres.1• 3 Many expensive platelet 
reference materials are on the market.3 Satisfactory 
8-parameter quality control materials for the EL T-8 
do not exist.'" 
In this paper the preparation of simple I !J.m 
diameter polystyrene latex sphere suspensions and 
their use as platelet controls in the EL T-8 instrument 
are described. 
Method and results 
A vial with a 2·5 ml suspension of Dow latex 
microspheres. diameter 1 ·091 1.1.m (SO 0·0082 1.1.m), 
was obtained from Serva (Serva Fcinbiochemica, 
0 6900 Heidelberg, West Germany). The 
approximate dry weight is I 0%. d(20°C) = l ·OS 
and n0 (20°) 1·59 (polystyrCne). The price is 
approximately ISO OM. After vortex-mixing, 201.1.1 
of the latex suspension was added to 12 ·0 ml I so lac 
(Ortho) and 0·200 ml gentamicin (10 mg/ml): 
normal 1 !J.m latex suspension. The low I 1.1.m latex 
suspension was prepared. by adding 8·0 ml Isolac 
and 0·10 ml gentamicin to 2·0 ml of the normal 
I 1.1.m suspension. The suspensions were at 4°C or 
at room temperature during storage and/or 
measurement: they were measured after manual 
mixing, air bubbles having been cleared before 
aspiration or after mixing on a roller mixer. The 
suspensions were periodically measured over a period 
of 12 weeks, during which the performance of the 
instrument was monitored with the commercial 
platelet control Quanticd?l', Normal (BHP Inc. 
West Chester, PA. USA) and was found to be 
satisfactory provided the ELT-8 was occasionally 
recalibrated (Table). The Table shows comparable 
Resulu <1! platelet meusurement.\' in ELT-8 of Quanticd 
Nurmul, normul and low I [J.Ill lute.-.: suspensions. Tufa! 
period 12 ,,•eeh. 
ii SD CV(%) 
[QU/[ 
Q~,~anti~d Total r><:riod 
'" 
~'1'1·3 ,., ~-~ 
norm~l (~60-300•) 
L<tex FirM 7 da~ 
" 
34S·O 11 ·I 3·~ 
normal Total po:riO<J 
" 
345·'1 ,., ~·~ 
La't IOdaY'> 
" 
341·1 H '·• 
Lut~~ lo" Fi,.,t 7 duy' 
" 
6'1·~ ,., ,.. 
Totul r><:riO<J ,. 10·0 ~-s ,., 
La't !0 du)'"> 
" 
6'·0 ~.o ;::.9 
"SiutC<J ranKC. 
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CVs for Quanti.::d Normal and the normal latex 
suspension. The Table also shows good linearity for 
the normal and low latex suspension (calculated 
value for the low suspension 2·0/10·1 · 345·9 
68·5). As can be ~-en in the Table. no significant 
differences exist betwc..-cn the mean counts of the 
first 10. the last 10, and the total number of measure~ 
ments of both the normal and the low latex 
suspensions. The greater imprecision in the first 
seven days comparc..-d to lhat in the other periods 
was cause.."(! by slightly too high values for both 
Quanticcl and the latex suspensions during days 6 
and 7. The instrument \\aS therefore deaned and 
recalibrated. 
Discussion 
The Table shows the excdlent performance of the 
I :.1.m latex suspensions as controls for ELT~S 
platelet measurement. Costs arc negligible (dilutions 
of I : 600 and I : 3000J compared with those of 
commen:ial controls. The PL T histogram shows two 
peaks approximatclv covering a normal native PL T 
distribution curve (Figurd. ~ 
•• Rul'1 SE>qui'nC<' •• 
--------- PLT h1=.togrom ------------
RBC htslogram -------------
Hi.Hogrum di.\plu.n of normul I ;1.111 luf(',\' .111.'{/('miml. 
Lombarts 
The response of a light-scattering sensor in a flow 
instrument is not a linear function of particle volume 
or diameter because of the strong dependence of 
such a response on the index of refraction, optical 
density, surface structure, and other optical 
properties of the particlc.7 K This is clearly 
demonstrated here; I (l.lll diameter latex beads, 
having an approximate volume of 0·5 fl. show 
approximately the same response as human platelets 
with a mean volume of 7·0-10·5 flY The index of 
refraction of latex is I ·593, whereas that of live cells 
is approximately 1·374.~ Obviously latex sphere 
suspensions cannot be used for platelet volume 
calibration in the EL T-8 but they arc shown to be 
simple, inexpensive quality control materials for 
EL T-8 platelet measurements. 
I am grateful to Professor Dr B Leijnsc. head of the 
Department of Chemical Pathology, Erasmus 
University/Department of Clinical Chemistry, 
Dijkzigt Hospital, Rotterdam, for valuable advice 
and criticism. 
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Sterile, Medium Scale Age Fractionation of Human 
Red Blood Cells 
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After sterile removal of white blood cells and the majority of platelets from 
blood in a regular transfusion bag, the remaining red blood cells were separated under 
sterile conditions into a relatively young and a relatively old fraction. Making use of 
the different densities of old and young red blood cells. the separation occurs in a 
double transfusion bag by centrifugation, after the cells have been carefully layered 
~.m top of Percol!® of ''tailor-made'' density. 
The successful results of this simple and inexpensive technique are assessed by 
comparing the creatine concentration and the acetylcholinesterase activity in both 
fractions. 
Thus. this medium scale fractionation technique yields hundreds of ml of sterile. 
young red blood cells. 
Keywords: Medium scale fractionation; Percell®. red blood cell fractionation: 
sterile fractionation. 
Introduction 
In the course of investigations into the laboratory preparation of quality 
control materials for flow haemocytometry [!], we were in need of a method for 
the sterile separation of hundreds of ml of young red blood cells (rbc). Perusal 
of the literature revealed only one medium or large scale method (hundreds or 
thousands of ml) for rbc fractionation. using the recently introduced blood cell 
separators [2-4]. These ·cell processors are, however, expensive. not universally 
present and primarily developed and in use for in vivo apheresis techniques [2-4]. 
The objective of this paper is to describe our develorment and evaluation of 
an alternative method for medium scale fractionation of rtc, t:mploying simple 
means. After separation of the huffy-coat in a plasma extrzctor [5]. white bleed 
cells (wbc) and the majority of·platelets (plt) are removed by the well-established 
routine method of sterile cotton-wool filtration [6]. Making use of the different 
densities of old and young rbc [7, 8], rbc fractionation is rerformed in a double 
transfusion bag by centrifugation, after blood has been carefully layered on top of 
Percoll® of a "tailor-made" density. 
Huematologia !7, 1984 
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Materials and Methods 
Preparation of red blood cell suspension for fractionation from citrated whole blood 
In this paper we shall describe the whole blood processing procedure for 
one normal 500 ml ACD or CPD blood unit. It will be evident that scaling up can 
be achieved by simultaneously processing several blood units. 
After routine centrifugation of the regular double blood bag and pressing 
out the plasma and buffy-coat in a plasma extractor [5], the remainder ofwbc and 
pit are removed by filtration through a sterile cotton-wool column. We used the 
Cellselect leukocyte filterset D from the NPBI (Nederlands Produktielaboratorium 
voor Bloedtransfusie-apparatuur en Infusiev!oeistoffen), P. 0. Box 9148, 1006 
AC Amsterdam (Order number 1004). This routine technique has been shown 
[6] to be the method of choice for the preparation of wbc-free and pit-poor rbc 
suspensions. 
After centrifugation and removal of the saline via the satellite bag in a plasma 
extractor [5], a representative blood cell sample is drawn without using the ports 
of the primary bag. This is done by entirely clamping the empty satellite bag at 
about one tenth from the top, leaving the headspace in connection with the pri-
mary bag via the transfer tubes and by carefully homogenizing the suspension in 
these compartments. The sample, obtained through one of the ports of the satellite 
bag, is to be used to determine the exact Percoll density needed for a successful 
fractionation (see below). 
Preparation of Percol/® 
Percoll ®, a colloidal silica coated with polyvinylpyrrolidone, was purchased 
from Pharmacia Fine Chemicals, Sweden, in a sterile l L unit (cost about $ 70). 
Percoll was divided into quantities sufficient for 1 blood bag by filling out 225 
ml into four 300-ml glass injection bottles each. After the addition of 17 ml of dis-
tilled water the Porcoll was sterilized for 20 min at 120 'C. Since Percoll has a low 
osmolality (20 mOsmjkg) and autoclaving with salts causes gelation, sterile saline 
solutions must be added after sterilization. To minimize the volum' of salt solu-
tions to be added afterwards, 17 ml of distilled water was added before steriliza-
tion and 8.3 ml of 27% sterile sodium chloride solution was added after steriliza-
tion, yielding an osmolality of about 300 mOsmjkg. These solutions are stable at 
room temperature. To achieve the approximate density of rbc (1.080-1.115) [9] 
some 38 ml of sterile 0.9% saline are supplemented yielding a working Percoll 
solution with a density of about 1.105. This density can easily be determined by 
refractometry, as indicated in the Percoll package insert. The exact density n~eded 
is dependent on (I) the density of the rbc to be fractionated and (2) the amount of 
r~maining saline after the majority of the saline had been removed after filtration 
of the blooj through the cotton-wool column. as well as on (3) the desired ratio 
of the fraction<; of relatively old and relatively young rbc. 
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Assessment of the desired Per coli density 
By the addition of increasing, exactly known amounts of extra saline, a series 
of test tubes of decreasing Percoll densities is prepared. After carefully layering 
aliquots of the sample rbc suspension (see above) on top of the Percoll solutions 
and after centrifugation, preferably under the same conditions as the actual large-
scale centrifugation, the desired density can be assessed. Thus, the calculated 
amount of extra saline can be added to the working Percoll solution (generally 
about 15 ml). 
Age fractionation 
By using 2 large, long-pronged clamps and 2 additional ordinary Kocher 
clamps, the red cell suspension is pressed into the bottom compartment of the pri-
mary blood bag, as shown in Fig. I. Via one of the ports of the satellite bag, Per-
coli of the appropriate density can be layered on top of the rbc without using the 
Fig. 1. Careful layering of Percell® of appropriate density on top of red blood cells, using 
several large, long-pronged clamps. The Percell was added via the satellite bag and one of the 
connecting tubes (light colour), obviating the need for using the injection ports. Since the sub-
sequent centrifugation occurs with the ports in downward position, they may not be used 
before centrifugation, to prevent leakage. The other connecting tube shown (dark colour) was 
used to take a representative red blood cell-saline sample for the preliminary accurate density 
assessment 
144 Heamatologia 17, 1984 
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Fig. 2. Typical result of the fractionation after centrifugation. By chemical means. as described 
in the text, the lower red blood cell (rbc) layer is shown to consist of comparatively old rbc, 
the upper layer of the comparatively young rbc 
ports of the primary bag. After sealing the connecting tubes (not too close to the 
primary bag) the satellite bag can be discarded. After inversion of the primary bag 
and careful removal of the clamps. the rbc are now on top of the Percoll. The bag 
is carefully placed upside down in a centrifuge beaker, that subsequently is stuffed 
up with rubber and plastic pads to prop the bag during centrifugation. This spin-
ning occurs at routine blood bank conditions. leakage being impossible because the 
ports are intact. Figure 2 shows 2 distinct (dark) cell layers after centrifugation, the 
bottom layer consisting of the relatively old fraction. 
Through one of the ports of the primary bag. the layers can consecutively be 
harvested and washed with saline in separate bags. Since the density of the Percoll 
is greatly decreased by the addition of saline, the washing should be performed with 
Hacmatotogia 17. 1984 
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the bags in the normal upright position, the cells being in the bottom layer after 
centrifugation. The saline can be pressed out in a plasma extractor and washing can 
·be repeated. 
Tests of age fractionation 
The content or activity of several substances in the rbc decrease with increas-
ing rbc age [7-8]. Of the many age indicators described we chose creatine and 
acetylcholinesterase (ACh-ase) (EC 3.1.1.7) because of their stability and discri-
minating power [7, 10]. 
There is a non-linear relationship between rbc age and the creatine content 
[10]. The creatine concentration in young rbc is considerably higher than in older 
rbc. Creatine was assayed by the colorimetric method of Griffiths [11] as modi-
fied by Li et al. [12]. The intra-assay coefficient of variation (CV) (n = 10) was 
3.4%. 
A Ch-ase activity in the rbc membrane decreases with age. The activity was 
determined according to the slightly modified method of Michel [13, 14]. In this 
method the pH decrease due to acetic acid formation from the substrate acetyl-
choline is a measure of A Ch-ase activity. The modification consists of accurately 
registering the pH decrease in an ABL-2 blood gas instrument (Radiometer Copen-
hagen). The inter-assay CV (n = 5) was found to be 4.1% against a stated CV 
of 16% in the original method [13]. 
Results 
Figure2 visualizes the result of fractionation, the bottom dark layer consisting 
of relatively old rbc. Table I compiles the creatine contents and A Ch-ase activities 
in washed samples of both fractions (blood No. I) as well as those in the fractions 
of three other blood units. Table 1 shows highly significant differences in both age 
markers between the two fractions of the four blood units. 
Table 1 
Typical creatine coments and acetylcholinesterase activities of young and old fractions of 
four blood units 
Creatine (#g/ml rbc*) 
Blood No. I 
Blood No.2 
Blood No.3 
Blood No.4 
* red blood cel!s 
young 
31.3 
38.8 
39.8 
35.5 
** acetylcholinesterase (EC 3.1.1. 7) 
old 
24.2 
25.7 
17.7 
20.1 
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young 
1.028 
1.985 
2.120 
1.847 
old 
0.896 
1.744 
1.696 
1.744 
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Discussion 
All existing rbc separation techniques are based on the fact that rbc density 
increases with cell age. Routine bloodbank centrifugation does not lead to cell 
separation [15]. Angle-head centrifugation (to enhance the internal circulation) 
at 30 °C (to improve the flow properties of rbc) at 39,000 x g for I hour leads to 
reasonable cell separation. However, this method requires a special angle-head 
rotor, is rather cumbersome and can handle only quantities of 80 ml blood [15]. 
Percoll has been successfully used before, but only on a small scale basis [7, 8]. 
The proposed method has been shown to separate rbc into a comparatively old 
and young fraction. The ratio of these fractions can be chosen by carefully assessing 
the proper Percoll density. Likewise, the 2 fractions can possibly be separated 
further into subfractions. 
The method can be scaled up by simultaneously processing several bags. 
After removal of the plasma from various blood units, rbc with different antigenic 
make-up can be mixed with no apparent damage to the cell membranes [16], of-
fering the possibility of preparing hundreds to thousands of ml of relatively young 
rbc. Scaling up is, however, rather time-consuming and could probably be done 
much easier with modern blood cell separators [2-4]. Our method seems to be 
most rewarding for medium scale purposes. 
Unfortunately, Pharmacia Sweden cannot guarantee the safe usage of Per-
coli® for in vivo purposes. Consequently, rbc fractionated with Percoll can only 
be used for in vitro goals. 
The authors wish to thank Messrs. C. A. van Beek and A. van Tiel, department of 
medical photography Leyenburg-Eye-Hospital, for making the photographs. They are much 
indebted to Dr. P. Draper. National Institute for Medical Research, London. for most valu~ 
able discussions. 
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3.3. 
3.3. COMPARISON OF THE DEGREE OF HAEMOLYSIS 
OF YOUNG AND OLD HUMAN RED BLOOD CELLS 
DURING STORAGE 
INTRODUCTION 
There is ample evidence that young rbc 
have better geometric, osmotic and membrane 
mechanical properties than old rbc (1). In a 
recent paper we have shown the superior 
mechanical properties of rbc kept in a high-K, 
low-Na preservation medium containing mannitol 
(S 2.3. ). 
The objectives of this study 
to compare the degrees of 
(DH's) during storage in 
are 
haemolysis 
young and 
old rbc-fractions; 
to evaluate whether 
would be a better 
for the preparation 
materials. 
METHODS AND RESULTS 
young 
starting 
of blood 
fractions 
material 
control 
The fractionation technique has been fully 
described in S 3.2. The method was shown to 
use inexpensive means, to be rather simple, not 
very time-consuming and to yield good age 
fractionation. 
The haemolysis immediately after 
separation and during storage of both fractions 
was determined by measurement of Hb in the 
supernatants of the fractions after 
centrifugation in Mhct capillary tubes (S 2.3). 
The intra-assay CV <n=lOl at a 0.37 mMol/L Hb-
conc was 0.9%. The preserved rbc were shown to 
be sterile by routine blood cultures. The Table 
shows highly significant differences between 
the DH's in both fractions. 
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Table. Highly significant differences between the degrees of haemolysis in 
young and old red blood cells 
Haemoglobin (Hb) concentrations (mllol/l> 
!After: wb • 
I 
I 0 days I 8.0 
124 days I 8.0 
143 days I 8.0 
I I 
• whole blood 
H supernatant 
young rbc 
s* ~-
0.01 0.13 
0.25 3.1 
1.21 15 
II old rbc 
II 
II wb * s* ~-II 
II 8.4 0.015 0.18 
II 8.4 0.42 5.0 
I I 8.4 1.66 20 
II 
<H ratio of Hb-concentrations in supernatant and whole blood (in ~) 
= degree of haemolysis 
DISCUSSION 
We did not measure the DH during storage 
in an unfractionated sample of the particular 
blood described in the Table. However, we found 
much lower DH's <about 2% after 43 days of 
storage) in other unfractionated blood samples 
(S 2.3: Fig.2). Thus, although there is a 
statistically highly significant difference 
between the DH's of both fractions, the 
separation technique does not yield a better 
starting material for the preparation of blood 
control materials. 
Since Percell is claimed by the 
manufacturer to be impermeable and non-toxic to 
biological membranes, we tend to ascribe the 
increased DH of the fractionated rbc to 
mechanical damage inflicted during the various 
manipulations (2). More careful attention to 
the execution of the necessary manipulations 
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might decrease mechanical trauma (2). 
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SUMMARY 
For rheological reasons high viscosity 
specimens are more sensitive to deficiencies, 
if any, in the aspiration systems of whole 
blood flow cytometers and consequently are more 
likely to give erroneous values. For this 
reason the rheological behaviour of 
hemocytometry controls was compared with that 
of patient blood specimens. It is shown that 
the behaviour of controls and patient specimens 
of comparable hematocrits is similar at shear 
rates that are probably occurring during 
aspiration (exceeding approximately 40 1/sl. 
The hematocrit is shown to be a major 
determinant of the viscosities of both controls 
and patient specimens. The results suggest that 
from a rheological point of view the 
fundamental !FCC premise is met, "that errors 
detected by means of control specimens exactly 
mirror errors occurring with patients' 
specimens", provided their hematocrits are 
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taken into account. 
KEY WORDS 
EDTA-anticoagulated blood; flow 
hemocytometry control materials; quality 
control; rheology; viscosity. 
INTRODUCTION 
Apart from the obvious requirement of 
stability of values of hemocytometry control 
materials, Bull (1) states two further 
desiderata for an ideal control material: "It 
should be inexpensive and convenient (to 
encourage frequent use) <2,3) and it should 
behave like fresh whole blood (so that it can 
be processed in the same way as blood samples) 
and thus provide control for the entire 
analytical process". Likewise, Groner (4) 
states that for quality control materials "it 
is desirable that these materials share all 
relevant characteristics with the specimen 
(blood sample)". 
This requirement implies a set of 
specific features of each material. It is 
recognized that the rheological properties are 
one of these features (5). For a variety of 
reasons vacuum leaks can occur in the blood 
aspiration system of Coulter (6) and other 
counters; this might go undetected if the 
viscosities of control materials would be much 
lower than those of patient EDTA-blood 
specimens. This might result in sluggish 
and/or incomplete patient blood flow and 
concomitant erratic values for the patient 
blood. Our own laboratory experience showed 
the crucial importance of the viscosity of 
blood: due to an insidious vacuum leak in the 
Coulter suction system our "abnormal high" 
viscosity control (hematocrit (Ht) 63%) 
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invariably gave too low values. (Ht is the 
most important single determinant of blood 
viscosity (7)). Rabinovitch (8) describes that 
the Coulter quality control material "4C" 
cannot be used on an Ortho ELT-8 instrument 
"for the simple reason that its viscosity 
results in variable aspiration volumes". 
A thorough search of the recent 
literature shows no data whatsoever on the 
viscosity of blood control materials 
(1,4,5,9-11). 
The objectives of this paper are: 
1. to gain preliminary insight in the 
viscosity characteristics (rheology) of 4 
commercial and 4 laboratory-made (3) control 
materials. 
2. to compare these characteristics with those 
of 4 routine patient EDTA-blood specimens with 
comparable Ht values. 
3. to investigate whether the use of plasma 
instead of our artificial preservation medium, 
containing albumin, (2) has any beneficial 
effect on the rheological behaviour of 
laboratory-made control materials. 
MATERIALS AND METHODS 
Viscosity measurement technique 
The viscosity measurements in this study 
were carried out with a Contraves Low Shear 30 
viscometer (Contraves AG, CH-8052 Zurich, 
Switzerland) (7, 12-14), using a cup width of 
0.5 mm. The (modified) technique, as described 
in full detail by Goslinga et al.(l4), has 
previously been shown to be highly reproducible 
due to automation and rigorous standardization: 
Coefficients of variation of approximately 3% 
at the lowest (0.016 1/s) and ca. 0.4% at the 
highest (118 1/s) shear rates were obtained. In 
short, salient features include: 
154 
1. Refinement of the zero-point setting by 
applying remote control, thus obviating 
unsatisfactory vibrations (13,14); 
2. Guarantee of accurate measurements by a 
calibration program with a calibrated 
standard oil; 
3. Consistent treatment of the specimens before 
the actual measurements by rotating them in 
a water bath of constant temperature; 
4. Invariable start of measurements, after 
thorough mixing, at the lowest shear rate, 
proceeding towards higher shear rates to 
avoid hysteresis variability (7,14); 
5. Routine-plotting of viscosity-versus-time 
curves (not shown) to facilitate the 
recognition of artefacts such as an air 
bubble, a small hair, a non-centered bob, 
clots or fibrin strands in the sample or an 
inhomogeneous blood sample, thus controlling 
the quality of the measurement technique; 
6. Automatic standardization of the time factor 
by computer-controlled (HP 98158) 
measurements. These measurements ar·e spread 
over the entire range of shear rates (0.016 
to 118 1/sl; At every shear rate a specific 
length of time is required between the 
beginning of the rotation and the moment of 
measurement, starting with 110 seconds at a 
rate of 0.016 1/s and decreasing to 10 
seconds at a shear rate of 118 1/s. Thus, 
the measurements on one sample could be made 
within five minutes, minimizing the effect 
of settling out of the red blood cells (rbc) 
during the measurement (13,14). 
To facilitate comparison of the values of 
the different specimens, the viscosities are 
graphically represented versus the shear rates 
in a double logarithmic coordinate system 
(yielding so-called rheograms: Fig.l, p. 158). 
For practical reasons the measurements were 
generally performed at 37.0 +/- O.l°C, although 
some samples were also measured at 20.0 +/- 0.1 
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°C. (Fig.3). 
Fresh patient EDTA-anticoagulated blood 
specimens 
Four fresh patient 
blood specimens (Fig. 1: 
varying hematocrits (Ht's) 
seven hours after drawing. 
Hemocytometry controls 
a. Laboratory controls 
EDTA-anticoagulated 
full curves a-d) of 
were measured within 
Two of the measur~d controls (Fig. 1, 
curves e and jl were prepared in an artificial 
(high-K, low-Na) suspending medium, containing 
3% albumin, as described before (3,15). 
Although this preservation medium. is quite 
satisfactory, there are two reasons to study 
the possibility of using normal transfusion 
plasma instead : 
1. Further simplification of blood control 
processing: (compatible) plasma can be 
stored frozen and consequently is ready at 
hand; 
2. Possibly hemorheological considerations. 
In a previous paper (15) we already 
mentioned that substances such as citrate, 
mannitol and sucrose are impermeable to rbc and 
consequently exert an oncotic effect. we found 
that the citrate concentration in the plasma 
anticoagulant CPD-A is insufficient to fully 
counterbalance the impermeable hemoglobin and 
other osmotically active substances such as 
lactate (15). This has recently been confirmed 
by Hoegman et al. (16). We invariably found 
satisfactory Mean Cell Volume (MCV) constancy 
after addition of 0.55% mannitol (final 
concentration) to CPD-A plasma. Nevertheless, 
our preliminary impression is that neither MCV 
nor Red cell Distribution Width (RDW) are 
constant during periods as long as those found 
in our described control (15). This needs 
156 
further investigation. Furthermore, it should 
be realized that the percentage of mannitol to 
be added is dependent on the (quite variable) 
citrate concentrations in the various citrate-
containing anticoagulants (17l. 
One of the objectives of this paper is to 
study whether the use of plasma instead of the 
artificial medium has any beneficial effect on 
the rheological behaviour of laboratory-made 
control materials (Fig. 1, curves g and kl. 
b. Commercial controls 
One "abnormal high" control viz. Hyland's 
"Eight-parameter High Abnormal" control, lot 
No. 3118 H was measured, 30 days before its 
expiration date (E. D. l (March 1, 1984) (Fig.l, 
curve fl. Its stated Ht was 56.5%. Three 
"normal" controls were measured: Coulter's "4 
C-Plus II Normal" control, lot No. 9378, was 
measured 7 days before its E.D. (January 9, 
1984) (Fig. 1, curve hl (Ht = 36%); Ortho's 
Hematology control blood, lot No. 83 L07/746, 
was measured 4 days before its E.D. (February 
5, 1984) (Fig. 1, curve il (Ht=38%l; Hyland's 
"Eight-parameter Normal" control, lot No. 398N, 
was measured 33 days before its E.D. (December 
31, 1983) (Fig. 1, curve ll (Ht=38%l. 
RESULTS 
Fig. 1 (full curves a-dl shows the 
well-known non-Newtonian character of fresh 
patient EDTA-blood specimens (7). The figures 
accompanying the curves designate the Ht's of 
the specimens. Although in normal blood Ht is 
the most important single determinant of blood 
viscosities (7), inspection of curves a-d shows 
that other (partly unknown) determinants can 
decisively affect fresh blood viscosity values 
over the entire shear rate range. 
The dashed curves f, h, i and 1 in Fig. 1 
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Fig 1. Composite display of rheoQl"ams, showing log. viscosities versus log. 
shear rates of various groups of specimens. All measurenents oere 
performed at :>7.00 +/- O.!C'C. Figures accompanying the curves designate 
hematocrits lin %) as measured in a Coulter Counter Model S-Plus II. 
Full curves (a-d): "fresh EDTA-anticoagulated blood specimens; Dashed 
curves (f,h, i, ll: commercial controls, viz.: Hyland's 'Eight-parameter 
Abnormal High' control (f), Coulter's '-41:-Plus II Nor~~al" control (h), 
Ortho's 'Normal Hematology' control (i) and Hyland's 'Eight-parameter 
Normal' control (J); Circled curves (e, g, J, kl: Laboratory-made 
controls viz.: open circles (g and k) plasma as the suspending medium 
and full circles (e and J) artificial suspending medium, containing 
albumin. For COOI!llents see the text. 
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represent the rheograms of the 4 commercial 
controls examined. They all show a 
characteristic (nearly-) Newtonian behaviour. 
(i.e. independence of viscosities on shear 
rates). The viscosities of the "Normal" Coulter 
(h), Ortho (il and Hyland (ll controls are of 
the same order of magnitude, and so are their 
Ht's (36-38%). In contrast, curve f, 
representing Hyland's "Abnormal High" control, 
roughly shows three to four times higher 
viscosities than the "Normal" controls. This 
clearly demonstrates that (also) in commercial 
controls Ht's have a decisive influence on 
their viscosities. 
Fig. 1 also shows that the viscosities of 
the "Normal" controls (h, i, ll approach those 
of EDTA-blood specimens with comparable Ht's 
(b-dl only at shear rates exceeding at least 
40 1/s (as estimated from the numerical values, 
which are not shown). On the other hand, Fig. 1 
demonstrates that the viscosities of Hyland's 
"Abnormal High" control (f) at shear rates 
exceeding 0.5 - 10 1/s are substantially higher 
than those of fresh EDTA-anticoagulated blood 
specimens with normal Ht's (Fig. 1, a-dl. 
The circled curves e, g, j and k in Fig. 1 
represent the rheological behaviour of our 
laboratory-made controls. The full-circled 
curves (e and jl make up the rheograms of cells 
in our artificial suspending medium, containing 
approximately 3% albumin; the open-circled 
curves (g and kl represent those of cells in 
mannitol-containing plasma. These media are 
further to be called artificial and plasma 
medium, respectively. Controls j (artificial 
medium) and k (plasma medium) approximately 
coincide with those of the "Normal" commercial 
controls h, i and 1. Consequently, their 
viscosities are also much lower than those of 
comparable EDTA-blood specimens with 
corresponding Ht's (b-dl (up to shear rates of 
approximately 40 1/sl. At the time of the 
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measurements specimens j and k were 6 weeks and 
ll weeks old, respectively. Specimen j 
<artificial medium) showed minimal hemolysis, 
whereas specimen k (plasmal exhibited 
substantial hemolysis. In contrast, curves e 
<artificial medium) and g (plasma medium) show 
a non-Newtonian, more or less parallel, 
behaviour. However, they fail to coincide with 
the fresh EDTA-blood curves. Curve e represents 
the rheogram of the multiparameter 
hemocytometry control, we recently described in 
detail (3). The control was ll weeks old at the 
time of the measurement, consequently hemolysis 
was rather extensive (3). Its viscosities at 
shear rates exceeding 30 1/s are broadly the 
same as those of the EDTA-specimen with an 
equal Ht (curve a). Curve g exhibits the 
rheogram of fresh rbc, suspended in plasma 
and measured 6 days after preparation. 
Fig. 2 shows the viscosity changes of the 
laboratory-made fresh blood cell-plasma control 
(corresponding to curve g in Fig. ll during 
storage at 4°C as a function of shear rates. At 
low shear rates the viscosities decrease, 
whereas at higher shear rates (exceeding 0.1 to 
1.0 1/sl viscosities increase. These effects 
are more pronounced with measurements at 20°C 
(full curves) than with those at 37°C (dashed 
curves). 
Fig. 3 shows that elevating the measuring 
temperature from 20°C to 37°c -this range 
largely spanning worldwide ambient 
temperatures- results in viscositiy decreases 
of approximately 30-50% at low (0.3 1/sl and 
30-40% at high shear rates (100 1/sl for both a 
fresh EDTA-blood specimen and for several 
commercial and laboratory-made controls <see 
legends to Fig. 3). 
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F1g 2. V1scosity changes of tne laboratory-made fresh reo ciooa cell-olasma 
control (corresponoing to curve g in Fig. 1l during storage at 40C as a 
function of shear rates. The full curves 1 and 4 reoresent measurements 
at 200C, the dashed curves 2 and 3 those at 370C. Curves 1 and 3 show 
tne changes after 1 month of storage, curves 2 and 4 those after 2 
months of storage. At low snear rates viscosities decrease due to 
decreased aggregation, whereas at higher shear rates (exceeding 0.1 to 
1. 0 1/sl viscosities increase due to decreased red blood cell 
deformabiiity. These effects are more oronounced witn measurements at 
200C than with those at 370C. 
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DISCUSSION 
The fresh patient blood specimens (Fig. 1, 
full curves a-d) exhibit the well-known 
non-Newtonian behaviour (7). Viscosities 
increase exponentially at the lower shear rates 
due to the presence of the plasma proteins 
albumin, fibrinogen and immunoglobulins; they 
overcome the zeta potential between red blood 
cells (rbcl and aggregate, forming rouleaux, 
these causing a disproportionate increase in 
viscosities (7,12,18). It seems appropriate to 
point out that erythrocyte sedimentation (ES), 
as routinely determined by the ESR(atel-test, 
actually is a low-shear system exerted by 
gravity (7). At the higher shear rates, 
rouleaux are dispersed and individual rbc are 
deformed into ellipsoids with their long axes 
aligned in the direction of flow (7,12,19). 
In contrast, the commercial controls (Fig. 
1, dashed curves f,h,i and ll and two of the 
four laboratory-made controls (Fig. 1, circled 
curves j and k) show nearly-Newtonian behaviour 
and their curves approximately coincide (apart 
from that of specimen f because of its higher 
Ht). The general rule is that in non-
aggregating suspensions much lower viscosities 
are observed at the lower shear rates, whereas 
at higher shear rates viscosities (slightly) 
increase due to decreased rbc-deformability and 
hence these suspensions ten;';. to behave as 
(nearly-)Newtonian fluids (20-25). It might be 
interesting to mention as an example that we 
found very low ESR-values for Coulter's and 
Hyland's "Normal" controls <Fig. 1, curves h 
and ll : 4 mm after 3h and 12-18 rom after 24h 
of sedimentation. On the other hand strong 
influences of the plasma composition on 
ESR-values and consequently on low shear 
viscosities are well-known from clinical 
practice. 
Finally the remaining two laboratory-made 
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not 
with 
controls <Fig. 1, circled curves e and g) show 
non-Newtonian behaviour. However they do 
coincide with fresh EDTA-blood specimens 
comparable Ht's. 
Unfortunately, we can only partly explain 
the discordant rheological behaviour of our 
laboratory-made controls. The data show that 
this discordance is not only due to the nature 
of the suspending medium : our albumin-
containing artificial medium (curves e 
and j) versus plasma <curves g and k). The 
non-Newtonian behaviour of the controls e and g 
at lower shear rates might be related to 
incomplete discocyte-echinocyte shape 
transformation and consequently only partly 
decreased cell-cell interaction. 
One of the controls was made from fresh 
rbc <curve g), the other three controls were 
6-11 weeks old and consequently partly 
hemolyzed. Viscosities are known to change 
during storage. At corresponding shear rates, 
hemolyzed packed rbc (packed ghosts) in 
suspension generally show viscosities slightly 
lower than those of intact rbc.(23) 
Fig. 2 shows the viscosity changes of the 
fresh plasma control g during storage at 4°c as 
a function of shear rates. We observed similar 
typical changes during storage of fresh 
EDTA-blood viscosities at (very) low shear 
rates decrease due to diminished aggregation 
and viscosities at high shear rates increase 
due to diminished deformability of the rbc 
(20-25). Fig. 2 shows that these storage 
changes are slightly more pronounced when the 
viscosities are measured at 20°C. However, Fig. 
2 also shows that the changes in this 
particular control specimen are only at most 
20% in the probably relevant shear rate range 
above 40 1/s (see below), which is negligible 
in comparison to the Ht-effect <vide infra). 
Similarly, we found negligible viscosity 
differences (ca. 10% at 20 C) after storage of 
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the Coulter control. (not shown : it should be 
mentioned, however, that we measured the 
control 6 weeks after its expiration date). 
Fig. 6 shows that the temperature effect 
between 20 C and 37°C on the viscosities is 
similar for both fresh EDTA-blood and the 
controls, including Hyland's "Abnormal High" 
control and is only slightly dependent on the 
shear rate. The viscosity changes amount to 
approximately 30-50%. It is important to 
realize that room temperature changes seem to 
have an equal effect on the viscosities of both 
patient and control specimens. 
Fig. 1 shows similar rheograms for Ortho's 
control and Coulter's "4C Plus II" control. 
Assuming that the rheogram of Coulter's control 
"4C" is similar to that of Coulter's control 
"4C Plus II", we cannot explain Rabinovitch's 
statement (8) mentioned in the INTRODUCTION, 
that Coulter's "4C" control cannot be used on 
an Ortho ELT-8 instrument "for the simple 
reason that its viscosity results in variable 
aspiration volumes". 
Figs. 1-3 confirm that the Ht is by far 
the most important single determinant of the 
viscosities of both fresh blood and the 
controls (7) : Fig. l(f) shows increases in the 
order of 300-400% for a commercial control and 
Fig. l(a) some 200% for fresh EDTA-blood due to 
Ht-differences, whereas Figs. 2 and 3 show only 
20% increase due to deformability decreases and 
only 60-50% due to temperature changes in the 
20°-37 C range. Thus, specimens with high Ht's 
will be much more sensitive to deficiencies, if 
any, in the aspiration systems of flow 
hemocytometers and consequently non-linearity 
or even erroneous values might occur. This 
explains our findings of too low values in an 
"Abnormal high" control, mentioned in the 
INTRODUCTION. It would be even more important 
if polycythemia specimens were to be analyzed. 
In the Contraves viscometer 28.7 
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revolutions per minute (rpm) and 98.0 rpm 
correspond to shear rates of 34.6 1/s and 118.2 
1/s, respectively. The fundamental question is 
what the magnitudes of shear rates are that 
occur during whole blood flow in the aspiration 
systems of whole blood flow cytometers. It 
depends on the vacuum applied and the different 
geometries in the suction system of the 
particular instrument used. Consequently, shear 
rates are likely to markedly vary at various 
locations in a particular instrument and, a 
fortiori, in different instruments. However, 
the appropriate shear rate range is very 
difficult to estimate; it would require 
extensive empirical model simulation studies 
(26). For this reason the viscosities were 
measured over a wide range of shear rates. 
Nevertheless, judging from the force with which 
blood samples are generally sucked up into the 
hemocytometers, it seems reasonable to 
speculate that shear rates will be rather 
high, probably exceeding 40 1/s. As Fig. 1 
clearly demonstrates, the magnitudes of 
occurring shear rates are decisive for the 
rheological behaviour of fresh EDTA specimens 
in comparison to that of control specimens : 
at rates exceeding approximately 40 1/s, their 
viscosities are numerically comparable. 
Consequently, the results suggest that from a 
rheological point of view the fundamental 
IFCC-premise ( 2 7) is met that "errors detected 
by means of control specimens exactly mirror 
errors occurring with patients' specimens". 
In conclusion, this paper provides 
insight in the viscosity characteristics of 
hemocytometry controls in comparison to those 
of fresh patient EDTA-blood specimens (Fig. 
ll. Moreover, the article strongly suggests 
that the use of plasma instead of our 
artificial suspending medium, containing 3% 
albumin (3), does not make the rheogram more 
identical to that of fresh blood and 
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consequently does not seem to have any 
beneficial effect on the rheological behaviour 
of laboratory-made hemocytometry controls. 
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Chapter Y. 
SUMMARY AND CONCLUSIONS 
1. SUMMARY 
In Ch I an INTRODUCTION to AND the 
OBJECTIVES of this thesis are given. The 
objectives and the terminology of Internal 
Quality Control (IQC), External Quality 
Assessment (EQA) and Quality Assurance (QA) are 
described in Section 1 (Sl). After a short 
introduction to the significance, the 
technological progress (S2) and the problems 
(53) of haemocytometry (hey), the objectives of 
this thesis are described in S4. 
The "STATE OF THE ART OF QUALITY 
ASSURANCE IN HAEMOCYTOMETRY" is reviewed in Ch 
II. Appropriate QA is a prerequisite for High-
Standard Laboratory Performance (HSLP) in the 
haematology laboratory. Comprehensive QA should 
comprise the pre-analytical (52), the 
analytical (S3) and the post-analytical (S4) 
phases of laboratory practice. 
In S2 the importance of special attention 
to the pre-analytical phase is emphasized, 
namely to the requisition of the appropriate 
tests, to the appropriate preparation of the 
patient as well as to the appropriate drawing, 
collection, administration, transport and 
storage of the blood specimens. 
The analytical phase discusses problems 
of precision and accuracy of the measuring 
instruments in IQC and EQA programmes (S3). 
S 3.1 elaborates on the basic problems of 
analytical QA in hey. The concepts of accuracy 
and precision are elucidated (Fig. 1). Although 
the advent of flow hcs has dramatically 
improved precision, accuracy (calibration) is 
still a major problem. Calibration problems are 
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compounded by the almost complete lack of 
reference (ref) preparations due to the 
instability of blood cells. Difficulties in 
preparing ref preparations have been discussed. 
Ref preparations are needed all the more since 
most routine flow hcs are in fact comparators 
(cf Ch III, S 3.2). The benificial effect of 
the only existing ref preparation, that for 
haemoglobinometry, has been demonstrated. Fig. 
2 (p.28) shows the consequences of the absence 
of ref preparations: substantial differences 
exist in counting results among different 
instruments. Flow hcs can achieve quite 
satisfactory precision, provided their 
functioning is carefully and continuously 
monitored in an IQC programme. The preparation 
of materials intended to contribute to IQC, is 
described in Ch IV. They serve three basic 
purposes of IQC: process control, retrospective 
IQC and blind control, in other words they 
contribute to the essence of (analytical) IQC 
viz. continuous self-auditing and continuous 
attempts at improving performance, as can be 
monitored by the various precision 
characteristics. Apart from the general 
problems, specific problems of calibration and 
IQC of individual cell parameters are briefly 
enumerated or referred to. They are either due 
to abnormalities of the particular blood 
specimen or to instrument deficiencies or 
malfunctions. 
S 3.2 and Table 1 (p.34J summarize methods 
primarily aimed at monitoring the analytical 
precision. Computation of patient values plays 
an important role in conjunction with the use 
of control materials. S 3.2 also mentions the 
approaches to IQC chosen in routine use to deal 
with the serious inconveniences of lack of ref 
preparations. Calibration of instruments is 
approached in essentially three ways: 
1. Analysis of a great number of fresh, normal 
blood specimens by manual or semi-automated 
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(digital) techniques (cf Ch III). 
2. Performance of a few repetitions of 
carefully performed calibration techniques. 
3. Acceptance of stated values of commercial 
IQC control materials as initial calibration 
values and comparing the values with those of 
stated values of other IQC materials and in one 
or more EQA-schemes. This pragmatic approach is 
theoretically objectionable, yet is undoubtedly 
the most widely used. It is a sure sign of the 
importance of attempts at value assignment 
techniques of (interlnational bodies, as 
described ins 3.6. 
S 3.3 describes the operational requirements 
in daily routine if High-Standard Laboratory 
Performance (HSLP) in the analytical phase is 
to be met. 
In S 3.4 the functions of EQA schemes are 
mentioned. Fig.3 (p.40) and Table II (p.42) 
give the order of magnitude of CV's of the 
different parameters in various schemes. They 
reflect the state of the art in EQA in hey, 
that is commented upon. Finally, some 
deficiencies of EQA surveys are discussed. 
InS 3.5 analytical goals are discussed. In 
my opinion, the laboratory must provide the 
most reliable quantitative data possible (as 
far as costs permit), monitored through 
objective QA procedures. 
In S 3.6 value assignments by (inter)-
national bodies are described. They encounter 
two main problems: 
1. The basic technological problems inherent in 
particle counting and sizing in general (cf Ch 
III). 
2. Specific problems due to the instability of 
blood cells, necessarily leading to usage of 
cell substitutes. In haematology the accepted 
ref count is produced by so-called digital 
instruments e.g. a Coulter Counter ZBI. The 
most promising cell substitutes as ref 
materials are latex particles, that can be 
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quite accurately sized by light 
microscopy. (Fig.4 ,p.47ll Two proposed schemes 
for assigning values to secondary ref materials 
using fresh blood as an intermedium, are 
mentioned. (Fig. 5, p.47 and Table III, p.49l 
In S 3.7 maintaining the common current 
practice of initially using IQC materials for 
calibration purposes is advocated. It is argued 
that theoretical objections to this practice 
might well be obviated by application of the 
recently described BCSH-protocol for precisely 
assigning values to IQC materials. However, 
this would require intensive regional or 
national cooperation. 
S 4 emphasizes the importance of the post-
analytical phase by quoting La Rochefoucauld's 
theorem, "it is not enough to have great 
qualities, one must make good use of them". It 
is a matter of course that adequate recording, 
reporting and laboratory-physician 
communication all contribute to this "good use" 
of the "great-quality" values hitherto aimed 
at. Interpretation of values is particularly 
important in this respect. Consequently several 
aspects of the interpretation and significance 
of hey values are elaborated on in S 4.2, 
namely the significance of successive counts, 
ref values and the clinical efficacy of hey 
tests are rather extensively discussed. 
Finally, aspects of cost-effectiveness 
and QA are briefly mentioned in S 5. One of the 
objectives of QA should be to reduce health 
care costs through appropriate test 
requisitions. 
Ch III discusses the BASIC PRINCIPLES AND 
PROBLEMS OF HAEMOCYTOMETRY. 
After a short introduction in S 1, S 2 
deals with manual haemocytometry (hey). 
In S 2.1 it is argued that counting chambers 
are unlikely to become suitable for calibration 
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purposes. 
S 2.2 enumerates the advantages and 
disadvantages of the ICSH-recommended Hb 
determination. The assets of a recently 
described alternative Hb-method are briefly 
mentioned. 
S 2.3 elaborates on the centrifugal (cf) 
Hct. In S 2.3.1 the MicroHct (MHct) method is 
advocated as a potential routine calibration 
method, in contrast to the official ICSH Macro 
(ref) method. InS 2.3.2 the cf Hct of normal 
blood is commented on; it is recommended as an 
intermedium for value assignments to 
calibration materials for flow hey instruments. 
S 2.3.3 states that the trapped plasma results 
of the cf Mhct of normal and even of 
pathological bloods range from 1.18 to 2.25%, 
provided the Mhct is performed at 13,000 x g 
for ten min. This is significantly lower than 
those--- stated in earlier publications. 
Discrepancies between cf Hct and flow hey Hct 
of pathological bloods are described; they can 
either be due to departures from normal red 
blood cell (rbcl deformability or due to hyper-
osmolar plasma. Finally, it is argued that the 
diagnostic value of the MCHC, being the ratio 
of Hb and Hct, is negligible because of its 
insensitivity to the characteristics of 
pathological cells. Ins 2.3.4 comments are 
given on the often serious discrepancies 
between Mhct and flow hey Hct of artificial 
blood. 
S 3 deals with the principles and 
problems of flow hey. 
In the Introduction (8 3.1) and in S 3.2 
flow hey instruments are classified into 
analogue and digital instruments on the one 
hand and electrical (aperture-impedance or 
resistive-particle) and optical (light-
scattering) instruments on the other hand. 
S 3.3 elaborates on the hydrodynamic 
properties of flow hey instruments. InS 3.3.1 
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the flow of fluids in the sensing apertures is 
discussed. In S 3.3.2 basic fluidic and 
electronic improvements enabling high 
resolution cell analyses are described: (2 
types of) hydrodynamic focusing, pulse editing 
and sweep flow are consecutively dealt with. 
S 3.4 studies the electrical (aperture-
impedance) counting and sizing, as first 
applied in Coulter Counter instruments. After 
an introductory (S 3.4.1), aspects of blood 
cell counting, with special emphasis on 
counting accuracy, are described in S 3.4.2. 
Blood cell sizing is dealt with in S 3.4.3. 
After a primer of sizing theory (S 3.4.3.1), 
the important shape factor and flow-induced 
<red) cell shape changes are introduced in the 
following (sublsections. They can have an 
important bearing on the accuracy of rbc sizing 
(MCV) in pathological blood and consequently on 
Hct and MCHC (cf S 2.3.3). The overall 
conclusion is that in impedance-sizing MCV and 
Hct will be found erroneously more extreme than 
the "true extreme value" at either extreme side 
of the mean, whereas the MCHC tends to be 
erroneously blunted, leading to erroneous 
constancy. (cf S 2.3.3 and Fig. 6, p. 55). 
RDW, a quantitative analogue of anisocytosis, 
can improve the classification of anaemias. 
However, considerable confusion can be brought 
about by the various prevailing ROW-
definitions, even among the different Coulter 
Counter Models. Rbc histograms can be used 
instead to avoid possible confusion. S 3.4.3.5 
briefly highlights the major features of plt 
sizing, such as the influence of anticoagulants 
and temperature on shape changes and MPV; plt 
distribution and PDW; inverse, non-linear 
relationship between MPV and plt count. 
Finally, a plea is made for strict 
standardization of Platelet Rich Plasma 
preparation. S 3.4.3.6 deals with partial wbc 
differentiation as accomplished in Coulter 
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counters. Good correlations of Coulter values 
with those of several other methods are 
described in the literature. The importance of 
adequate wbc-threshold setting for accurate wbc 
counting, sizing and partial differentiation is 
stressed. 
Finally, inS 3.5 some special features 
of optical Clight-scatteringl cell counting and 
sizing are briefly discussed. These can - inter 
alia - bring about MCV (Hct, MCHC) values at 
variance with those measured in aperture 
impedance counters. 
Ch IV descibes the PREPARATION AND 
EVALUATION OF INTERNAL QUALITY CONTROL 
MATERIALS FOR FLOW HAEMOCYTOMETRY. For a 
summary of this Ch we refer to its prologue and 
to the Summaries of the individual Sections. 
Ch v (this Chl consists of the SUMMARY 
AND CONCLUSIONS. 
2. CONCLUSIONS 
- Appropriate QA is a prerequisite for High-
Standard Laboratory Performance in hey (Ch 
II, S ll. The laboratory must provide the 
most reliable, quantitative data possible, 
as far as costs permit, monitored through 
objective QA procedures (Ch II, s 3.5). 
- The pre-analytical conditions should be 
standardized as much as possible (Ch II, S 
2). 
- The advent of flow hcs has dramatically 
improved precision, accuracy (calibration) 
on the other hand is still a major problem 
due to lack of stable ref preparations 
<except for Hbl and due to basic 
technological particle counting and sizing 
problems CCh II, Ch III). 
- EQA schemes play an important role in 
assessing the state of the art in QA in 
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hey (Ch II, S 3.4). 
- Cell <particle) counting is a basic 
technological problem due to possible 
particle adhesion, aggregation, 
coincidence counting etc (Ch III, s 3.4). 
In practice, digital flow hcs are used to 
approximate the true counts. (Ch II, S 
3. 6). 
- Accurate (red) cell sizing (MCV, Hct, MCHC 
determinations) in flow hey demands 
simultaneous meas.urements of individual 
cell deformability (shape 
factorl(electrical counters), refractive 
index <optical counters) and plasma 
osmolality. This applies especially to 
pathological rbc. (Ch III, S 3.4.3 and S 
3.5). Accurate platelet sizing (MPV, PDW) 
requires special attention to several 
factors (Ch III, s 3.4.3.5). (Partial) wbc 
differentiation (sizing) is successfully 
accomplished in several multiparameter 
flow hcs. 
- For pragmatic reasons the current practice 
of <initially) using (commercially-) 
assigned values of IQC materials for 
calibration should be maintained. (Supra) 
regional or national application of a 
recently described BCSH protocol for 
assigning values to these IQC materials 
could obviate objections to the use of IQC 
materials for calibration purposes (Ch II, 
83.7). 
- Mhct of normal, fresh human blood is a 
practical calibration method for flow hey 
Hct, provided it is performed under 
carefully controlled and specified 
conditions. On the other hand, there are 
several possible reasons for discrepancies 
between flow hey Hct and cf (M)hct of 
pathological and/or artificial bloods (Ch 
III, S 2.3). 
- Ch IV describes the methods to prepare IQC 
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materials in the laboratory. Ease of 
preparation and low cost provide the means 
to frequently monitor the instruments, 
thus contributing to optimization of IQC. 
Optimization should comprise process 
control, retrospective IQC and blind 
control; all these elements contribute to 
the essence of IQC: continuous self-
auditing and continuous attempts at 
improving laboratory performance. 
Furthermore, patient MCV, MCH and MCHC can 
be very useful, additional parameters in 
IQC, especially if appropriate computer 
algorithms are applied (Ch II, Table I). 
- A plethora of unusual, but important 
interferences in individual blood specimen 
hey can occur. Especially an abnormal MCHC 
can help recognize them (Ch II, S 3.1.2). 
- In flow hey MCH and MCHC generally give no 
clinical information additional to the 
MCV. In contrast, the combination of RDW 
and MCV enable full classification of 
anaemias. (Ch II, S 4. 2. 3; Ch III, S 
3.4.3.4). 
- Different, prevailing definitions for RDW 
and PDW (Ch III, S 3.4.3) can lead to 
considerable confusion. 
- One of the objectives of QA should be to 
reduce health care costs -inter alia-
through appropriate test requisitions and 
interpretations (Ch II, S 4 and S 5). 
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SMNVATIINS 15UIIIlary in Dutch) 
In Hoofdstuk I (H I *l worden de "INLEIDINB EN DE DOa5Ta.LINGEN" 
van dit proefschrift gegeven. De doelstellingen en de terminologie van Interne 
Kwaliteits Kootrole llKKl, Externe KMaliteits Vaststelling IEKVl en Kwaliteits 
Betolaking IKBl worden beschreven in Sektie I IS ll. Na een korte inleiding tot 
de betekenis, de technologische vooruitgang (5 2) en de problemen (5 3l van de 
hemocytometri~ lletterliJk: het meten van bloedcellenl, MOrden de 
doelstellingen van dit proefschrift genoemd in 5 4. 
In H II liOrdt een overzicht gegeven van de 'STAND VAN ZAKEN OP HET 
SEBIED VAN KWALITEITSBEWAKINS IN DE HEM!JCYTOMETRIE'. Seschikte KB is een 
eerste vereiste voor Laboratorium-Werk-Van-Hoge-Kwaliteit (LWHKl in het 
hesatologisch laboratorium. Allesomvattende KB dient de pre-analytische IS 2l, 
de analytische (5 3l en de post-analytische IS 4l fasen van de 
laboratoriumpraktiJk te bestriJken. 
Voornaamste afkortingen (zie ook 'MaJor abbreviations", p. 10; Engelse 
equivalenten MOrden, waar nodig, tussen haakJes toegevoegdl. 
cf = centri fugaal 
EKV = Externe Kwaliteits Vaststelling (: EGA) 
flowhcs = flow hemocyt011eters 
H = Hoofdstuk 
Hb = Hemoglobine 
hcie = hemocytometrie (: hcyl 
IKK = Interne Kwaliteits Kontrole (: !Gel 
KB = Kwaliteits Beoaking (: QA) 
LWHK = Laboratorium-Werk-van-Hoge-Kwaliteit (: HSLPl 
MCHC = g~iddelde ~ncentratie van tlemaglobine in rode 
~!len 
MCV = ge~iddelde rode ~~ ~olume 
Mhct = Microhematokriet 
p. = pagina 
plt = bloedplaatJes 
rbc = rode bloed cellen 
ref = referentie 
s = Sektie 
Vgl = VergeliJk 
wbc = Mitte bloed cellen. 
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In S 2 100rdt de nadruk gelegd op het belang van speciale aandacht voor 
de pre-analvtische fase, met name voor het aanvragen van geschikte bepalingen, 
voor de Juiste voorbereiding van de patient, alsmede voor de Juiste afnalle, 
verzending, administratie, transport en opslag van bloedaonsters. 
De analvtische ~ CS 3l bespreekt de problemen van precisie en 
Juistheid van de meetinstr~~~~enten in IKV en EKV programma's. 
S 3.1 gaat uitgebreid in op de fundamentele problemen van analytische 
KB in de hellocytOIIIetrie (hciel. De begrippen • JUistheid" en "precisie' worden 
toegelicht (Fig. 1, p. 24). Ofschoon de komst van de zgn. 'fl0>1 
hE!IIOCytometers• Cfl010 hcs; automatische bloedcelmetersl de precisie ingriJpend 
heeft verbeterd, !evert de Juistheid (iJkingl nog steeds een groot probleem 
op. !Jkproblemen IOOrden verergerd door het vriJwel volledige gebrek aan 
referentie (ref) preparaten ten gevolge van de instabiliteit van bloedcellen. 
De moeiliJkheden biJ de bereiding van ref preparaten 100rden besproken. Ref 
preparaten ziJn te meer nodig daar de llleeSte routine fl010 hcs in feite 
vergeliJkende apparaten ziJn CVgl H III, S 3.2). Het heilzame effekt van het 
enige bestaande ref preparaat, dat voor de hemoglobine CHbl meting, wordt 
aangetoond. Fig. 2 (p. 28) toont de konsekwenties van de afwezigheid van ref 
preparaten: er bestaan aanmerkeliJke verschillen in telresultaten tussen 
verschillende instrumenten. FlOM hcs kunnen een heel bevredigende precisie tot 
stand brengen, mits een nauNgezet en ononderbroken toezicht op hun N.rking 
IOOrdt uitgeoefend in een IKK-programma. In H IV IOOrdt de bereiding beschreven 
van materialen, die bedoeld ziJn om te gebruiken biJ de IKK. ZiJ dragen biJ 
tot de verNezenliJking van drie fundamentele doeleinden van IKK 
procesbeheersing, retrospectieve IKK en blinde kontrole, 11.a.w. ziJ dragen biJ 
tot het wezen van de Canalytischel IKK nl. ononderbroken zelfkritiek en 
kontinue pogingen tot het verbeteren van de kNaliteit, zoals voortdurend kan 
IOOrden nagegaan m. b. v. de verschil!ende precisie grootheden. Behalve de 
algemene problemen, worden de specifieke problemen van iJking en IKK van 
individuele celkenmerken kort genoemd of wordt er naar verNezen. ZiJ ZiJn of 
te WiJten aan abnormaliteiten van het specifieke bloed110nster of aan gebreken 
of slecht funktioneren van de apparatuur. 
S 3.2 en Table I Cp. 34) vatten de methoden samen, die op de eerste 
plaats gericht ziJn op het voortdurend nagaan van de analytische precisie. 
Berekening van patientenMaarden speelt daarbiJ een belangriJke rol in 
kombinatie ~~et het gebruik van kontrole materialen. S 3.2 vernoemt ook de 
diverse wiJzen van aanpak van IKK, zoals gekozen in de dageliJkse routine, ten 
einde de ernstige ongemakken t. g. v. gebrek aan ref preparaten zo goed mogeliJk 
het hoofd te bieden. !Jking van instrumenten wordt in wezen op drie manieren 
benaderd : 
1. analyse van een groot aantal verse, normale bloedmonsters m. b. v. manuele 
of semi-automatische (digitalel technieken CVgl. H !Ill; 
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2. enkele herhalingen van nauwgezet u1tgevoerde manuele iJktechnieken; 
3. aanvaarding van opgegeven waarden van kommerciele IKK materialen a!s 
initiele ijkMaarden en vergeliJking van deze waarden met die van 
opgegeven waarden van andere IKK materialen en met die in een of meer EKV 
programma's. Hoelle! deze pragmatische benadering theoretisch aanvechtbaar 
is, MOrdt ZiJ ongetwiJfeld het meest frekwent gebruikt. Het geeft 
duideliJk het belang aan van pogingen tot ontwikkelir1g van 
waardentoekenningstechnieken door (interlnationale lichamen, zoals 
beschreven in S 3. 6. 
S 3.3 beschriJft de werkwiJzen die vereist MOrden in de dageliJkse 
routine, wil men LWHK in de analytische fase kunnen garanderen. 
In S 3.4 MOrden de funkties van EKV-programma' s genoemd. Fig. 3 (p. 
40) en Tabel II (p. 42l geven de grootteorde aan van de spreiding c.q. de 
variatiekoefficienten (DJ' sl van de verschillende parameters in de diverse 
programma's. ZiJ geven de stand van zaken in EKV in de hcie weer, waarop 
koamentaar wordt gegeven. Tenslotte worden enkele gebreken van EKV programma's 
besproken. 
In S 3.5 MOrden de analytische doelstellingen besproken. M. i. moet het 
laboratorium zo betrouwbaar mogeliJk (voor zover de kosten dit toelatenl 
kwantitatieve gegevens verschaffen, gegenereerd via obJektieve KB procedures. 
In S 3.6 MOrden de waardentoekenningsprocedures door (interlnationale 
lichamen besproken. ZiJ kampen met tl<ee hoofdproblemen : 
1. de fundamentele technologische problemen inherent aan telling en grootte-
vaststelling van deeltJes in het algemeen (Vgl. H IIIJ; 
2:. specifieke problemen t.g.v. de instabiliteit var1 bloedcellen, 
noodzakelijkerwiJS leidend tot het gebruik van celsubstituten. 
In de hematologie worden celtellingen, verricht door zgn. digitale 
instrumenten, b.v. een Coulter Counter ZBI, in het algemeen aanvaard als ref 
telmethode. Latex deeltJes, waarvan de grootte heel "Juist' (accuraatl kan 
MOrden vastgesteld m.b.v. lichtmicroscopie (Fig. 4, p. 47J, ziJn de meest 
veelbelovende celsubstituten. Er worden twee voorgestelde schema's genoemd 
voor het toekennen van waarden aan sekundaire ref materialen, waarbiJ vers 
bloed als intermedium wordt gebruikt (Fig. 5, p. 47 en Tabel III, p. 49l. 
In S 3. 7 MOrdt gepleit voor het handhaven van de alledaagse 
praktijkgewoonte om in eerste instantie IKK materialen te gebruiken voor. 
i.J!\doeleinden. Er wordt beargumenteerd dat theoretische bezwarer, teger' deze 
praktiJk zeer we! te niet gedaan zouden kunnen worden door toepassir1g van het 
onlangs beschreven BCSH-protokol (p. 49) voor het toeker,ner, van waarden aan 
IKK materialen. Dit zou evenwel intensieve regionale of nationale samenwerking 
vereisen. 
S 4 benadrukt het be lang var, de postanalytische fase door het ci teren 
van het theorema van La Rochefoucauld, "het is niet voldoende om een goede 
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kwaliteit te hebben, men moet er ook een goed gebruik van maken". Het spreekt 
vanzel f, dat adekwate administratie, rapportage en kommunikatie tussen 
laboratorium en medikus alle biJdragen tot dit "goede gebruik" van de waarden 
van 'goede kwaliteit', waar tot nu toe naar gestreefd Nerd. Met name de 
interpretatie van waarden is biJzonder belangriJk in dit opzicht. Daarom wordt 
in 5 4.2 ingegaan op verschi!lende aspekten van de ir.terpretatie en betekenis 
van hcie waarden; met name de betekenis van opvolgende tellir.gen, ref waarden 
en de klinische efficientie oorden vriJ uitgebreid besproken. 
Tenslotte worden in 5 5 in het kort enkele aspekten van kosten en KB 
genoemd. Een van de doelste!lingen van KB behoort te ziJn het terugbrer•gen van 
kosten in de gezondheidszorg d.m. v. adekwate aanvrager. van laboratorium 
b2Palingen. 
H Ill (p. 62 - p. lOll bespreekt de FUNDiliiENTELE PRJNCIPE5 EN 
PROBLEMEN VAN DE HEJIIOCYTOIIETRJE. Na een korte inleiding in 5 1, behandelt S 2 
de manuele hcie. 
In 5 2.1 wordt beargumenteerd waarom telkamers waarschiJnliJk nooit 
geschikt worden voor iJkdoeleinden. 
S 2. 2 somt de voor- en nadelen op van de door de ICSH aanbevoler. Hb-
bepaling. De voordelen van een onlangs beschreven alternatieve Hb-methode 
worden in het kort genoemd. 
S 2.3 behandelt uitvoerig de centrifugale (cf) Hematocriet (Hct; dit 
is het volume van de rode bloedcellen als percentage van het totale bloed 
volume). In S 2.3.1 wordt de MikroHct (Mhctl methode aanbevoler. als een 
potentiele routine iJkmethode, in tegenstelling tot de officiele l~kro 
(ref) methode. InS 2.3.2 wordt kommnentaar gegeven op de cf Hct van normaal 
bloed; hiJ wordt aanbevolen als een intermedium voor waardentoeker,.ing aan 
iJkmaterialen voor automatische bloedcelmeters. S 2. 3. 3 beschriJft dat het 
percentage ingesloten plasma biJ de cf ~hct van normale er. zelfs van 
pathologische bloedmonsters varieren van 1.18 tot 2.25 ~. mits de Mhct wordt 
uitgevoerd biJ 13.000 x g gedurende tien minuten. Deze percentages ziJn 
signifikant lager dan die opgegeven in vroegere publikaties. Er worden 
diskrepanties beschreven tussen de cf Hct en de Hct verricht met automatische 
bloedcelmeters (zgn 'flow hcie Hct"l biJ pathologische bloedmonsters; deze 
kunnen of te wiJten ZiJn aan afwiJkingen van de normale vervormbaarheid van 
rode bloedcellen (rbc) of aan hyperosmolair plasma. Tenslotte wordt gesteld 
dat de diagnostische waarde van MCHC (de g~iddelde tib ~ncentratie per rode 
bloed~l, ziJnde de verhouding tussen het Hb en de Hctl verwaarloosbaar is 
vanwege ziJn ongevoeligheid voor de kenmerken van pathologische rbc. In S 
2.3.4 110rdt kommentaar gegeven op de vaak ernstige diskrepanties tussen de 
Mhct en de "flow hcie" Hct van kunstmatige bloedmonsters. 
S 3 behandelt de grondbeginselen en de problemen van de zgn flow hcie 
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(meting van bloedcellen in een vloeistofstroom, zoals algemeen toegepast biJ 
automatische bloedcelmeters, te noemen fl011 hemocytometers of fl011 hcie 
instrumentenl. In de Inleiding (S 3.1l en in S 3.2 worden fl011 hcie 
instrumenten geklassificeerd in analoge en digitale instrumenten aan de ene 
kant en elektrische (apertuur-impedantiel en optische (licht-verstrooiingsl 
instrumenten aan de andere kant. S 3.3 weidt uit over de hydrodynamische 
eigenschappen van flow hcie instrumenten. In S 3.3.1 wordt de vloeistofstroom 
in de meetopeningen (aperturenl besproken. In S 3.3.2 worden fundamentele 
hydrodynamische en elektronische verbeteringen besproken die celanalyses van 
hoog oplossend vermogen mogeliJk maken : (2 typenl hydrodynamische 
focuser1ng, signaalbetoerking ('pulse editing") en de zgn "sweep flow' worden 
behandeld. S 3.4 bestudeert de elektrische (apertuur-impedantiel hcie, zoals 
als eerste toegepast in zgn Coulter Counter instrumenten. Na een inleiding (5 
3. 4.1) worden enkele aspekten van het tell en van bloedcellen, met speciale 
nadruk op de te!Juistheid, beschreven in S 3.4.2. De groottebepaling van 
bloedcellen wordt behandeld in S 3.4.3. Na een basale inleiding tot de theorie 
van groottebepalingen (S 3.4.3.!) worden de belangriJke vormfaktor en de door 
de (vloeistoflstroom te~~eeggebrachte veranderinoen in celvormen beschreven in 
de volgende (sublsekties. ZiJ kunnen een belangriJke invloed hebben op de 
JUistheid van de groottebepaling van rbc ·(MCV, dit is het g~iddelde rode ~! 
Yolumel in pathologisch bloed en dientengevolge op de Hct en de MCHC !Vgl S 
2.3.3). Samenvattend is de konklusie dat biJ groottebepalingen m.b.v. 
impedantie de MeV en de Hct (foutiefl extremer gevonden zullen worden dan de 
'ware extreme waarde' aan beide extreme ziJden van het gemiddelde, terwiJl de 
MCHC daarentegen (dientengevolge) foutief "afgestompt' 110rdt, leidend tot een 
foutieve konstantheid !Vgl S 2.3.3, p. 68 en Fig. 6, p. 55l. RDW (de Bode eel 
~istributie breedte of ~iJdtel, een kwantitatief analogon van de anisocytose 
(d.i. rode cellen van abnormaal-ongeliJke groottel kan de klassifikatie van 
anemieen (vormen van bloedarmoedel verbeterer.. Er kan echter aanmerkeliJke 
verwarring ontstaan door de verschillende, bestaande RDw-definities, zelfs 
tussen de verschillende modellen Coulter Counters. Rbc-histogrammen kunnen in 
plaats van de RDW gebruikt MOrden ten einde eventuele verwarring te vermiJden. 
S 3.4.3.5 legt in het kort de nadruk op de belangriJkste aspekten van de 
groottebepaling van bloedplaatJes !pltl, zoals de invloed van anticoagulantia 
en de temperatuur Dp vormveranderingen en de MPV (g~iddelde ~It ~olumel; plt 
distributie en PDW !Elt ~istributie ~iJdtel; omgekeerde, niet-lineaire relatie 
tussen MP\1 en het aantal plt. Tens!Dtte 110rdt een pleidooi gehouden voor 
strikte standaardisatie van de bereiding van PlaatJes-RiJk-Plasma. S 3.4.3.6 
behandelt de gedeelteliJke witte bloedcel !•bel differentiatie, ze<als te<t 
stand gebracht in Coulter Coulters. Er worden in de literatuur goede 
korreiaties beschreven tussen Coulter waarden en die van verschillende andere 
methoden. De nadruk wordt gelegd op het belang van adekwate wbc-
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drespelinstelling ten einde • Juiste' (accurate) wbc tellingen, 
groottebepa!ingen en gedeelteliJke differentiatie te kunnen garanderen. 
Tenslotte MOrden in het kort in S 3.5 enkele spedale kenmerken van de 
optische Hicht-verstrooiings) hcie besproken. Deze kunnen o.a. i'ICV (Hct, 
IIOJC) waarden opleveren, die afwiJken van die gemeten in apertuur-impedantie 
tellers. 
H IV beschriJft de BEREIDIN6 EN EVlll.liATIE VAN !N'!ERNE 
KWAI..ITEITSKONTROLE i'IATERIALEN VOOR FLOW HEJIIIJCYTOIIETRIE. Uitsluitend bloed, in 
het algemeen alleen menseliJk bloed, is geschikt als potentieel kontrole (en 
iJk) IBateriaal voor bloedceltellers. Het is echter wegens ziJn instabiliteit 
slechts ongeveer twee dagen als zodanig geschikt. In dit H worden 
bereidingsmethoden beschreven om bloed en/of bepaalde bloedkomponenten een 
aantal maanden geschikt te houden als IKK-materiaa!. Het voork6men van 
zwelling (MCV-vergroting) en van het stukgaan van rbc' (hemolysel is daarbiJ 
een van de grootste opgaven. Het hemolyseprobleem is groter gebleken voor 
optische dan voor elektrische bloedceltellers, daar de laatste vee! minder 
gevoelig ziJn voor hemolyse. Voor een meer gedetailleerde samenvatting van dit 
H wordt om praktische redenen verwezen naar ziJn (Engelstalige) voorwoord (p. 
100) en naar de samenvattingen van de individuele (Engelstalige) Sekties. 
H V bestaat ui t de Slli'IENVATIINS EN KONKLUSIES. 
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NAWOORD EN DANKBETUIGING 
(epilogue and acknowledgements) 
De problematiek van de kwaliteitsbewaking 
van bloedceltellers wordt in ons laboratoriurn 
dagelijks in de praktijk gevoeld sinds de komst 
van de Coulter Counter Model S in september 
1972. Een gedeelte van de fundamenten van het 
hier beschreven onderzoek stamt dan ook al 
vanaf die tijd. Jarenlang hebben we over een 
vrij efficient kwaliteitskontrole systeem 
kunnen beschikken door tegen lage kosten zelf 
voldoende kontrolemateriaal te bereiden, uit-
gaande van verlopen transfusiebloed. De 
storende, technische onvolkomenheden van dit 
rnateriaal, alsmede de steeds hogere eisen die 
de nieuwere generatie celtellers aan kontrole 
materialen stelden, schreeuwden a.h.w. om 
vervolmaking daarvan. In maart 1980 werd dan 
ook hiermee begonnen, ditrnaal met de bedoeling 
de eventuele resultaten in een proefschift neer 
te leggen. Velen zijn mij daarbij tot onmisbare 
steun geweest. 
Allereerst m~Jn promotor, Prof. Dr. 
B.Leijnse, die sindsdien in ontelbare, urenlan-
ge besprekingen het onderzoek heeft begeleid en 
met zijn grote interesse en zijn fundamentele 
benadering wezenlijke bijdragen heeft geleverd 
tot de totstandkoming en kwaliteit van dit 
geschrift. U was voor mij een baken in zee in 
de moeizame en eenzame strijd tegen de bloed-
elementen. Het verheugt mij dan ook zeer uit-
eindelijk vele publikaties met U te hebben 
mogen verrichten. Uw stiptheid heb ik als aan-
genaam en uiterst belangrijk ervaren, speciaal 
voor een promovendus-op-afstand. Dit alles 
maakte U tot een voor m~J ideale promotor, 
waarvoor ik u zeer erkentelijk blijf. 
zeer veel dank ben ik ook verschuldigd 
aan mijn naaste kollega, Dr.A.L.Koevoet, Hoofd 
van het Centraal Klinisch Chemisch Laboratorium 
van het Leyenburg Ziekenhuis, voor de gelegen-
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heid die hij mij geboden heeft dit proefschrift 
te bewerken, maar vooral voor de ontelbare 
prive-uren die hij daadwerkelijk heeft besteed 
aan de totstandkoming ervan m.b.v. zijn KAYPRO 
800 microcomputer. Ik realiseer me hoeveel 
tijd en inspanning je dit gekost meet hebben; 
ik zal dit nooit vergeten. 
Gaarne zou ik ook Prof.Dr.J.Abels, Prof. 
Dr.H.G. van Eijk en Prof.Dr.J.B.J.Soons willen 
danken voor hun bereidheid zitting te nemen in 
de promotiecornmissie en voor al hun daaruit 
voortvloeiende werkzaamheden. 
Dank ben ik zeker ook verschuldigd aan 
Dr.J.Bender, chirurg, voor bet ontsteken en 
aanwakkeren van de promotievlam. Ik stel bet 
zeer op pr~JS, dat hij en mijn <studielvriend-
van-het-eerste-uur, Drs.E.K.A.Winckers, m~Jn 
paranimfen willen zijn. Ook Dr.J.C.M. van der 
Vijver, internist, wil ik danken voor de morele 
steun. 
De hulp van Jhr.Dr.J.A. van der Does en 
van de beer J.K.Jagdewsing, resp. direkteur en 
hoofdanalist van de bloedbank "' s-Gravenhage en 
omstreken" wil ik in dank memoreren. 
Dr.M.S.Harvey (Academisch Ziekenhuis, 
Leiden), as a tribute to you I prefer to 
acknowledge you in your mother tongue for your 
willingness to correct the greater part of my 
manuscript. This thesis, dealing with quality 
assurance, equally demands for quality of the 
vehicle of modern <technological) 
communication, the English language. 
Zender de gastvrijheid en de bereidwil-
lige en aktieve medewerking van Dr.H.Goslinga, 
anesthesist, en Ing.J.H.A.Heuvelmans <St.Lucas 
Ziekenhuis, Amsterdam) was bet artikel over bet 
rheologische gedrag van bloedmonsters (p. 152) 
nooit "geworden". Mijn grote dank voor de pu-
blikatie die uit onze samenwerking heeft kunnen 
ontstaan. 
Dr.P.F.H.Franck, biochemisch laboratorium 
Utrecht, was onmiddellijk bereid de fosfo-
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lipiden- en vetzuursamenstelling van de rode-
celmembranen van onze kontrolematerialen te 
onderzoeken. Dergelijke analyses dragen 
fundamenteel bij tot de verdieping van het 
inzicht in deze belangrijke materie. Ook u wil 
ik gaarne danken voor uw belangeloze 
medewerking. 
Zeer vele anderen hebben bijgedragen tot 
dit proefschrift. Vele kollega's (en/of hun 
medewerkers) hebben mij met raad en/of daad of 
anderszins bijgestaan, met name zou ik m~Jn 
dank willen uitspreken jegens : Drs. H.A.Assink 
<Wilhelhelmina Ziekenhuis, Assenl;Dr.F.A.J.T.M. 
van den Bergh, Drs.F.M.F.G.Olthuis en 
Drs.R.H.M.Peters (Ziekenhuis de Stadsmaten, 
Enschedel; Dr.I.C.Dijkhuis (Apotheek Haagse 
Ziekenhuizenl en Ir.N.C. den Boer, Dr.G.J.M. 
Boerma en Dr.R.F.A.Weber (Academisch Zieken-
huis, Rotterdam). 
Ook in het Ziekenhuis Leyenburg zijn 
velen mij terwille geweest, waarvan ik enkelen 
met name zou willen noemen. Ons onvolprezen 
"trouble-shoot-team" o.l .. v. de heer P. van der 
Harst zorgde steeds voor een perfekt 
funktionerend meetinstrument. De heren C.A. van 
Beek en A. van Tiel hebben m~J steeds op 
bijzonder prettige wijze bijgestaan met hun 
tekenkundig en fotografisch werk. 
De raadgevende en bemiddelende rol van de 
heer A.J. van Gerrevink, afdeling inkoop van de 
Apotheek Haagse Ziekenhuizen, wil ik ook in 
dankbaarheid vermelden. 
Gaarne wil ik alle naaste familieleden en 
vrienden, die mogelijk onder onze langdurige 
afwezigheid hebben geleden, danken. 
Tenslotte zou ik mijn moeder, nu ik mijn 
akademische studie hiermede officieel afsluit, 
nogmaals zeer willen danken voor de gelegenheid 
die ze mij onder moeilijke omstandigheden heeft 
geboden om te studeren. 
En, "lest best", mijn vrouw Diane. Zender 
jouw jarenlange, dagelijkse steun in moreel en 
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organisatorisch opzicht zou ik de enorme hoe-
veelheid werk die dit proefschrift met zich 
heeft meegebracht nooit hebben kunnen verrich-
ten. Ook het in leesbare vorm omzetten van al 
ID1Jn "hierogliefen" heeft je veel tijd gekost. 
Dit werk is in vele opzichten ons werk. 
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CURRICULUM VITAE 
De schrijver van dit proefschrift is 
geboren op 12 juni 1938 in Zundert (NB). 
Op het St.Norbertuslyceum te Roosendaal 
(1950-1953) en op het O.L.Vrouwelyceum te Breda 
(1953-1956) volgde hij het Gymnasium-B. 
Hij studeerde Farmacie aan de 
RijksUniversiteit te Utrecht (Prof. Dr. J.A.C. 
van Pinxterenl in de jaren 1956-1966 met als 
hoofdvak farmaceutische en als bijvak 
biochemische analyse (verricht bij het 
toenmalige Philips- Duphar te Weespl. Zijn 
doktoraalskriptie handelde over "struktuur-wer-
kingsrelaties van coca- en tropa-alkaloiden". 
In 1967-1968 vervu1de hij zijn mi1itaire 
dienstp1icht, waarvan 1 jaar a1s hoofd van de 
Apotheek van het voorma1ig Mi1itair Hospitaa1 
te 's-Gravenhage. In 1968-1971 specia1iseerde 
hij zich in de k1inische chemie in het 
St.Canisius Ziekenhuis te Nijmegen <Drs. 
H.J.Petersl. Sinds eind 1971 is hij werkzaam op 
het Centraa1 K1inisch Chemisch Laboratorium van 
het Leyenburg Ziekenhuis te 's-Gravenhage, 
a1waar dit proefschrift werd bewerkt. 
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